Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	json	split
ARU encodes the OST3 / 6 subunit of the hetero - oligomeric plant oligosaccharyltransferase complex ( OST ), which catalyses the co - or posttranslational transfer of pre - assembled carbohydrate oligomers ( Glc3Man9GlcNAc2) to asparagine ( N) residues of polypeptides43. N - glycosylation affects the substrate protein ' s folding, targeting, and / or processing through the ER.	ARU,0,3,Gene/Protein	OST3,16,20,Gene/Protein	plant,60,65,Organism/Species	oligosaccharyltransferase,66,91,Gene/Protein	OST,102,105,Gene/Protein	carbohydrate,183,195,Chemical/Drug	asparagine,228,238,Chemical/Drug	"[{""token"": ""ARU"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""OST3"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""plant"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""oligosaccharyltransferase"", ""start_span"": 66, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""OST"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""carbohydrate"", ""start_span"": 183, ""end_span"": 195, ""type"": ""Chemical/Drug""}, {""token"": ""asparagine"", ""start_span"": 228, ""end_span"": 238, ""type"": ""Chemical/Drug""}]"	test
All fusion proteins displayed a wild - type - like subcellular localization in the synergids of aru embryo sacs: FER - GFP and LRE - Citrine were observed at the micropylar end of the synergids, and NTA - GFP was re - localized there upon PT arrival ( Supplementary Fig. 10 ).	aru,96,99,Gene/Protein	FER,113,116,Gene/Protein	GFP,119,122,Gene/Protein	LRE,127,130,Gene/Protein	Citrine,133,140,Gene/Protein	NTA,199,202,Gene/Protein	GFP,205,208,Gene/Protein	"[{""token"": ""aru"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""FER"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""LRE"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Citrine"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""NTA"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	test
The resulting vectors, pFER :: ARU - GFP and pMYB98 :: ARU - GFP were transformed into Agrobacterium tumefaciens strain CV1310, and homozygous aru - 1 plants were transformed by the floral dip method57.	ARU,31,34,Gene/Protein	GFP,37,40,Gene/Protein	ARU,55,58,Gene/Protein	GFP,61,64,Gene/Protein	Agrobacterium tumefaciens strain CV1310,87,126,Organism/Species	aru - 1,143,150,Gene/Protein	plants,151,157,Organism/Species	"[{""token"": ""ARU"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""Agrobacterium tumefaciens strain CV1310"", ""start_span"": 87, ""end_span"": 126, ""type"": ""Organism/Species""}, {""token"": ""aru - 1"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Organism/Species""}]"	test
By cutting this vector with HpaI and BamHI, part of the ARU coding sequence and the downstream sequence were removed and replaced with the respective fragment of ARU coupled to GFP - tNOS, resulting in pARU ( 1, 492 bp ):: ARU - GFP, which was transformed into Col - 0.	HpaI,28,32,Gene/Protein	BamHI,37,42,Gene/Protein	ARU,56,59,Gene/Protein	ARU,162,165,Gene/Protein	GFP,177,180,Gene/Protein	ARU,203,206,Gene/Protein	GFP,229,232,Gene/Protein	"[{""token"": ""HpaI"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""BamHI"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 229, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	test
The survival effect of S100A8 / 9 involves the MEK - ERK signaling pathway, and is partially mediated through TLR4 and the integrin CD11b / CD18	S100A8,23,29,Gene/Protein	MEK,47,50,Gene/Protein	ERK,53,56,Gene/Protein	TLR4,110,114,Gene/Protein	integrin,123,131,Gene/Protein	CD11b,132,137,Gene/Protein	CD18,140,144,Gene/Protein	"[{""token"": ""S100A8"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""MEK"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""integrin"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	test
Furthermore, the inhibitor PD98059 ( MEK inhibitor) reduced ERK phosphorylation by more than 50% ( Fig. 6B) and abolished the S100A8 / 9 survival effect by 50 − 100% at various concentrations ( Fig. 6C ), suggesting that the S100A8 / 9 complex survival effect involves the MEK - ERK signaling pathway.	PD98059,27,34,Chemical/Drug	MEK,37,40,Gene/Protein	ERK,60,63,Gene/Protein	S100A8,126,132,Gene/Protein	S100A8,225,231,Gene/Protein	MEK,273,276,Gene/Protein	ERK,279,282,Gene/Protein	"[{""token"": ""PD98059"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""MEK"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 225, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""MEK"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 279, ""end_span"": 282, ""type"": ""Gene/Protein""}]"	test
Apoptosis - related proteins during spontaneous constitutive PCD in the presence of S100A8 / 9. SDS - PAGE of McL1, Bcl - xl, A1, Bcl2, and survivin in spontaneous constitutive apoptosis, with and without addition of S100A8 / 9.	S100A8,84,90,Gene/Protein	McL1,110,114,Gene/Protein	Bcl - xl,116,124,Gene/Protein	A1,126,128,Gene/Protein	Bcl2,130,134,Gene/Protein	survivin,140,148,Gene/Protein	S100A8,217,223,Gene/Protein	"[{""token"": ""S100A8"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""McL1"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - xl"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""A1"", ""start_span"": 126, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Bcl2"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""survivin"", ""start_span"": 140, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 217, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	test
The complications they cause such as learning disorders, memory - formation deficits and epilepsy, have profound effects on patients ' daily life. 1, 2 Numerous gene mutations are involved in these pathologies, including genes associated with postsynaptic components. 3, 4 Moreover, recent studies provide increasing evidence of the importance of epigenetic mechanisms in the underlying pathobiology, 5 and mutations of genes involved in epigenetic regulation are found in patients with neurodevelopmental disorders. 6, 7 In addition, recent report suggests that several histone - modification genes, including both histone methyltransferases and demethylases, are causative risk genes for such disorders. 8 Nevertheless, our knowledge of the involvement of histone modifications in neurodevelopmental disorders is limited.	epilepsy,89,97,Disease/Disorder	neurodevelopmental disorders,487,515,Disease/Disorder	histone,571,578,Gene/Protein	histone methyltransferases,616,642,Gene/Protein	demethylases,647,659,Gene/Protein	histone,758,765,Gene/Protein	neurodevelopmental disorders,783,811,Disease/Disorder	"[{""token"": ""epilepsy"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""neurodevelopmental disorders"", ""start_span"": 487, ""end_span"": 515, ""type"": ""Disease/Disorder""}, {""token"": ""histone"", ""start_span"": 571, ""end_span"": 578, ""type"": ""Gene/Protein""}, {""token"": ""histone methyltransferases"", ""start_span"": 616, ""end_span"": 642, ""type"": ""Gene/Protein""}, {""token"": ""demethylases"", ""start_span"": 647, ""end_span"": 659, ""type"": ""Gene/Protein""}, {""token"": ""histone"", ""start_span"": 758, ""end_span"": 765, ""type"": ""Gene/Protein""}, {""token"": ""neurodevelopmental disorders"", ""start_span"": 783, ""end_span"": 811, ""type"": ""Disease/Disorder""}]"	test
Next, sections were incubated with NeuN ( anti - mouse NeuN 1: 100 MAB377, Millipore, Darmstadt, Germany) or GFAP ( anti - mouse GFAP 1: 500, sc58766, Santa Cruz Biotechnology, Dallas, TX, USA) antibodies diluted in PBS overnight at 4 ° C followed by washing with PBS three times at room temperature.	NeuN,35,39,Gene/Protein	mouse,49,54,Organism/Species	NeuN,55,59,Gene/Protein	GFAP,109,113,Gene/Protein	mouse,123,128,Organism/Species	GFAP,129,133,Gene/Protein	sc58766,142,149,Chemical/Drug	"[{""token"": ""NeuN"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism/Species""}, {""token"": ""NeuN"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""GFAP"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""GFAP"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""sc58766"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Chemical/Drug""}]"	test
The membrane was blocked with 5% not - fat dry milk in PBS containing 0. 05% tween - 20 ( PBS - T) and incubated for 1 h at room temperature or overnight at 4 ° C, with PSD95 antibody ( anti - mouse PSD95 1: 500, MA1 - 046, Thermo Scientific, Waltham, MA, USA) or GAPDH antibody ( anti - rabbit GAPDH 1: 1000, sc - 25778, Santa Cruz Biotechnology) diluted in PBS - T containing 1% non - fat dry milk.	tween - 20,77,87,Chemical/Drug	PSD95,169,174,Gene/Protein	mouse,193,198,Organism/Species	PSD95,199,204,Gene/Protein	GAPDH,264,269,Gene/Protein	rabbit,288,294,Organism/Species	GAPDH,295,300,Gene/Protein	"[{""token"": ""tween - 20"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""PSD95"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 193, ""end_span"": 198, ""type"": ""Organism/Species""}, {""token"": ""PSD95"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""GAPDH"", ""start_span"": 264, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 288, ""end_span"": 294, ""type"": ""Organism/Species""}, {""token"": ""GAPDH"", ""start_span"": 295, ""end_span"": 300, ""type"": ""Gene/Protein""}]"	test
These included meeting DSM - IV criteria for PTSD, aspects of comorbidity ( current substance abuse, suicidal ideation, axis 1 disorder other than anxiety or mood disorder, comorbid personality disorder, chronic pain, physical disability due to the trauma, history of major depression ), taking psychotropic medication, and a higher level of education.	PTSD,45,49,Disease/Disorder	substance abuse,84,99,Disease/Disorder	axis 1 disorder,120,135,Disease/Disorder	anxiety,147,154,Disease/Disorder	mood disorder,158,171,Disease/Disorder	personality disorder,182,202,Disease/Disorder	major depression,268,284,Disease/Disorder	"[{""token"": ""PTSD"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""substance abuse"", ""start_span"": 84, ""end_span"": 99, ""type"": ""Disease/Disorder""}, {""token"": ""axis 1 disorder"", ""start_span"": 120, ""end_span"": 135, ""type"": ""Disease/Disorder""}, {""token"": ""anxiety"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Disease/Disorder""}, {""token"": ""mood disorder"", ""start_span"": 158, ""end_span"": 171, ""type"": ""Disease/Disorder""}, {""token"": ""personality disorder"", ""start_span"": 182, ""end_span"": 202, ""type"": ""Disease/Disorder""}, {""token"": ""major depression"", ""start_span"": 268, ""end_span"": 284, ""type"": ""Disease/Disorder""}]"	test
To focus on genes that are truly relevant to encephalitogenicity and not simply involved in general inflammatory responses, we compared gene arrays of LEW. 1AV1 ( RT1av1) rats immunized with the encephalitogenic MOG stretch MOG 91 - 108 to naive LEW. 1AV1 ( RT1av1) rats and rats immunized with the adjuvant CFA alone as well as rats immunized with the non - encephalitogenic MOG 73 - 90 determinant.	rats,171,175,Organism/Species	MOG,212,215,Gene/Protein	MOG,224,227,Gene/Protein	rats,266,270,Organism/Species	rats,275,279,Organism/Species	rats,329,333,Organism/Species	MOG,376,379,Gene/Protein	"[{""token"": ""rats"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Organism/Species""}, {""token"": ""MOG"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 266, ""end_span"": 270, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 275, ""end_span"": 279, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 329, ""end_span"": 333, ""type"": ""Organism/Species""}, {""token"": ""MOG"", ""start_span"": 376, ""end_span"": 379, ""type"": ""Gene/Protein""}]"	test
( B) Quantitative expression of Cxcr4 in cells eluted from the CNS of CFA ( white bars, n = 6 )-, MOG 73 - 90 in CFA ( gray bars, n = 6 )- and MOG 91 - 108 in CFA ( n = 6 )- immunized LEW. 1AV1 ( RT1av1) rats. Cxcr4 was upregulated in MOG 91 - 108 in CFA - immunized rats compared to the other groups ( ANOVA, * P < 0. 001) on day 12 p. i.	Cxcr4,32,37,Gene/Protein	MOG,98,101,Gene/Protein	MOG,143,146,Gene/Protein	rats,204,208,Organism/Species	Cxcr4,210,215,Gene/Protein	MOG,235,238,Gene/Protein	rats,267,271,Organism/Species	"[{""token"": ""Cxcr4"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Organism/Species""}, {""token"": ""Cxcr4"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 235, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 267, ""end_span"": 271, ""type"": ""Organism/Species""}]"	test
( C) Quantitative expression of Cd38 of lymphocytes eluted from the CNS of CFA ( white bars, n = 6 )-, MOG 73 - 90 in CFA ( gray bars, n = 6 )- and MOG 91 - 108 in CFA ( n = 6 )- immunized LEW. 1AV1 ( RT1av1) rats on day 12 p. i. Cd38 was upregulated in MOG 91 - 108 in CFA - immunized rats compared to the other groups ( ANOVA, * P < 0. 001 ).	Cd38,32,36,Gene/Protein	MOG,103,106,Gene/Protein	MOG,148,151,Gene/Protein	rats,209,213,Organism/Species	Cd38,230,234,Gene/Protein	MOG,254,257,Gene/Protein	rats,286,290,Organism/Species	"[{""token"": ""Cd38"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Organism/Species""}, {""token"": ""Cd38"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 254, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 286, ""end_span"": 290, ""type"": ""Organism/Species""}]"	test
Upregulation of both Cxcl12 and Cxcr4 mRNA expression was observed in CFA - and MOG 1 - 125 in CFA - immunized DA ( RT1av1) rats in spinal cord compared to naive rats, IFA - injected or MOG 1 - 125 in IFA - immunized DA ( RT1av1) rats ( ANOVA, P < 0. 001 ).	Cxcl12,21,27,Gene/Protein	Cxcr4,32,37,Gene/Protein	MOG,80,83,Gene/Protein	rats,124,128,Organism/Species	rats,162,166,Organism/Species	MOG,186,189,Gene/Protein	rats,230,234,Organism/Species	"[{""token"": ""Cxcl12"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""Cxcr4"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Organism/Species""}, {""token"": ""MOG"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Organism/Species""}]"	test
( D) Expression of S1p1 ( Edg1 ), Akt2, Cxcr4 and Cd38 was assessed in FTY720 - treated rats ( white bars, n = 9) compared to vehicle - treated controls ( black bars, n = 9) by quantitative PCR.	S1p1,19,23,Gene/Protein	Edg1,26,30,Gene/Protein	Akt2,34,38,Gene/Protein	Cxcr4,40,45,Gene/Protein	Cd38,50,54,Gene/Protein	FTY720,71,77,Chemical/Drug	rats,88,92,Organism/Species	"[{""token"": ""S1p1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Edg1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Akt2"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Cxcr4"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Cd38"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""FTY720"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Organism/Species""}]"	test
FITC - conjugated monoclonal antibody ( mAb) against CD45RA ( OX - 33) and TCRAB ( R73) and phycoerythrin ( PE )- conjugated mAb against CD4 ( OX - 35) and MHC II ( OX - 6) and appropriate isotype controls were purchased from Becton Dickinson ( Heidelberg, Germany ).	antibody,29,37,Gene/Protein	CD45RA,53,59,Gene/Protein	TCRAB,75,80,Gene/Protein	phycoerythrin,92,105,Gene/Protein	PE,108,110,Gene/Protein	CD4,137,140,Gene/Protein	MHC II,156,162,Gene/Protein	"[{""token"": ""antibody"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""CD45RA"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""TCRAB"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""phycoerythrin"", ""start_span"": 92, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 108, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""MHC II"", ""start_span"": 156, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	test
For each gene, the wild - type ( WT) genomic locus was targeted with a replacement plasmid containing 5 ′ and 3 ′ regions of PUF1 or PUF2 and a positive selectable marker, Toxoplasma gondii dhfr / ts or human DHFR, respectively.	PUF1,125,129,Gene/Protein	PUF2,133,137,Gene/Protein	Toxoplasma gondii,172,189,Organism/Species	dhfr,190,194,Gene/Protein	ts,197,199,Gene/Protein	human,203,208,Organism/Species	DHFR,209,213,Gene/Protein	"[{""token"": ""PUF1"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""PUF2"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Toxoplasma gondii"", ""start_span"": 172, ""end_span"": 189, ""type"": ""Organism/Species""}, {""token"": ""dhfr"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""ts"", ""start_span"": 197, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 203, ""end_span"": 208, ""type"": ""Organism/Species""}, {""token"": ""DHFR"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	test
( C) Confocal microscopy analysis of HepG2 cells cultured for 5 and 24 hours post - infection ( p. i .) with WT, puf1 (-) or puf2 (-) sporozoites, using antibodies against UIS4 ( red ), CSP ( 5 h p. i ., green) or HSP70 ( 24 h p. i ., green ).	infection,84,93,Disease/Disorder	puf1,113,117,Gene/Protein	puf2,125,129,Gene/Protein	antibodies,153,163,Gene/Protein	UIS4,172,176,Gene/Protein	CSP,186,189,Gene/Protein	HSP70,214,219,Gene/Protein	"[{""token"": ""infection"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Disease/Disorder""}, {""token"": ""puf1"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""puf2"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 153, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""UIS4"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""CSP"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""HSP70"", ""start_span"": 214, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	test
The founding member of the Puf family, Drosophila melanogaster Pumilio ( DmPUM ), regulates, amongst other functions, abdominal development in the fly via translational repression of the maternally inherited hunchback ( hb) mRNA [ 34 ].	Puf,27,30,Gene/Protein	Drosophila melanogaster,39,62,Organism/Species	Pumilio,63,70,Gene/Protein	DmPUM,73,78,Gene/Protein	fly,147,150,Organism/Species	hunchback,208,217,Gene/Protein	hb,220,222,Gene/Protein	"[{""token"": ""Puf"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Drosophila melanogaster"", ""start_span"": 39, ""end_span"": 62, ""type"": ""Organism/Species""}, {""token"": ""Pumilio"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""DmPUM"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""fly"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Organism/Species""}, {""token"": ""hunchback"", ""start_span"": 208, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""hb"", ""start_span"": 220, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	test
While Puf1 in principle might be able to functionally complement for Puf2 function, depletion of Puf1 at the mRNA level precludes a hypothetical functional overlap in vivo. In this regard, it should be noted that P. berghei Puf1 and Puf2 proteins are very different in size ( 1183 versus 477 amino acids, respectively ), and share only little homology (∼ 27% identity) restricted to the Puf domains.	Puf1,6,10,Gene/Protein	Puf2,69,73,Gene/Protein	Puf1,97,101,Gene/Protein	Puf1,224,228,Gene/Protein	Puf2,233,237,Gene/Protein	amino acids,292,303,Chemical/Drug	Puf,387,390,Gene/Protein	"[{""token"": ""Puf1"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""Puf2"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Puf1"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Puf1"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""Puf2"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""amino acids"", ""start_span"": 292, ""end_span"": 303, ""type"": ""Chemical/Drug""}, {""token"": ""Puf"", ""start_span"": 387, ""end_span"": 390, ""type"": ""Gene/Protein""}]"	test
Strains of P. aeruginosa are ubiquitously present in the environment [ 1 ], which is due to their capacity to colonize different ecological niches [ 2 ], [ 3] and metabolic versatility [ 4 ]. P. aeruginosa is an opportunistic pathogen able to infect different animals and plants [ 5 ], [ 6 ], being a frequent cause of hospital - acquired infections including ventilator associated pneumonia [ 7] and catheter infections in immuno - compromised patients. P. aeruginosa lung infections are the main cause of morbidity and mortality in cystic fibrosis ( CF) patients [ 8 ].	animals,260,267,Organism/Species	plants,272,278,Organism/Species	hospital - acquired infections,319,349,Disease/Disorder	ventilator associated pneumonia,360,391,Disease/Disorder	catheter infections,401,420,Disease/Disorder	cystic fibrosis,534,549,Disease/Disorder	CF,552,554,Disease/Disorder	"[{""token"": ""animals"", ""start_span"": 260, ""end_span"": 267, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 272, ""end_span"": 278, ""type"": ""Organism/Species""}, {""token"": ""hospital - acquired infections"", ""start_span"": 319, ""end_span"": 349, ""type"": ""Disease/Disorder""}, {""token"": ""ventilator associated pneumonia"", ""start_span"": 360, ""end_span"": 391, ""type"": ""Disease/Disorder""}, {""token"": ""catheter infections"", ""start_span"": 401, ""end_span"": 420, ""type"": ""Disease/Disorder""}, {""token"": ""cystic fibrosis"", ""start_span"": 534, ""end_span"": 549, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 552, ""end_span"": 554, ""type"": ""Disease/Disorder""}]"	test
Inulin and FOS are considered prebiotics, based on the observation that they promote the growth of certain beneficial gut bacteria such as bifidobacteria [ 30 ], [ 31 ], but they have been also found to inhibit the growth of pathogenic bacteria such as Salmonella typhimurium [ 32 ], S. enteritidis [ 33] Listeria monocytogenes or the fungus Candida albicans [ 34 ].	bacteria,122,130,Organism/Species	bifidobacteria,139,153,Organism/Species	bacteria,236,244,Organism/Species	Salmonella typhimurium,253,275,Organism/Species	Listeria monocytogenes,305,327,Organism/Species	fungus,335,341,Organism/Species	Candida albicans,342,358,Organism/Species	"[{""token"": ""bacteria"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""bifidobacteria"", ""start_span"": 139, ""end_span"": 153, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 236, ""end_span"": 244, ""type"": ""Organism/Species""}, {""token"": ""Salmonella typhimurium"", ""start_span"": 253, ""end_span"": 275, ""type"": ""Organism/Species""}, {""token"": ""Listeria monocytogenes"", ""start_span"": 305, ""end_span"": 327, ""type"": ""Organism/Species""}, {""token"": ""fungus"", ""start_span"": 335, ""end_span"": 341, ""type"": ""Organism/Species""}, {""token"": ""Candida albicans"", ""start_span"": 342, ""end_span"": 358, ""type"": ""Organism/Species""}]"	test
Samples were boiled in 5 × Laemmli buffer ( 220 mM Tris, 312 µM SDS, 50% ( v / v) glycerol, 1% ( v / v) 2 - mercaptoethanol, 22. 5 mM EDTA, pH 6. 8, containing traces of bromphenol blue) for 5 min, separated by SDS - PAGE, electroblotted to PVDF membranes ( Millipore, Madrid, Spain ), and exposed to the primary antibodies against ERK, p - ERK ( both from Sigma ), p - P38, p - JNK and phosphorylated IkB - P, respectively ( all three from Cell signalling, Danvers, MA ).	glycerol,82,90,Chemical/Drug	bromphenol blue,170,185,Chemical/Drug	ERK,332,335,Gene/Protein	ERK,341,344,Gene/Protein	P38,370,373,Gene/Protein	JNK,379,382,Gene/Protein	IkB,402,405,Gene/Protein	"[{""token"": ""glycerol"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""bromphenol blue"", ""start_span"": 170, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""ERK"", ""start_span"": 332, ""end_span"": 335, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 341, ""end_span"": 344, ""type"": ""Gene/Protein""}, {""token"": ""P38"", ""start_span"": 370, ""end_span"": 373, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 379, ""end_span"": 382, ""type"": ""Gene/Protein""}, {""token"": ""IkB"", ""start_span"": 402, ""end_span"": 405, ""type"": ""Gene/Protein""}]"	test
Originally described in the epidermal growth factor receptor and breakpoint cluster region – c - abl kinase domains 14 – 18, this has now also been described for echinoderm microtubule - associated protein - like 4 ( EML4 )– ALK by Choi et al ., and others who have described the appearance of such mutations in the fusion EML4 – ALK protein that confers resistance to crizotinib 19 – 22.	epidermal growth factor receptor,28,60,Gene/Protein	abl kinase,97,107,Gene/Protein	EML4,217,221,Gene/Protein	ALK,225,228,Gene/Protein	EML4,323,327,Gene/Protein	ALK,330,333,Gene/Protein	crizotinib,369,379,Chemical/Drug	"[{""token"": ""epidermal growth factor receptor"", ""start_span"": 28, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""abl kinase"", ""start_span"": 97, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""EML4"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 225, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""EML4"", ""start_span"": 323, ""end_span"": 327, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 330, ""end_span"": 333, ""type"": ""Gene/Protein""}, {""token"": ""crizotinib"", ""start_span"": 369, ""end_span"": 379, ""type"": ""Chemical/Drug""}]"	test
The aim of this study was to investigate the role of human β - defensin 3 ( hBD3) in the initiation stage of atherosclerosis with human umbilical vein endothelial cells ( HUVECs) triggered by tumor necrosis factor - ( TNF -) α.	human,53,58,Organism/Species	β - defensin 3,59,73,Gene/Protein	hBD3,76,80,Gene/Protein	atherosclerosis,109,124,Disease/Disorder	human,130,135,Organism/Species	tumor necrosis factor,192,213,Gene/Protein	( TNF -) α,216,226,Gene/Protein	"[{""token"": ""human"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism/Species""}, {""token"": ""\u03b2 - defensin 3"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""hBD3"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""atherosclerosis"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Organism/Species""}, {""token"": ""tumor necrosis factor"", ""start_span"": 192, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""( TNF -) \u03b1"", ""start_span"": 216, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	test
This process is mediated mainly by elevated cell adhesion molecules such as intercellular adhesion molecule - 1 ( ICAM - 1 ), vascular cell adhesion molecule - 1 ( VCAM - 1 ), and endothelial cell selectin ( E - selectin ).	cell adhesion molecules,44,67,Gene/Protein	intercellular adhesion molecule - 1,76,111,Gene/Protein	ICAM - 1,114,122,Gene/Protein	vascular cell adhesion molecule - 1,126,161,Gene/Protein	VCAM - 1,164,172,Gene/Protein	endothelial cell selectin,180,205,Gene/Protein	E - selectin,208,220,Gene/Protein	"[{""token"": ""cell adhesion molecules"", ""start_span"": 44, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 76, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 126, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""endothelial cell selectin"", ""start_span"": 180, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 208, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	test
Brain sections were incubated with rabbit anti - Iba1 antibody ( Wako, 1: 250 ), rabbit anti - CD4 antibody ( Bioss, 1: 250 ), and rat anti - F4 / 80 antibody ( Bio - Rad, 1: 250) at 4 ° C overnight, followed by incubation at room temperature for 1 h with the secondary antibody ( Cy3 - conjugated AffiniPure goat anti - rabbit IgG, Jackson ImmunoReseach, 1: 500 ).	rabbit,35,41,Organism/Species	Iba1,49,53,Gene/Protein	rabbit,81,87,Organism/Species	CD4,95,98,Gene/Protein	rat,131,134,Organism/Species	goat,309,313,Organism/Species	rabbit,321,327,Organism/Species	"[{""token"": ""rabbit"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""Iba1"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""rat"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""goat"", ""start_span"": 309, ""end_span"": 313, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 321, ""end_span"": 327, ""type"": ""Organism/Species""}]"	test
The protein levels of Bax, Bcl - 2, phosphorylated - p38MAPK ( p - p38MAPK ), phosphorylated - JNK ( p - JNK ), and GAPDH were determined by Western blot analysis ( i ).	Bax,22,25,Gene/Protein	Bcl - 2,27,34,Gene/Protein	p38MAPK,53,60,Gene/Protein	p38MAPK,67,74,Gene/Protein	JNK,95,98,Gene/Protein	JNK,105,108,Gene/Protein	GAPDH,116,121,Gene/Protein	"[{""token"": ""Bax"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""p38MAPK"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""p38MAPK"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""GAPDH"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	test
In the present study, 2ccPA treatment suppressed markers of the NLRP3 inflammasome ( NLRP3, P2X7, and IL - 1b) but not of M2 microglia ( Arg1, Fizz1, and Ym1 ), suggested that 2ccPA suppressed the microglial M1 proinflammatory activation.	NLRP3,64,69,Gene/Protein	NLRP3,85,90,Gene/Protein	P2X7,92,96,Gene/Protein	IL - 1b,102,109,Gene/Protein	Arg1,137,141,Gene/Protein	Fizz1,143,148,Gene/Protein	Ym1,154,157,Gene/Protein	"[{""token"": ""NLRP3"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""NLRP3"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""P2X7"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1b"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""Arg1"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Fizz1"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Ym1"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	test
The maximum zone of inhibition and the respective minimum inhibitory concentration ( MIC) values recorded were Klebsiella pneumoniae ( 23 mm, 4 µg / mL) followed by Escherichia coli ( 20 mm, 12 µg / mL ), Pseudomonas aeruginosa ( 20 mm, 32 µg / mL ), Vibrio cholerae ( 18 mm, 64 µg / mL ), Bacillus subtilis ( 15 mm, 48 µg / mL ), Salmonella paratyphi ( 13 mm, 32 µg / mL) and Staphylococcus aureus ( 11 mm, 12 µg / mL) ( Table 1 ).	Klebsiella pneumoniae,111,132,Organism/Species	Escherichia coli,165,181,Organism/Species	Pseudomonas aeruginosa,205,227,Organism/Species	Vibrio cholerae,251,266,Organism/Species	Bacillus subtilis,290,307,Organism/Species	Salmonella paratyphi,331,351,Organism/Species	Staphylococcus aureus,377,398,Organism/Species	"[{""token"": ""Klebsiella pneumoniae"", ""start_span"": 111, ""end_span"": 132, ""type"": ""Organism/Species""}, {""token"": ""Escherichia coli"", ""start_span"": 165, ""end_span"": 181, ""type"": ""Organism/Species""}, {""token"": ""Pseudomonas aeruginosa"", ""start_span"": 205, ""end_span"": 227, ""type"": ""Organism/Species""}, {""token"": ""Vibrio cholerae"", ""start_span"": 251, ""end_span"": 266, ""type"": ""Organism/Species""}, {""token"": ""Bacillus subtilis"", ""start_span"": 290, ""end_span"": 307, ""type"": ""Organism/Species""}, {""token"": ""Salmonella paratyphi"", ""start_span"": 331, ""end_span"": 351, ""type"": ""Organism/Species""}, {""token"": ""Staphylococcus aureus"", ""start_span"": 377, ""end_span"": 398, ""type"": ""Organism/Species""}]"	test
Further in vitro study demonstrated that nicotine enhanced intracellular Ca2 + and activity of calcineurin ( CaN) through α7 - nAChR, increased the nucleic expressions of NFATc2 and the bindings to SOX9 promoter, and thus reduced the acetylation of H3K9 and H3K14 in SOX9 promoter.	nicotine,41,49,Chemical/Drug	calcineurin,95,106,Gene/Protein	CaN,109,112,Gene/Protein	α7 - nAChR,122,132,Gene/Protein	NFATc2,171,177,Gene/Protein	SOX9,198,202,Gene/Protein	SOX9,267,271,Gene/Protein	"[{""token"": ""nicotine"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""calcineurin"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""CaN"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""\u03b17 - nAChR"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""SOX9"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""SOX9"", ""start_span"": 267, ""end_span"": 271, ""type"": ""Gene/Protein""}]"	test
The nuclear factor of activated T cells ( NFAT) transcription factor NFATp ( NFATc2) is a repressor of chondrogenesis [ 21] and can interact with histone deacetylase ( HDAC) proteins to induce gene silencing [ 22 ].	nuclear factor of activated T cells,4,39,Gene/Protein	NFAT,42,46,Gene/Protein	transcription factor,48,68,Gene/Protein	NFATp,69,74,Gene/Protein	NFATc2,77,83,Gene/Protein	histone deacetylase,146,165,Gene/Protein	HDAC,168,172,Gene/Protein	"[{""token"": ""nuclear factor of activated T cells"", ""start_span"": 4, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 48, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""histone deacetylase"", ""start_span"": 146, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""HDAC"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	test
Therefore, we hypothesized that nicotine could decrease Sox9 ’ s promoter histone acetylation and inhibit its expression through HDAC recruitment by the activated nAChR / Ca2 +/ calcineurin / NFAT pathway in BMSCs.	nicotine,32,40,Chemical/Drug	Sox9,56,60,Gene/Protein	histone,74,81,Gene/Protein	HDAC,129,133,Gene/Protein	nAChR,163,168,Gene/Protein	calcineurin,178,189,Gene/Protein	NFAT,192,196,Gene/Protein	"[{""token"": ""nicotine"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""histone"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""HDAC"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""nAChR"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	test
In this study, we confirmed that nicotine interfered with BMSC transplantation repair of cartilage defects by inhibiting Sox9 expression in vivo and that nicotine - induced Sox9 gene suppression via nAChRs is mediated directly by decreasing the histone acetylation of the Sox9 promoter.	nicotine,33,41,Chemical/Drug	Sox9,121,125,Gene/Protein	nicotine,154,162,Chemical/Drug	Sox9,173,177,Gene/Protein	nAChRs,199,205,Gene/Protein	histone,245,252,Gene/Protein	Sox9,272,276,Gene/Protein	"[{""token"": ""nicotine"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""nAChRs"", ""start_span"": 199, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""histone"", ""start_span"": 245, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	test
Equal amounts of protein lysates ( 40 mg / lane) were loaded and resolved on 10% sodium - dodecyl sulfate - polyacrylamide gel electrophoresis ( SDS - PAGE) ( Sigma - Aldrich) and then were transferred onto nitrocellulose filters and probed with rabbit anti - Col2A1, Sox9, β - actin, histone 3, NFATc2 ( 1: 900) ( all from Santa Cruz Biotechnology ), and p - NFATc2 ( 1: 500) ( Abcam, Cambridge, MA, USA) antibodies at 4 ° C overnight.	rabbit,246,252,Organism/Species	Col2A1,260,266,Gene/Protein	Sox9,268,272,Gene/Protein	β - actin,274,283,Gene/Protein	histone 3,285,294,Gene/Protein	NFATc2,296,302,Gene/Protein	NFATc2,360,366,Gene/Protein	"[{""token"": ""rabbit"", ""start_span"": 246, ""end_span"": 252, ""type"": ""Organism/Species""}, {""token"": ""Col2A1"", ""start_span"": 260, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 268, ""end_span"": 272, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - actin"", ""start_span"": 274, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""histone 3"", ""start_span"": 285, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 296, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 360, ""end_span"": 366, ""type"": ""Gene/Protein""}]"	test
Thus, we measured the phosphatase activity of calcineurin in 0. 5 h after nicotine stimulus and found that the enzyme activity of calcineurin was also increased in a concentration - dependent manner ( Fig. 3b ). Fig. 3Effects of nicotine on intracellular Ca2 + concentration and phosphatase activity of calcineurin in BMSCs.	phosphatase,22,33,Gene/Protein	calcineurin,46,57,Gene/Protein	nicotine,74,82,Chemical/Drug	calcineurin,130,141,Gene/Protein	nicotine,229,237,Chemical/Drug	phosphatase,279,290,Gene/Protein	calcineurin,303,314,Gene/Protein	"[{""token"": ""phosphatase"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""calcineurin"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 229, ""end_span"": 237, ""type"": ""Chemical/Drug""}, {""token"": ""phosphatase"", ""start_span"": 279, ""end_span"": 290, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 303, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	test
The results showed that the expression of Sox9 had no change when 10 μM MLA and Si - NFATc2 were given 0. 5 h before the nicotine exposure ( Fig. 4n and o ), implying that interventions aimed at α7 - nAChR and NFATc2 could reverse nicotine ’ s suppressive effect on the expression of Sox9.	Sox9,42,46,Gene/Protein	NFATc2,85,91,Gene/Protein	nicotine,121,129,Chemical/Drug	α7 - nAChR,195,205,Gene/Protein	NFATc2,210,216,Gene/Protein	nicotine,231,239,Chemical/Drug	Sox9,284,288,Gene/Protein	"[{""token"": ""Sox9"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""\u03b17 - nAChR"", ""start_span"": 195, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 210, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 231, ""end_span"": 239, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 284, ""end_span"": 288, ""type"": ""Gene/Protein""}]"	test
Assay was performed after 24 h of in vitro culture. a Interaction of NFATc2 and HDAC1 under stimulus of nicotine with different concentrations. b Effects of MLA and Si - NFATc2 on the interaction of NFATc2 and HDAC1 induced by nicotine.	NFATc2,69,75,Gene/Protein	HDAC1,80,85,Gene/Protein	nicotine,104,112,Chemical/Drug	NFATc2,170,176,Gene/Protein	NFATc2,199,205,Gene/Protein	HDAC1,210,215,Gene/Protein	nicotine,227,235,Chemical/Drug	"[{""token"": ""NFATc2"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""HDAC1"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""NFATc2"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 199, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""HDAC1"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 227, ""end_span"": 235, ""type"": ""Chemical/Drug""}]"	test
Therefore, nicotine could activate Ca2 +/ Calcineurin / NFAT signaling in BMSCs throughα7 - nAChR, resulting in recruitment of HDAC1, which decreased histone acetylation of the Sox9 promoter region and finally inhibited BMSC chondrogenic differentiation.	nicotine,11,19,Chemical/Drug	Calcineurin,42,53,Gene/Protein	NFAT,56,60,Gene/Protein	nAChR,92,97,Gene/Protein	HDAC1,127,132,Gene/Protein	histone,150,157,Gene/Protein	Sox9,177,181,Gene/Protein	"[{""token"": ""nicotine"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""Calcineurin"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""nAChR"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""HDAC1"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""histone"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	test
In this study, we showed that nicotine at a dose under the actual exposure of nicotine dependence in daily life had an adverse effect on the chondrogenic repair of BMSCs in cartilage defects and that nicotine suppressed BMSC chondrogenic differentiation via the activation Ca2 +/ Calcineurin / NFATc2 signaling, which decreased the histone acetylation of the Sox9 promoter region.	nicotine,30,38,Chemical/Drug	nicotine dependence,78,97,Disease/Disorder	nicotine,200,208,Chemical/Drug	Calcineurin,280,291,Gene/Protein	NFATc2,294,300,Gene/Protein	histone,332,339,Gene/Protein	Sox9,359,363,Gene/Protein	"[{""token"": ""nicotine"", ""start_span"": 30, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine dependence"", ""start_span"": 78, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""nicotine"", ""start_span"": 200, ""end_span"": 208, ""type"": ""Chemical/Drug""}, {""token"": ""Calcineurin"", ""start_span"": 280, ""end_span"": 291, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 294, ""end_span"": 300, ""type"": ""Gene/Protein""}, {""token"": ""histone"", ""start_span"": 332, ""end_span"": 339, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 359, ""end_span"": 363, ""type"": ""Gene/Protein""}]"	test
The assay kits of corticosterone ( CORT ), corticotrophin - releasing hormone ( CRH ), adrenocorticotropin ( ACTH ), and arginine vasopressin ( AVP) were purchased from Nanjing Jiancheng Institute of Biotechnology, Nanjing, China.	corticosterone,18,32,Chemical/Drug	corticotrophin - releasing hormone,43,77,Gene/Protein	CRH,80,83,Gene/Protein	adrenocorticotropin,87,106,Gene/Protein	ACTH,109,113,Gene/Protein	arginine vasopressin,121,141,Gene/Protein	AVP,144,147,Gene/Protein	"[{""token"": ""corticosterone"", ""start_span"": 18, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""corticotrophin - releasing hormone"", ""start_span"": 43, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CRH"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""adrenocorticotropin"", ""start_span"": 87, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""ACTH"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""arginine vasopressin"", ""start_span"": 121, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""AVP"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	test
NOB treatment largely restored Cebpa mRNA expression ( ZT14) and circadian phase relative to RC ( Fig. 3a ). Fig. 3NOB rescued Cebpa and Cebpb mRNA and protein circadian expression in the liver from HFD fed mice. a Real - time RT - PCR analysis of Cebpa and Cebpb in livers collected at the indicated circadian times from mice with the indicated diet and treatment as in Fig. 2a.	Cebpa,31,36,Gene/Protein	Cebpa,127,132,Gene/Protein	Cebpb,137,142,Gene/Protein	mice,207,211,Organism/Species	Cebpa,248,253,Gene/Protein	Cebpb,258,263,Gene/Protein	mice,322,326,Organism/Species	"[{""token"": ""Cebpa"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""Cebpa"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Cebpb"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Organism/Species""}, {""token"": ""Cebpa"", ""start_span"": 248, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""Cebpb"", ""start_span"": 258, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 322, ""end_span"": 326, ""type"": ""Organism/Species""}]"	test
Furthermore, pronounced expression changes in C / EBP subunits were observed in the mutant mice, including both phase shifts and reduced levels ( p30 and C / EBPβ ). Cps1 and Cebpa mRNA expression was also compromised in the mutant mice, showing strongly reduced levels and dampened circadian amplitude ( Fig. 6b ).	C / EBP,46,53,Gene/Protein	mice,91,95,Organism/Species	p30,146,149,Gene/Protein	C / EBPβ,154,162,Gene/Protein	Cps1,166,170,Gene/Protein	Cebpa,175,180,Gene/Protein	mice,232,236,Organism/Species	"[{""token"": ""C / EBP"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""p30"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP\u03b2"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""Cps1"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""Cebpa"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 232, ""end_span"": 236, ""type"": ""Organism/Species""}]"	test
The proportion of patients referred to specialists ( 74% PHN versus 18% HZ) and the number of specialist visits per case ( 3. 5 and 3. 9 for PHN - 1 month and PHN 3 - months vs 0. 2 for HZ) were also higher for PHN patients compared to HZ patients.	PHN,57,60,Disease/Disorder	HZ,72,74,Disease/Disorder	PHN,141,144,Disease/Disorder	PHN,159,162,Disease/Disorder	HZ,186,188,Disease/Disorder	PHN,211,214,Disease/Disorder	HZ,236,238,Disease/Disorder	"[{""token"": ""PHN"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 72, ""end_span"": 74, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 186, ""end_span"": 188, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 236, ""end_span"": 238, ""type"": ""Disease/Disorder""}]"	test
No studies identified provided a breakdown of the cost elements that are included in a ‘ hospital stay ’. Table 4 Mean cost per hospitalised case of HZ / PHN, by country Country HZ / PHN HZ ( without PHN) PHN Belgium [ 40 ]-€ 5, 982 (€ 798 - 31, 689 )-( all ages) France [ 41 ]-€ 2, 774. 28 ( 50 + years )€ 3, 731. 09 ( 50 + years) Germany [ 31 ]-€ 4, 189. 74 ( 50 + years )€ 4, 279. 68 ( 50 + years )€ 3, 282. 64 ( all ages )€ 4, 112. 03 ( all ages) Italy [ 29 ]-€ 3, 188. 16 ± € 1, 614. 99 ( 50 + years )€ 3, 451. 38 ± € 3, 248. 43 ( 50 + years) Spain [ 37, 45, 52, 53 ]€ 3, 366. 4 - 4, 505. 6 € 5, 019. 84 ( aged 40 – 49 )€ 5, 108. 04 ( aged 50 – 59 )( all ages )€ 4, 495. 68 – 5, 139. 54 ( aged 50 – 59 )€ 4, 732. 56 ( aged 60 – 69 )€ 4, 210. 92 – 4, 782. 96 ( aged 60 – 69 )€ 4, 478. 04 ( 70 +)€ 4, 062. 24 – 4, 556. 16 ( aged 70 +)	HZ,149,151,Disease/Disorder	PHN,154,157,Disease/Disorder	HZ,178,180,Disease/Disorder	PHN,183,186,Disease/Disorder	HZ,187,189,Disease/Disorder	PHN,200,203,Disease/Disorder	PHN,205,208,Disease/Disorder	"[{""token"": ""HZ"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 178, ""end_span"": 180, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 187, ""end_span"": 189, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Disease/Disorder""}]"	test
Molecular identity of RBSDV P7 - 1 transgenic Arabidopsis plants. ( A) Selection of P7 - 1 transgenic lines on MS medium with kanamycin or without kanamycin ( MS ).	RBSDV,22,27,Organism/Species	P7 - 1,28,34,Gene/Protein	Arabidopsis,46,57,Organism/Species	plants,58,64,Organism/Species	P7 - 1,84,90,Gene/Protein	kanamycin,126,135,Chemical/Drug	kanamycin,147,156,Chemical/Drug	"[{""token"": ""RBSDV"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Arabidopsis"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""kanamycin"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Chemical/Drug""}, {""token"": ""kanamycin"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Chemical/Drug""}]"	test
Interestingly, the distribution of genomic divergence for pairs of wisent was bimodal in all cases ( fig. 4 ), but the relative levels of genomic divergence between species were similar to that measured using only transversion sites. Fig. 4Comparison of pairwise genomic divergence within three bovid species: wisent ( Bison bonasus ), domestic cattle ( Bos taurus ), and yak ( Bos grunniens ).	wisent,67,73,Organism/Species	wisent,310,316,Organism/Species	Bison bonasus,319,332,Organism/Species	domestic cattle,336,351,Organism/Species	Bos taurus,354,364,Organism/Species	yak,372,375,Organism/Species	Bos grunniens,378,391,Organism/Species	"[{""token"": ""wisent"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 310, ""end_span"": 316, ""type"": ""Organism/Species""}, {""token"": ""Bison bonasus"", ""start_span"": 319, ""end_span"": 332, ""type"": ""Organism/Species""}, {""token"": ""domestic cattle"", ""start_span"": 336, ""end_span"": 351, ""type"": ""Organism/Species""}, {""token"": ""Bos taurus"", ""start_span"": 354, ""end_span"": 364, ""type"": ""Organism/Species""}, {""token"": ""yak"", ""start_span"": 372, ""end_span"": 375, ""type"": ""Organism/Species""}, {""token"": ""Bos grunniens"", ""start_span"": 378, ""end_span"": 391, ""type"": ""Organism/Species""}]"	test
We performed a total of 105 comparisons considering all possible combinations of wisent, all wisent with either domestic cattle or aurochs as candidate admixer, and domestic cattle and aurochs with all wisent as candidate admixer.	wisent,81,87,Organism/Species	wisent,93,99,Organism/Species	domestic cattle,112,127,Organism/Species	aurochs,131,138,Organism/Species	domestic cattle,165,180,Organism/Species	aurochs,185,192,Organism/Species	wisent,202,208,Organism/Species	"[{""token"": ""wisent"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Organism/Species""}, {""token"": ""domestic cattle"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""domestic cattle"", ""start_span"": 165, ""end_span"": 180, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 185, ""end_span"": 192, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 202, ""end_span"": 208, ""type"": ""Organism/Species""}]"	test
TIGIT, which also belongs to the B7 / CD28 superfamily, acts as a co - inhibitory molecule by directly down regulating proliferation of human T cells [ 22 ], but also by modulating cytokine secretion of DCs, decreasing IL - 12 and enhancing IL - 10 productions [ 23 ].	TIGIT,0,5,Gene/Protein	B7,33,35,Gene/Protein	CD28,38,42,Gene/Protein	human,136,141,Organism/Species	cytokine,181,189,Gene/Protein	IL - 12,219,226,Gene/Protein	IL - 10,241,248,Gene/Protein	"[{""token"": ""TIGIT"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""B7"", ""start_span"": 33, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Organism/Species""}, {""token"": ""cytokine"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 219, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	test
Finally, CD160, through its binding to its ligand Herpes Virus Entry Mediator ( HVEM ), an atypical member of TNF - receptor superfamily, delivers a co - inhibitory signalling to CD4 + T cells or CD8 + T cells dampening their activation in HIV - infected individuals [ 31, 32 ].	CD160,9,14,Gene/Protein	Herpes Virus Entry Mediator,50,77,Gene/Protein	HVEM,80,84,Gene/Protein	TNF - receptor,110,124,Gene/Protein	CD4,179,182,Gene/Protein	CD8,196,199,Gene/Protein	HIV,240,243,Organism/Species	"[{""token"": ""CD160"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""Herpes Virus Entry Mediator"", ""start_span"": 50, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""HVEM"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""TNF - receptor"", ""start_span"": 110, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Organism/Species""}]"	test
CD4 + T - cell subsets were identified by CD27, CD45RA, and CCR7 expression on CD4 + T cells after exclusion of dump positive cells ( LIVE / DEAD, CD14 and CD19 ).	CD4,0,3,Gene/Protein	CD27,42,46,Gene/Protein	CD45RA,48,54,Gene/Protein	CCR7,60,64,Gene/Protein	CD4,79,82,Gene/Protein	CD14,147,151,Gene/Protein	CD19,156,160,Gene/Protein	"[{""token"": ""CD4"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""CD45RA"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""CCR7"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	test
In a second set of experiments, total memory CD4 + T cells ( CD3 + CD4 + CD45RA -) were sorted based on their expression of PD - 1, TIGIT and LAG - 3.	CD4,45,48,Gene/Protein	CD3,61,64,Gene/Protein	CD4,67,70,Gene/Protein	CD45RA,73,79,Gene/Protein	PD - 1,124,130,Gene/Protein	TIGIT,132,137,Gene/Protein	LAG - 3,142,149,Gene/Protein	"[{""token"": ""CD4"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CD45RA"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	test
These experiments provide evidence that memory CD4 + T cells expressing PD - 1, TIGIT and / or LAG - 3 are enriched for HIV - infected CD4 + T cells harboring inducible proviruses during ART.	CD4,47,50,Gene/Protein	PD - 1,72,78,Gene/Protein	TIGIT,80,85,Gene/Protein	LAG - 3,95,102,Gene/Protein	HIV,120,123,Organism/Species	CD4,135,138,Gene/Protein	proviruses,169,179,Organism/Species	"[{""token"": ""CD4"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""proviruses"", ""start_span"": 169, ""end_span"": 179, ""type"": ""Organism/Species""}]"	test
TLR4 gene ( number accession of GenBank: NM - 138554. 1) codifies the best understood TLR member involved in recognition of LPS, the prototypic TLR4 ligand, and other exogenous and endogenous ( i. e. HSPs, hyaluronic acid, β - defensin - 2, ox - LDL, fibronectin and amyloid peptide) ligands.	TLR4,0,4,Gene/Protein	TLR,86,89,Gene/Protein	TLR4,144,148,Gene/Protein	HSPs,200,204,Gene/Protein	β - defensin - 2,223,239,Gene/Protein	fibronectin,251,262,Gene/Protein	amyloid,267,274,Gene/Protein	"[{""token"": ""TLR4"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""TLR"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""HSPs"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - defensin - 2"", ""start_span"": 223, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 251, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""amyloid"", ""start_span"": 267, ""end_span"": 274, ""type"": ""Gene/Protein""}]"	test
In this study, we analyzed the expression levels of GmPT1 and GmPT2, but there could be other Pi transporters in soybean, which raises the question of whether other Pi transporters can affect Pi acquisition, translocation and remobilization and what is the relative contribution of these genes to overall Pi transporter function in plants?	GmPT1,52,57,Gene/Protein	GmPT2,62,67,Gene/Protein	Pi transporters,94,109,Gene/Protein	soybean,113,120,Organism/Species	Pi transporters,165,180,Gene/Protein	Pi transporter,305,319,Gene/Protein	plants,332,338,Organism/Species	"[{""token"": ""GmPT1"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""Pi transporters"", ""start_span"": 94, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""soybean"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""Pi transporters"", ""start_span"": 165, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""Pi transporter"", ""start_span"": 305, ""end_span"": 319, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 332, ""end_span"": 338, ""type"": ""Organism/Species""}]"	test
Due to space limitations, sequence information for only 1 – 2 representative species from each vertebrate group ( viz. generally the same as those employed for phylogenetic studies for mammals, birds, fishes, reptiles and amphibians) for different DGK isozymes is shown in the alignment files.	vertebrate,95,105,Organism/Species	mammals,185,192,Organism/Species	birds,194,199,Organism/Species	fishes,201,207,Organism/Species	reptiles,209,217,Organism/Species	amphibians,222,232,Organism/Species	DGK,248,251,Gene/Protein	"[{""token"": ""vertebrate"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""mammals"", ""start_span"": 185, ""end_span"": 192, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Organism/Species""}, {""token"": ""fishes"", ""start_span"": 201, ""end_span"": 207, ""type"": ""Organism/Species""}, {""token"": ""reptiles"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Organism/Species""}, {""token"": ""amphibians"", ""start_span"": 222, ""end_span"": 232, ""type"": ""Organism/Species""}, {""token"": ""DGK"", ""start_span"": 248, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	test
These results suggest that an intratubular matrix containing FN and BDNF promotes motor axon regeneration and reinnervation of target muscles, whereas LM and LM + NGF / NT3 groups showed values similar to the COL control group.	FN,61,63,Gene/Protein	BDNF,68,72,Gene/Protein	LM,151,153,Gene/Protein	LM,158,160,Gene/Protein	NGF,163,166,Gene/Protein	NT3,169,172,Gene/Protein	COL,209,212,Gene/Protein	"[{""token"": ""FN"", ""start_span"": 61, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 151, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 158, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""COL"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	test
In fact, it has been reported that the pro - regenerative effects of NGF and NT3 are reduced after blocking the α7 subunit of integrins in sensory neurons [ 36 ], and that synergistic actions between integrins and NTF receptors may be attributed to the sustained activation of Src and the downstream signaling Akt intermediate [ 37 ].	NGF,69,72,Gene/Protein	NT3,77,80,Gene/Protein	α7 subunit of integrins,112,135,Gene/Protein	integrins,200,209,Gene/Protein	NTF receptors,214,227,Gene/Protein	Src,277,280,Gene/Protein	Akt,310,313,Gene/Protein	"[{""token"": ""NGF"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""\u03b17 subunit of integrins"", ""start_span"": 112, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""integrins"", ""start_span"": 200, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""NTF receptors"", ""start_span"": 214, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""Src"", ""start_span"": 277, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""Akt"", ""start_span"": 310, ""end_span"": 313, ""type"": ""Gene/Protein""}]"	test
The in vivo results demonstrated that introduction of a collagen matrix enriched with LM + MP. NGF / NT3 or FN + MP. BDNF within the tube used for nerve repair in adult rats promoted preferential regeneration of sensory and motor axons respectively.	collagen,56,64,Gene/Protein	LM,86,88,Gene/Protein	NGF,95,98,Gene/Protein	NT3,101,104,Gene/Protein	FN,108,110,Gene/Protein	BDNF,117,121,Gene/Protein	rats,169,173,Organism/Species	"[{""token"": ""collagen"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 86, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 108, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Organism/Species""}]"	test
On the other hand, although we still found in vivo a significant preferential regeneration of sensory neurons in animals treated with LM + MP. NGF / NT3 and of motor neurons in animals treated with FN + MP. BDNF, the differences in the amount of regenerated neurons were reduced from the short to the long term study.	animals,113,120,Organism/Species	LM,134,136,Gene/Protein	NGF,143,146,Gene/Protein	NT3,149,152,Gene/Protein	animals,177,184,Organism/Species	FN,198,200,Gene/Protein	BDNF,207,211,Gene/Protein	"[{""token"": ""animals"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""LM"", ""start_span"": 134, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Organism/Species""}, {""token"": ""FN"", ""start_span"": 198, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	test
Six endogenous putative transporter genes, YALI0B19470g, YALI0C15488g, YALI0C21406g, YALI0D24607g, YALI0D20108g and YALI0E32901g, were identified.	transporter,24,35,Gene/Protein	YALI0B19470g,43,55,Gene/Protein	YALI0C15488g,57,69,Gene/Protein	YALI0C21406g,71,83,Gene/Protein	YALI0D24607g,85,97,Gene/Protein	YALI0D20108g,99,111,Gene/Protein	YALI0E32901g,116,128,Gene/Protein	"[{""token"": ""transporter"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""YALI0B19470g"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488g"", ""start_span"": 57, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406g"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607g"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D20108g"", ""start_span"": 99, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901g"", ""start_span"": 116, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	test
Six putative transporter genes, YALI0B19470g, YALI0C15488g, YALI0C21406g, YALI0D24607g, YALI0D20108g, and YALI0E32901g, were amplified from Y. lipolytica WSH - Z06 genomic DNA with the primers listed in Table 6.	transporter,13,24,Gene/Protein	YALI0B19470g,32,44,Gene/Protein	YALI0C15488g,46,58,Gene/Protein	YALI0C21406g,60,72,Gene/Protein	YALI0D24607g,74,86,Gene/Protein	YALI0D20108g,88,100,Gene/Protein	YALI0E32901g,106,118,Gene/Protein	"[{""token"": ""transporter"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""YALI0B19470g"", ""start_span"": 32, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488g"", ""start_span"": 46, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406g"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607g"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D20108g"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901g"", ""start_span"": 106, ""end_span"": 118, ""type"": ""Gene/Protein""}]"	test
In the first set four groups of rats were used: 1) control rats injected with vehicle, 2) hyperammonemic rats injected with vehicle, 3) control rats injected with 20 mg / kg GR3027, and 4) hyperammonemic rats injected with 20 mg / kg GR3027.	rats,32,36,Organism/Species	rats,59,63,Organism/Species	rats,105,109,Organism/Species	rats,144,148,Organism/Species	GR3027,174,180,Chemical/Drug	rats,204,208,Organism/Species	GR3027,234,240,Chemical/Drug	"[{""token"": ""rats"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 234, ""end_span"": 240, ""type"": ""Chemical/Drug""}]"	train
Spatial learning and memory was assessed in control ( C V) or hyperammonemic ( HA V) rats treated with vehicle and hyperammonemic rats treated with 3 ( HA 3 ), 10 ( HA 10 ), or 20 ( HA 20) mg / kg GR3027 ( A and B) and in sham - operated control rats ( SM V) or PCS rats treated with vehicle ( PCS V) and PCS rats treated with 0. 7 ( PCS 0. 7) or 2. 5 ( PCS 2. 5) mg / kg GR3027 ( C and D ). A and C: escape latencies to reach the platform during learning sessions. B and D: time spent in the correct quadrant during the memory test.	rats,85,89,Organism/Species	rats,130,134,Organism/Species	GR3027,197,203,Chemical/Drug	rats,246,250,Organism/Species	rats,266,270,Organism/Species	rats,309,313,Organism/Species	GR3027,372,378,Chemical/Drug	"[{""token"": ""rats"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 246, ""end_span"": 250, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 266, ""end_span"": 270, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 309, ""end_span"": 313, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 372, ""end_span"": 378, ""type"": ""Chemical/Drug""}]"	train
Spatial learning in the radial maze was assessed in control ( C V) or hyperammonemic ( HA V) rats treated with vehicle or ( for hyperammonemic rats) treated with 3 ( HA 3 ), 10 ( HA 10) or 20 ( HA 20) mg / kg GR3027 ( A and B ), in sham - operated control rats ( SM V) or PCS rats treated with vehicle ( PCS V ), and in PCS rats treated with 0. 7 ( PCS 0. 7) or 2. 5 ( PCS 2. 5) mg / kg GR3027 ( C and D ). A and C: working errors during the different sessions. B and D: working errors during days 1 and 2.	rats,93,97,Organism/Species	rats,143,147,Organism/Species	GR3027,209,215,Chemical/Drug	rats,256,260,Organism/Species	rats,276,280,Organism/Species	rats,324,328,Organism/Species	GR3027,387,393,Chemical/Drug	"[{""token"": ""rats"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 256, ""end_span"": 260, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 276, ""end_span"": 280, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 324, ""end_span"": 328, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 387, ""end_span"": 393, ""type"": ""Chemical/Drug""}]"	train
We also detected other proteins that were recognized by antibodies from P. vivax - infected patients, but which were not confirmed by peptide sequencing: EV15 - like protein, kynurenine - oxoglutarate transaminase, long chain fatty acid transport protein 6, FAM45A protein, FAM180A, and TMLHE ( Fig. 3, Supplementary Table 1 ).	antibodies,56,66,Gene/Protein	EV15 - like protein,154,173,Gene/Protein	kynurenine - oxoglutarate transaminase,175,213,Gene/Protein	long chain fatty acid transport protein 6,215,256,Gene/Protein	FAM45A,258,264,Gene/Protein	FAM180A,274,281,Gene/Protein	TMLHE,287,292,Gene/Protein	"[{""token"": ""antibodies"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""EV15 - like protein"", ""start_span"": 154, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine - oxoglutarate transaminase"", ""start_span"": 175, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""long chain fatty acid transport protein 6"", ""start_span"": 215, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""FAM45A"", ""start_span"": 258, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""FAM180A"", ""start_span"": 274, ""end_span"": 281, ""type"": ""Gene/Protein""}, {""token"": ""TMLHE"", ""start_span"": 287, ""end_span"": 292, ""type"": ""Gene/Protein""}]"	train
Using different approaches, we found that: ( 1) anemic patients infected with P. vivax have higher levels of IgG against erythrocyte proteins; ( 2) band 3 and spectrin proteins are the main molecular targets in nRBCs differentially recognized by IgGs from anemic patients with patent P. vivax infection; and ( 3) a P. vivax protein of unknown function is mimetic to human spectrin suggesting that molecular mimicry may contribute to autoantibody immune responses to nRBCs.	IgG,109,112,Gene/Protein	band 3,148,154,Gene/Protein	spectrin,159,167,Gene/Protein	IgGs,246,250,Gene/Protein	human,366,371,Organism/Species	spectrin,372,380,Gene/Protein	autoantibody,433,445,Gene/Protein	"[{""token"": ""IgG"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""band 3"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""spectrin"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""IgGs"", ""start_span"": 246, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 366, ""end_span"": 371, ""type"": ""Organism/Species""}, {""token"": ""spectrin"", ""start_span"": 372, ""end_span"": 380, ""type"": ""Gene/Protein""}, {""token"": ""autoantibody"", ""start_span"": 433, ""end_span"": 445, ""type"": ""Gene/Protein""}]"	train
A population - based sample of 1, 011 Chinese men and women aged 35 – 54 years was employed to measure plasma amylin, inflammatory markers ( C - reactive protein [ CRP] and interleukin - 6 [ IL - 6 ]), insulin, glucose and lipid profiles.	amylin,110,116,Gene/Protein	C - reactive protein,141,161,Gene/Protein	CRP,164,167,Gene/Protein	interleukin - 6,173,188,Gene/Protein	IL - 6,191,197,Gene/Protein	insulin,202,209,Gene/Protein	glucose,211,218,Chemical/Drug	"[{""token"": ""amylin"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""C - reactive protein"", ""start_span"": 141, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""CRP"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 6"", ""start_span"": 173, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""glucose"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Chemical/Drug""}]"	train
Adjusted odds ratios for MetS according to amylin quartiles, obesity status ( A ), and quartiles of CRP ( B ), IL - 6 ( C ), insulin ( D ), HOMA - IR ( E ).	MetS,25,29,Disease/Disorder	amylin,43,49,Gene/Protein	obesity,61,68,Disease/Disorder	CRP,100,103,Gene/Protein	IL - 6,111,117,Gene/Protein	insulin,125,132,Gene/Protein	IR,147,149,Disease/Disorder	"[{""token"": ""MetS"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Disease/Disorder""}, {""token"": ""amylin"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""obesity"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""CRP"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""IR"", ""start_span"": 147, ""end_span"": 149, ""type"": ""Disease/Disorder""}]"	train
High glucose increases the relative amount of amylin to insulin secretion from islets isolated from dexamethasone - or glucose - treated rats in comparison with islets isolated from fed and fasted rats [ 31 ].	glucose,5,12,Chemical/Drug	amylin,46,52,Gene/Protein	insulin,56,63,Gene/Protein	dexamethasone,100,113,Chemical/Drug	glucose,119,126,Chemical/Drug	rats,137,141,Organism/Species	rats,197,201,Organism/Species	"[{""token"": ""glucose"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""amylin"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""dexamethasone"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Organism/Species""}]"	train
We found that participants in the higher amylin quartile had higher amylin / insulin ratio and higher risk of MetS, supporting the involvement of amylin in MetS independent of insulin.	amylin,41,47,Gene/Protein	amylin,68,74,Gene/Protein	insulin,77,84,Gene/Protein	MetS,110,114,Disease/Disorder	amylin,146,152,Gene/Protein	MetS,156,160,Disease/Disorder	insulin,176,183,Gene/Protein	"[{""token"": ""amylin"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""amylin"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""MetS"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Disease/Disorder""}, {""token"": ""amylin"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""MetS"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Disease/Disorder""}, {""token"": ""insulin"", ""start_span"": 176, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
In our recent in vitro study, we observed that tumor necrosis factor - α ( TNF - α ), a proinflammatory cytokine elevated in obesity and insulin resistance, could induce amylin gene expression in murine pancreatic β - cells and islets, and also could activate human amylin promoter through multiple signaling pathways [ 33 ].	tumor necrosis factor - α,47,72,Gene/Protein	TNF - α,75,82,Gene/Protein	obesity,125,132,Disease/Disorder	insulin resistance,137,155,Disease/Disorder	amylin,170,176,Gene/Protein	human,260,265,Organism/Species	amylin,266,272,Gene/Protein	"[{""token"": ""tumor necrosis factor - \u03b1"", ""start_span"": 47, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""obesity"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Disease/Disorder""}, {""token"": ""insulin resistance"", ""start_span"": 137, ""end_span"": 155, ""type"": ""Disease/Disorder""}, {""token"": ""amylin"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 260, ""end_span"": 265, ""type"": ""Organism/Species""}, {""token"": ""amylin"", ""start_span"": 266, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
Vertebrate iGluR are divided into three subtypes according to selective agonists: N - methyl - D - aspartate receptors ( NMDAR ), kainate, and α - Amino - 3 - hydroxy - 5 - methyl - 4 - isoxazolepropionic acid receptors ( AMPAR ).	Vertebrate,0,10,Organism/Species	iGluR,11,16,Gene/Protein	N - methyl - D - aspartate receptors,82,118,Gene/Protein	NMDAR,121,126,Gene/Protein	kainate,130,137,Chemical/Drug	α - Amino - 3 - hydroxy - 5 - methyl - 4 - isoxazolepropionic acid receptors,143,219,Gene/Protein	AMPAR,222,227,Gene/Protein	"[{""token"": ""Vertebrate"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 11, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""N - methyl - D - aspartate receptors"", ""start_span"": 82, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""NMDAR"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""kainate"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""\u03b1 - Amino - 3 - hydroxy - 5 - methyl - 4 - isoxazolepropionic acid receptors"", ""start_span"": 143, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""AMPAR"", ""start_span"": 222, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
Based on the phylogeny of the iGluR proteins each protostome subunit was classified as NMDAR, AMPAR, kainate receptor or as orphan genes that do not show a clear relationship with vertebrate subtypes ( Table 1 ). Fig. 2Unrooted bootstrap consensus phylogenetic tree.	iGluR,30,35,Gene/Protein	protostome,50,60,Organism/Species	NMDAR,87,92,Gene/Protein	AMPAR,94,99,Gene/Protein	kainate receptor,101,117,Gene/Protein	orphan genes,124,136,Gene/Protein	vertebrate,180,190,Organism/Species	"[{""token"": ""iGluR"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""protostome"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Organism/Species""}, {""token"": ""NMDAR"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""AMPAR"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""kainate receptor"", ""start_span"": 101, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""orphan genes"", ""start_span"": 124, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""vertebrate"", ""start_span"": 180, ""end_span"": 190, ""type"": ""Organism/Species""}]"	train
In contrast to Grin and AMPAR genes, extensive divergence of kainate receptor genes in Deuterostomia and Protostomia suggests that they are the least conserved iGluR subtype across Bilateria.	Grin,15,19,Gene/Protein	AMPAR,24,29,Gene/Protein	kainate receptor,61,77,Gene/Protein	Deuterostomia,87,100,Organism/Species	Protostomia,105,116,Organism/Species	iGluR,160,165,Gene/Protein	Bilateria,181,190,Organism/Species	"[{""token"": ""Grin"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""AMPAR"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""kainate receptor"", ""start_span"": 61, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Deuterostomia"", ""start_span"": 87, ""end_span"": 100, ""type"": ""Organism/Species""}, {""token"": ""Protostomia"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""Bilateria"", ""start_span"": 181, ""end_span"": 190, ""type"": ""Organism/Species""}]"	train
Studies of candidate iGluR genes in the ctenophore Mnemiopsis leidyi, which is currently thought basal to bilaterian animals [ 78 ], revealed that ctenophore iGluR form a monophyletic clade separate from, and ancestral to, chordates [ 79 ].	iGluR,21,26,Gene/Protein	ctenophore,40,50,Organism/Species	Mnemiopsis leidyi,51,68,Organism/Species	animals,117,124,Organism/Species	ctenophore,147,157,Organism/Species	iGluR,158,163,Gene/Protein	chordates,223,232,Organism/Species	"[{""token"": ""iGluR"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""ctenophore"", ""start_span"": 40, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""Mnemiopsis leidyi"", ""start_span"": 51, ""end_span"": 68, ""type"": ""Organism/Species""}, {""token"": ""animals"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""ctenophore"", ""start_span"": 147, ""end_span"": 157, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""chordates"", ""start_span"": 223, ""end_span"": 232, ""type"": ""Organism/Species""}]"	train
Multiple studies in the past decades have shown that the CP of plant viruses can act in processes such as delivery of the virus into the host cell, nuclear shuttling of viral genomes, viral replication, translation of viral proteins, viral movement within the host plant, or manipulation of host defenses, besides its canonical role in capsid formation and virus transmission [ reviewed in ( Bol, 2008; Callaway et al ., 2001 )].	CP,57,59,Gene/Protein	plant,63,68,Organism/Species	viruses,69,76,Organism/Species	virus,122,127,Organism/Species	plant,265,270,Organism/Species	capsid,336,342,Gene/Protein	virus,357,362,Organism/Species	"[{""token"": ""CP"", ""start_span"": 57, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""plant"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Organism/Species""}, {""token"": ""viruses"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 265, ""end_span"": 270, ""type"": ""Organism/Species""}, {""token"": ""capsid"", ""start_span"": 336, ""end_span"": 342, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 357, ""end_span"": 362, ""type"": ""Organism/Species""}]"	train
In the dsDNA human polyomavirus JC, one of the CPs, named VP1, is efficiently transported to the nucleus and localized in discrete nuclear speckles only in the presence of the other two CPs, VP2 and VP3 ( Shishido - Hara et al ., 2000 ).	human,13,18,Organism/Species	polyomavirus JC,19,34,Organism/Species	CPs,47,50,Gene/Protein	VP1,58,61,Gene/Protein	CPs,186,189,Gene/Protein	VP2,191,194,Gene/Protein	VP3,199,202,Gene/Protein	"[{""token"": ""human"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism/Species""}, {""token"": ""polyomavirus JC"", ""start_span"": 19, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""CPs"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""VP1"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""CPs"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""VP2"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""VP3"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
Using transient expression of CP - GFP and GFP - CP fusion proteins in N. benthamiana we could observe that, as previously described, CP from TYLCV localizes to the nucleolus, and weakly to the nucleoplasm ( Rojas et al ., 2001; Figure 1A ); a similar subcellular distribution has also been shown for other geminiviral CPs ( Unseld et al ., 2001; Guerra - Peraza et al ., 2005; Sharma and Ikegami, 2010 ).	CP,30,32,Gene/Protein	GFP,35,38,Gene/Protein	GFP,43,46,Gene/Protein	CP,49,51,Gene/Protein	CP,134,136,Gene/Protein	TYLCV,142,147,Organism/Species	CPs,319,322,Gene/Protein	"[{""token"": ""CP"", ""start_span"": 30, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 49, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 134, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""TYLCV"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Organism/Species""}, {""token"": ""CPs"", ""start_span"": 319, ""end_span"": 322, ""type"": ""Gene/Protein""}]"	train
In order to determine whether the viral infection may change the subcellular localization of the CP, we co - infiltrated a TYLCV infectious clone together with the clones to express CP - GFP or GFP - CP.	viral infection,34,49,Disease/Disorder	CP,97,99,Gene/Protein	TYLCV,123,128,Organism/Species	CP,182,184,Gene/Protein	GFP,187,190,Gene/Protein	GFP,194,197,Gene/Protein	CP,200,202,Gene/Protein	"[{""token"": ""viral infection"", ""start_span"": 34, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""CP"", ""start_span"": 97, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""TYLCV"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""CP"", ""start_span"": 182, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 200, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
Succession of stages of CP localization in the presence of the virus. N. benthamiana leaves were co - infiltrated with A. tumefaciens carrying a construct to express CP - GFP, and a TYLCV infectious clone or an empty vector ( EV) as control. ( A) The subcellular localization of CP - GFP in four independent cells was observed under the confocal microscope every 15 min from 21 h post - infiltration ( hpi) to 27 hpi; representative images are shown.	CP,24,26,Gene/Protein	virus,63,68,Organism/Species	CP,166,168,Gene/Protein	GFP,171,174,Gene/Protein	TYLCV,182,187,Organism/Species	CP,279,281,Gene/Protein	GFP,284,287,Gene/Protein	"[{""token"": ""CP"", ""start_span"": 24, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Organism/Species""}, {""token"": ""CP"", ""start_span"": 166, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""TYLCV"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Organism/Species""}, {""token"": ""CP"", ""start_span"": 279, ""end_span"": 281, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 284, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
In order to investigate whether the CP - containing nuclear speckles formed upon TYLCV infection correspond to some of the known subnuclear structures, we decided to co - express the GFP - or RFP - fused CP, with or without TYLCV, with established nuclear markers that are found distributed in nucleoplasmic bodies.	CP,36,38,Gene/Protein	TYLCV,81,86,Organism/Species	infection,87,96,Disease/Disorder	GFP,183,186,Gene/Protein	RFP,192,195,Gene/Protein	CP,204,206,Gene/Protein	TYLCV,224,229,Organism/Species	"[{""token"": ""CP"", ""start_span"": 36, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""TYLCV"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Disease/Disorder""}, {""token"": ""GFP"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""RFP"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 204, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""TYLCV"", ""start_span"": 224, ""end_span"": 229, ""type"": ""Organism/Species""}]"	train
Running the target prediction on 866 human miRNAs ( 39 EBV miRNAs) and 7208 human mRNAs ( 3 ' UTRs) resulted in 283362 human miRNA / human mRNAs ( 11663 EBV miRNA / human mRNAs) pairs.	human,37,42,Organism/Species	EBV,55,58,Organism/Species	human,76,81,Organism/Species	human,119,124,Organism/Species	human,133,138,Organism/Species	EBV,153,156,Organism/Species	human,165,170,Organism/Species	"[{""token"": ""human"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism/Species""}, {""token"": ""EBV"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""EBV"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Organism/Species""}]"	train
Unbound lineage - negative cells were harvested and stained for the aforementioned GMP markers using rat anti - mouse Sca - 1 ( D7 ), c - kit ( 2B8 ), CD150 ( mShad ), CD105 ( MJ7 / 18 ), and CD16 / 32 ( 93) ( Table S1 ).	rat,101,104,Organism/Species	mouse,112,117,Organism/Species	Sca - 1,118,125,Gene/Protein	c - kit,134,141,Gene/Protein	CD150,151,156,Gene/Protein	CD105,168,173,Gene/Protein	CD16,192,196,Gene/Protein	"[{""token"": ""rat"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism/Species""}, {""token"": ""Sca - 1"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""c - kit"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""CD150"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""CD105"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
In the current investigation, ( 1) we performed microarray profiles using the PKD / Mhm [ 26 ], [ 27] to measure the transcriptional changes ( mRNA and miRNAs expressions ), ( 2) comparative transcriptomic studies were conducted to elucidate the similarities with human ADPKD [ 28 ], mouse ( PKD1L3 / L3 [ 29] and PKD1 −/− [ 30 ]), Hnf1α - deficient [ 24] and Glis2lacZ / lacZ [ 25 ], and ( 3) in addition we investigated the possible regulatory roles of miRNAs on the expression levels of mRNAs change in PKD / Mhm using miRWalk database [ 31 ].	PKD,78,81,Disease/Disorder	human,264,269,Organism/Species	ADPKD,270,275,Disease/Disorder	mouse,284,289,Organism/Species	PKD1,292,296,Gene/Protein	Hnf1α,332,337,Gene/Protein	PKD,506,509,Disease/Disorder	"[{""token"": ""PKD"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 264, ""end_span"": 269, ""type"": ""Organism/Species""}, {""token"": ""ADPKD"", ""start_span"": 270, ""end_span"": 275, ""type"": ""Disease/Disorder""}, {""token"": ""mouse"", ""start_span"": 284, ""end_span"": 289, ""type"": ""Organism/Species""}, {""token"": ""PKD1"", ""start_span"": 292, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""Hnf1\u03b1"", ""start_span"": 332, ""end_span"": 337, ""type"": ""Gene/Protein""}, {""token"": ""PKD"", ""start_span"": 506, ""end_span"": 509, ""type"": ""Disease/Disorder""}]"	train
Interestingly, Pla2g2a, Pla2g4a and Ptgfrn genes ( involved in cAMP mediated signaling and calcium regulation) were also up - regulated, while negative regulators ( such as Rgs9, Rgs12 and Rgs14) of GPCR signaling were down - regulated.	Pla2g2a,15,22,Gene/Protein	Pla2g4a,24,31,Gene/Protein	Ptgfrn,36,42,Gene/Protein	Rgs9,173,177,Gene/Protein	Rgs12,179,184,Gene/Protein	Rgs14,189,194,Gene/Protein	GPCR,199,203,Gene/Protein	"[{""token"": ""Pla2g2a"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Pla2g4a"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""Ptgfrn"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Rgs9"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""Rgs12"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""Rgs14"", ""start_span"": 189, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""GPCR"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
Comparison between PKD / Mhm rat and human ADPKD datasets. This table shows the common genes obtained by comparing PKD / Mhm rat and human datasets.	PKD,19,22,Disease/Disorder	rat,29,32,Organism/Species	human,37,42,Organism/Species	ADPKD,43,48,Disease/Disorder	PKD,115,118,Disease/Disorder	rat,125,128,Organism/Species	human,133,138,Organism/Species	"[{""token"": ""PKD"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Disease/Disorder""}, {""token"": ""rat"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism/Species""}, {""token"": ""ADPKD"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Disease/Disorder""}, {""token"": ""PKD"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Disease/Disorder""}, {""token"": ""rat"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Organism/Species""}]"	train
Agents such as sorafenib [ 87, 88 ], erlotinib [ 89 – 91 ], lapatinib [ 92 ], panitumumab [ 93 ], cetuximab [ 94 ], sunitinib [ 95 ], and bevacizumab [ 89, 96] have all been evaluated in phase II trials as single agents or in combination with gemcitabine combination with no significant increase in overall survival noted.	sorafenib,15,24,Chemical/Drug	erlotinib,37,46,Chemical/Drug	lapatinib,60,69,Chemical/Drug	panitumumab,78,89,Chemical/Drug	cetuximab,98,107,Chemical/Drug	sunitinib,116,125,Chemical/Drug	gemcitabine,243,254,Chemical/Drug	"[{""token"": ""sorafenib"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""erlotinib"", ""start_span"": 37, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""lapatinib"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""panitumumab"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""cetuximab"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""sunitinib"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""gemcitabine"", ""start_span"": 243, ""end_span"": 254, ""type"": ""Chemical/Drug""}]"	train
Major classes of dressings include: alginate, for example Aquacel ( ConvaTec, Bridgewater, NJ, USA ), Comfeel ( Coloplast, Minneapolis, MN, USA ), or Sorbsan ( Mylan, Morgantown, WV, USA ); antimicrobial, for example Acticoat ( Smith & Nephew, London, UK) or Silverlon ( Argentum, Geneva, IL, USA ); collagen, for example Fibracol ( Johnson & Johnson, New Brunswick, NJ) or Puracol ( Medline, Mundelein, IL, USA ); hydrocolloid, for example Duoderm ( ConvaTec, Bridgewater, NJ, USA ), Granuflex ( ConvaTec, Bridgewater, NJ, USA ), or Tegaderm ( 3M, Maplewood, MN, USA ); hydrogel, for example Dermagel ( Maximilian Zenho & Co, Brussels, Belgium ), SilvaSorb ( Medline, Mundelein, IL, USA ), or Skintegrity ( Medline, Mundelein, IL, USA ); and polyurethane foam, for example Allevyn ( Smith & Nephew, London, UK) or Lyofoa ( Molnycke, Gothenburg, Sweden ).	Comfeel,102,109,Chemical/Drug	Mylan,160,165,Chemical/Drug	Silverlon,259,268,Chemical/Drug	collagen,300,308,Gene/Protein	Fibracol,322,330,Chemical/Drug	Puracol,374,381,Chemical/Drug	Granuflex,485,494,Chemical/Drug	"[{""token"": ""Comfeel"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""Mylan"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Chemical/Drug""}, {""token"": ""Silverlon"", ""start_span"": 259, ""end_span"": 268, ""type"": ""Chemical/Drug""}, {""token"": ""collagen"", ""start_span"": 300, ""end_span"": 308, ""type"": ""Gene/Protein""}, {""token"": ""Fibracol"", ""start_span"": 322, ""end_span"": 330, ""type"": ""Chemical/Drug""}, {""token"": ""Puracol"", ""start_span"": 374, ""end_span"": 381, ""type"": ""Chemical/Drug""}, {""token"": ""Granuflex"", ""start_span"": 485, ""end_span"": 494, ""type"": ""Chemical/Drug""}]"	train
As expected, the CUG513 initiated PTENα ORF was translated into three distinct proteins with masses of 120 + kDa ( PTENα - GFP ), 120 kDa ( PTENβ - GFP) and 90 kDa ( PTEN - GFP) ( Fig. 2b, lower panel ).	PTENα,34,39,Gene/Protein	PTENα,115,120,Gene/Protein	GFP,123,126,Gene/Protein	PTENβ,140,145,Gene/Protein	GFP,148,151,Gene/Protein	PTEN,166,170,Gene/Protein	GFP,173,176,Gene/Protein	"[{""token"": ""PTEN\u03b1"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b1"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""PTEN"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
Separate plasmids expressing C - terminal GFP - tagged PTEN, PTENα or PTENβ were constructed, and to ensure expression of only a single isoform in each instance, we created an ATG1032 > ATA mutation in GFP - tagged PTENα and PTENβ ( Fig. 4a ).	GFP,42,45,Gene/Protein	PTEN,55,59,Gene/Protein	PTENα,61,66,Gene/Protein	PTENβ,70,75,Gene/Protein	GFP,202,205,Gene/Protein	PTENα,215,220,Gene/Protein	PTENβ,225,230,Gene/Protein	"[{""token"": ""GFP"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""PTEN"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b1"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b1"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
These results raised the possibility that PTENβ acts as a nucleolin phosphatase. In vitro dephosphorylation assays further verified Cdk1 / CyclinB1 - phosphorylated nucleolin Thr84 is a target of PTENβ for dephosphorylation ( Fig. 5j, lane 5 versus lane 4 ).	PTENβ,42,47,Gene/Protein	nucleolin,58,67,Gene/Protein	phosphatase,68,79,Gene/Protein	Cdk1,132,136,Gene/Protein	CyclinB1,139,147,Gene/Protein	nucleolin,165,174,Gene/Protein	PTENβ,196,201,Gene/Protein	"[{""token"": ""PTEN\u03b2"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""phosphatase"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Cdk1"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""CyclinB1"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
The interaction between host and parasite genotypes govern, for example, the variability of the virulence and transmission of Holospora undulata [ 26 ], and the production of the fruiting bodies of the fungus Epichloë elymi depends on the genotype of the grass Elymus hystrix on which the fungus is growing [ 27 ].	parasite,33,41,Organism/Species	Holospora undulata,126,144,Organism/Species	fungus,202,208,Organism/Species	Epichloë elymi,209,223,Organism/Species	grass,255,260,Organism/Species	Elymus hystrix,261,275,Organism/Species	fungus,289,295,Organism/Species	"[{""token"": ""parasite"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""Holospora undulata"", ""start_span"": 126, ""end_span"": 144, ""type"": ""Organism/Species""}, {""token"": ""fungus"", ""start_span"": 202, ""end_span"": 208, ""type"": ""Organism/Species""}, {""token"": ""Epichlo\u00eb elymi"", ""start_span"": 209, ""end_span"": 223, ""type"": ""Organism/Species""}, {""token"": ""grass"", ""start_span"": 255, ""end_span"": 260, ""type"": ""Organism/Species""}, {""token"": ""Elymus hystrix"", ""start_span"": 261, ""end_span"": 275, ""type"": ""Organism/Species""}, {""token"": ""fungus"", ""start_span"": 289, ""end_span"": 295, ""type"": ""Organism/Species""}]"	train
After excision, chondrocytes were cultured and expanded in low - glucose DMEM with 10% fetal bovine serum ( Lonza, Waverly, Australia ), 2 mM glutamax, 10 mM 4 -( 2 - hydroxyethyl )- 1 - piperazineethanesulfonic acid ( HEPES ), 0. 1 mM non - essential amino acids ( NEAAs ), 0. 5 µg · mL − 1 amphotericin B ( Fungizone ®; Thermo Fisher Scientific, Waltham, MA, USA ), 50 U · mL − 1 penicillin G sodium, 50 µg · mL − 1 streptomycin ( all Invitrogen; Thermo Fisher Scientific, Waltham, MA, USA ), 0. 4 mM l - proline and 0. 1 mM ascorbic acid ( Sigma) and used at passage 3.	glutamax,142,150,Chemical/Drug	amino acids,252,263,Chemical/Drug	amphotericin B,292,306,Chemical/Drug	Fungizone,309,318,Chemical/Drug	penicillin G sodium,382,401,Chemical/Drug	streptomycin,418,430,Chemical/Drug	ascorbic acid,527,540,Chemical/Drug	"[{""token"": ""glutamax"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""amino acids"", ""start_span"": 252, ""end_span"": 263, ""type"": ""Chemical/Drug""}, {""token"": ""amphotericin B"", ""start_span"": 292, ""end_span"": 306, ""type"": ""Chemical/Drug""}, {""token"": ""Fungizone"", ""start_span"": 309, ""end_span"": 318, ""type"": ""Chemical/Drug""}, {""token"": ""penicillin G sodium"", ""start_span"": 382, ""end_span"": 401, ""type"": ""Chemical/Drug""}, {""token"": ""streptomycin"", ""start_span"": 418, ""end_span"": 430, ""type"": ""Chemical/Drug""}, {""token"": ""ascorbic acid"", ""start_span"": 527, ""end_span"": 540, ""type"": ""Chemical/Drug""}]"	train
Antibodies for collagen type I ( I - 8H5, MP Biomedicals, Seven Hills, Australia, 1: 300 dilution ), collagen type II ( II - II6B3, Developmental Studies Hybridoma Bank ( DSHB ), Iowa City, IA, USA, 1: 200 dilution ), collagen type X ( 14 - 9771 - 82 Clone X53, Jomar Bioscience Pty Ltd ., Kensington, Australia, 1: 300 dilution ), aggrecan ( 969D4D11, Life Technologies 1: 300 dilution) or isotype controls ( mouse IgG, Jackson, 1: 1000) were used.	Antibodies,0,10,Gene/Protein	collagen type I,15,30,Gene/Protein	collagen type II,101,117,Gene/Protein	collagen type X,218,233,Gene/Protein	aggrecan,332,340,Gene/Protein	mouse,410,415,Organism/Species	IgG,416,419,Gene/Protein	"[{""token"": ""Antibodies"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""collagen type I"", ""start_span"": 15, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""collagen type II"", ""start_span"": 101, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""collagen type X"", ""start_span"": 218, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""aggrecan"", ""start_span"": 332, ""end_span"": 340, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 410, ""end_span"": 415, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 416, ""end_span"": 419, ""type"": ""Gene/Protein""}]"	train
The observed MBP - E6 in vitro p53 degradation activity was comparable to that observed for a mutant MBP - E6 in which six or four ( bold) cysteines ( C16, C51, C80, C97, C111, C140) were all replaced with serines [ 28, 29 ].	MBP,13,16,Gene/Protein	E6,19,21,Gene/Protein	p53,31,34,Gene/Protein	MBP,101,104,Gene/Protein	E6,107,109,Gene/Protein	cysteines,139,148,Chemical/Drug	serines,206,213,Chemical/Drug	"[{""token"": ""MBP"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""E6"", ""start_span"": 19, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""E6"", ""start_span"": 107, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""cysteines"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""serines"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Chemical/Drug""}]"	train
The classic suf locus contains sufA, sufB, sufC, sufD, sufS, and sufE ( Fig. S2 ).	suf,12,15,Gene/Protein	sufA,31,35,Gene/Protein	sufB,37,41,Gene/Protein	sufC,43,47,Gene/Protein	sufD,49,53,Gene/Protein	sufS,55,59,Gene/Protein	sufE,65,69,Gene/Protein	"[{""token"": ""suf"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""sufA"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""sufB"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""sufC"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""sufD"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""sufS"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""sufE"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}]"	train
The family Geminiviridae is divided into four genera, ( Begomovirus, Mastrevirus, Curtovirus and Topocuvirus) that encompass viruses that differ in genome organization as well as their insect vectors.	Geminiviridae,11,24,Organism/Species	Begomovirus,56,67,Organism/Species	Mastrevirus,69,80,Organism/Species	Curtovirus,82,92,Organism/Species	Topocuvirus,97,108,Organism/Species	viruses,125,132,Organism/Species	insect,185,191,Organism/Species	"[{""token"": ""Geminiviridae"", ""start_span"": 11, ""end_span"": 24, ""type"": ""Organism/Species""}, {""token"": ""Begomovirus"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""Mastrevirus"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""Curtovirus"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""Topocuvirus"", ""start_span"": 97, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""viruses"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Organism/Species""}, {""token"": ""insect"", ""start_span"": 185, ""end_span"": 191, ""type"": ""Organism/Species""}]"	train
Infection of tobacco with Tobacco mosaic virus ( TMV) or bacteria, or treatment with fungal elicitors, salicylic acid ( SA) or H2O2, strongly induces several WRKY genes [ 29, 30 ].	Infection,0,9,Disease/Disorder	tobacco,13,20,Organism/Species	Tobacco mosaic virus,26,46,Organism/Species	TMV,49,52,Organism/Species	bacteria,57,65,Organism/Species	salicylic acid,103,117,Chemical/Drug	WRKY,158,162,Gene/Protein	"[{""token"": ""Infection"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Disease/Disorder""}, {""token"": ""tobacco"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Organism/Species""}, {""token"": ""Tobacco mosaic virus"", ""start_span"": 26, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""TMV"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""salicylic acid"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Chemical/Drug""}, {""token"": ""WRKY"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
The SAC DNA sequence shows 93% nucleotide sequence identity with both NADH dehydrogenase subunit 1 ( ndh1) and NADH dehydrogenase subunit 2 ( ndh2) of N. tabacum mitochondrial genes, also known as NADH oxidoreductase.	SAC,4,7,Gene/Protein	nucleotide,31,41,Chemical/Drug	NADH dehydrogenase subunit 1,70,98,Gene/Protein	ndh1,101,105,Gene/Protein	NADH dehydrogenase subunit 2,111,139,Gene/Protein	ndh2,142,146,Gene/Protein	NADH oxidoreductase,197,216,Gene/Protein	"[{""token"": ""SAC"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""NADH dehydrogenase subunit 1"", ""start_span"": 70, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""ndh1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""NADH dehydrogenase subunit 2"", ""start_span"": 111, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""ndh2"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""NADH oxidoreductase"", ""start_span"": 197, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
In recent studies, we have shown that secretions from Bifidobacteria infantis, another “ pioneer ” bacteria, can mediate IL - 1β - induced anti - inflammation in fetal intestine via the TLR4 receptor [ 11 ], suggesting that increased expression of TLR2 and TLR4 on the immature intestinal surface may help to mediate anti - inflammation from these “ pioneer ” neonatal bacteria.	Bifidobacteria infantis,54,77,Organism/Species	bacteria,99,107,Organism/Species	IL - 1β,121,128,Gene/Protein	TLR4 receptor,186,199,Gene/Protein	TLR2,248,252,Gene/Protein	TLR4,257,261,Gene/Protein	bacteria,369,377,Organism/Species	"[{""token"": ""Bifidobacteria infantis"", ""start_span"": 54, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""TLR4 receptor"", ""start_span"": 186, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 248, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 257, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 369, ""end_span"": 377, ""type"": ""Organism/Species""}]"	train
This anti - inflammation is both TLR2 and TLR4 dependent and mediated in part through a down regulation of P - c - Jun and P - c - Fos of the AP1 ( TLR2 response ), a developmentally - regulated transcription factor.	TLR2,33,37,Gene/Protein	TLR4,42,46,Gene/Protein	c - Jun,111,118,Gene/Protein	c - Fos,127,134,Gene/Protein	AP1,142,145,Gene/Protein	TLR2,148,152,Gene/Protein	transcription factor,195,215,Gene/Protein	"[{""token"": ""TLR2"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 195, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
In this study, we tested the hypothesis that different LED - generated light qualities ( ranging from UV - A to green) can alter the growth as well as the metabolic composition ( flavonoids and glucosinolates) of Brassica oleracea var. italic ( broccoli) plants and indirectly influence ( via plant metabolites) the choice of host plant and performance of the cabbage aphid B. brassicae.	flavonoids,179,189,Chemical/Drug	glucosinolates,194,208,Chemical/Drug	broccoli,245,253,Organism/Species	plants,255,261,Organism/Species	plant,293,298,Organism/Species	plant,331,336,Organism/Species	cabbage aphid,360,373,Organism/Species	"[{""token"": ""flavonoids"", ""start_span"": 179, ""end_span"": 189, ""type"": ""Chemical/Drug""}, {""token"": ""glucosinolates"", ""start_span"": 194, ""end_span"": 208, ""type"": ""Chemical/Drug""}, {""token"": ""broccoli"", ""start_span"": 245, ""end_span"": 253, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 255, ""end_span"": 261, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 293, ""end_span"": 298, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 331, ""end_span"": 336, ""type"": ""Organism/Species""}, {""token"": ""cabbage aphid"", ""start_span"": 360, ""end_span"": 373, ""type"": ""Organism/Species""}]"	train
Broccoli plants in a previous study that were grown under UV - B treatments contained up to 4100 μg g - 1 d. w. of single kaempferol glycosides such as kaempferol - 3 - O - caffeoyl - sophoroside - 7 - O - glucoside [ 6 ], while broccoli plants treated with longer wavelength in the present study contained low concentrations (< 100 μg g - 1 d. w .) of all specific kaempferol glycosides even though the illumination times, overall light intensities, and plant stages were the same in both studies ( Fig 7 ).	Broccoli,0,8,Organism/Species	plants,9,15,Organism/Species	kaempferol glycosides,122,143,Chemical/Drug	broccoli,229,237,Organism/Species	plants,238,244,Organism/Species	kaempferol glycosides,366,387,Chemical/Drug	plant,455,460,Organism/Species	"[{""token"": ""Broccoli"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""kaempferol glycosides"", ""start_span"": 122, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""broccoli"", ""start_span"": 229, ""end_span"": 237, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Organism/Species""}, {""token"": ""kaempferol glycosides"", ""start_span"": 366, ""end_span"": 387, ""type"": ""Chemical/Drug""}, {""token"": ""plant"", ""start_span"": 455, ""end_span"": 460, ""type"": ""Organism/Species""}]"	train
The green peach aphid Myzus persicae, on the other hand, preferred Chinese cabbage plants with reduced concentrations of glucosinolates, indicating that secondary plant metabolites could affect host selection by aphids [ 38 ].	green peach aphid,4,21,Organism/Species	Myzus persicae,22,36,Organism/Species	Chinese cabbage,67,82,Organism/Species	plants,83,89,Organism/Species	glucosinolates,121,135,Chemical/Drug	plant,163,168,Organism/Species	aphids,212,218,Organism/Species	"[{""token"": ""green peach aphid"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Organism/Species""}, {""token"": ""Myzus persicae"", ""start_span"": 22, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""Chinese cabbage"", ""start_span"": 67, ""end_span"": 82, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Organism/Species""}, {""token"": ""glucosinolates"", ""start_span"": 121, ""end_span"": 135, ""type"": ""Chemical/Drug""}, {""token"": ""plant"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Organism/Species""}, {""token"": ""aphids"", ""start_span"": 212, ""end_span"": 218, ""type"": ""Organism/Species""}]"	train
The in vitro studies on the BCRP efflux system have demonstrated that some cell lines displayed erratic efflux profiles of doxorubicin and rhodamine 123, and these observations were attributable to 482nd position in the amino acid sequence consisting of arginine, glycine or threonine residues which are susceptible to numerous posttranslational modifications [ 18 - 20 ].	BCRP,28,32,Gene/Protein	doxorubicin,123,134,Chemical/Drug	rhodamine 123,139,152,Chemical/Drug	amino acid,220,230,Chemical/Drug	arginine,254,262,Chemical/Drug	glycine,264,271,Chemical/Drug	threonine,275,284,Chemical/Drug	"[{""token"": ""BCRP"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""doxorubicin"", ""start_span"": 123, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""rhodamine 123"", ""start_span"": 139, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""amino acid"", ""start_span"": 220, ""end_span"": 230, ""type"": ""Chemical/Drug""}, {""token"": ""arginine"", ""start_span"": 254, ""end_span"": 262, ""type"": ""Chemical/Drug""}, {""token"": ""glycine"", ""start_span"": 264, ""end_span"": 271, ""type"": ""Chemical/Drug""}, {""token"": ""threonine"", ""start_span"": 275, ""end_span"": 284, ""type"": ""Chemical/Drug""}]"	train
Previously, it was shown that one of the four human homologs of Drosophila piwi, PIWIL1 ( a. k. a ., HIWI ), is expressed in CD34 + cells of normal human peripheral blood [ 5 ].	human,46,51,Organism/Species	Drosophila,64,74,Organism/Species	piwi,75,79,Gene/Protein	PIWIL1,81,87,Gene/Protein	HIWI,101,105,Gene/Protein	CD34,125,129,Gene/Protein	human,148,153,Organism/Species	"[{""token"": ""human"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""Drosophila"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""piwi"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""PIWIL1"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""HIWI"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Organism/Species""}]"	train
Enucleated red blood cells were lysed with BD FACS Lysing Solution ( BD Biosciences) following manufacturer ' s protocol and remaining cells were stained with antibodies to detect donor derived cells and committed lineages: CD45. 2 - FITC, B cells ( B220 - APC ), T cells ( CD3 - PE Cy5 ), Myeloid ( CD11b - PE ).	antibodies,159,169,Gene/Protein	B220,250,254,Gene/Protein	APC,257,260,Gene/Protein	CD3,274,277,Gene/Protein	PE,280,282,Gene/Protein	CD11b,300,305,Gene/Protein	PE,308,310,Gene/Protein	"[{""token"": ""antibodies"", ""start_span"": 159, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""B220"", ""start_span"": 250, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""APC"", ""start_span"": 257, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 274, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 280, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 300, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 308, ""end_span"": 310, ""type"": ""Gene/Protein""}]"	train
Based on their carbohydrate specificity, divalent cation requirements, presence of conserved sequence motifs in their carbohydrate binding domains ( CRDs ), and most recently their structural folds, animal lectins have classified into several families such as C -, F -, I - and P - type lectins, ficolins and galectins.	carbohydrate,15,27,Chemical/Drug	carbohydrate,118,130,Chemical/Drug	animal,199,205,Organism/Species	lectins,206,213,Gene/Protein	P - type lectins,278,294,Gene/Protein	ficolins,296,304,Gene/Protein	galectins,309,318,Gene/Protein	"[{""token"": ""carbohydrate"", ""start_span"": 15, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""carbohydrate"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""animal"", ""start_span"": 199, ""end_span"": 205, ""type"": ""Organism/Species""}, {""token"": ""lectins"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""P - type lectins"", ""start_span"": 278, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""ficolins"", ""start_span"": 296, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""galectins"", ""start_span"": 309, ""end_span"": 318, ""type"": ""Gene/Protein""}]"	train
( A) Shrimp hemocytes ( 2 × 104 cells / ml) were added to the slide glass pre - coated with rMjGal, rMjGal with lactose, Trx - His, or Trx - His with lactose.	Shrimp,5,11,Organism/Species	rMjGal,92,98,Gene/Protein	rMjGal,100,106,Gene/Protein	lactose,112,119,Chemical/Drug	Trx,121,124,Gene/Protein	Trx,135,138,Gene/Protein	lactose,150,157,Chemical/Drug	"[{""token"": ""Shrimp"", ""start_span"": 5, ""end_span"": 11, ""type"": ""Organism/Species""}, {""token"": ""rMjGal"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""rMjGal"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""lactose"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""Trx"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""Trx"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""lactose"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Chemical/Drug""}]"	train
In this study, we identified and functionally characterized for the first time a novel galectin from the kuruma shrimp, M. japonicus. The shrimp galectin is upregulated by infectious challenge, and can recognize and opsonize potentially pathogenic bacteria by binding to the hemocyte surface and promoting phagocytosis, and silencing of its expression in vivo results in reduced bacterial clearance rates in hemolymph, suggesting that MjGal plays a key role in immune defense against bacterial infection.	galectin,87,95,Gene/Protein	kuruma shrimp,105,118,Organism/Species	shrimp,138,144,Organism/Species	galectin,145,153,Gene/Protein	bacteria,248,256,Organism/Species	MjGal,435,440,Gene/Protein	bacterial infection,484,503,Disease/Disorder	"[{""token"": ""galectin"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""kuruma shrimp"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""shrimp"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Organism/Species""}, {""token"": ""galectin"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 248, ""end_span"": 256, ""type"": ""Organism/Species""}, {""token"": ""MjGal"", ""start_span"": 435, ""end_span"": 440, ""type"": ""Gene/Protein""}, {""token"": ""bacterial infection"", ""start_span"": 484, ""end_span"": 503, ""type"": ""Disease/Disorder""}]"	train
The Shank3 TG mice mildly overexpress Shank3 proteins ( by approximately 50 %) compared to wild - type ( WT) mice, and thus, could potentially model human patients with SHANK3 gene duplications who usually have an additional copy of SHANK3 gene.	Shank3,4,10,Gene/Protein	mice,14,18,Organism/Species	Shank3,38,44,Gene/Protein	mice,109,113,Organism/Species	human,149,154,Organism/Species	SHANK3,169,175,Gene/Protein	SHANK3,233,239,Gene/Protein	"[{""token"": ""Shank3"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Organism/Species""}, {""token"": ""Shank3"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Organism/Species""}, {""token"": ""SHANK3"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""SHANK3"", ""start_span"": 233, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
The actin filament bundling protein, α - actinin 2 ( ACTN2 ), is the only common interactor for all four proteins. ( C) The interactome network of Shank3, TSC1 / TSC2 and Rhes.	actin,4,9,Gene/Protein	α - actinin 2,37,50,Gene/Protein	ACTN2,53,58,Gene/Protein	Shank3,147,153,Gene/Protein	TSC1,155,159,Gene/Protein	TSC2,162,166,Gene/Protein	Rhes,171,175,Gene/Protein	"[{""token"": ""actin"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1 - actinin 2"", ""start_span"": 37, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""ACTN2"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""TSC1"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""TSC2"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""Rhes"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
Among them, we hypothesized that actin regulatory pathway might be important, because ACTN2, an actin filament bundling protein ( Djinovic - Carugo et al ., 1999 ), was identified as the only common interactor for Shank3, TSC1 / TSC2, and Rhes.	actin,33,38,Gene/Protein	ACTN2,86,91,Gene/Protein	actin,96,101,Gene/Protein	Shank3,214,220,Gene/Protein	TSC1,222,226,Gene/Protein	TSC2,229,233,Gene/Protein	Rhes,239,243,Gene/Protein	"[{""token"": ""actin"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""ACTN2"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 214, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""TSC1"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""TSC2"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""Rhes"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Moreover, PICK1, a common interactor for Shank3 and TSC1 / TSC2, is also involved in regulating actin cytoskeleton by inhibiting the actin - nucleating Arp2 / 3 complex ( Rocca et al ., 2008 ).	PICK1,10,15,Gene/Protein	Shank3,41,47,Gene/Protein	TSC1,52,56,Gene/Protein	TSC2,59,63,Gene/Protein	actin,96,101,Gene/Protein	actin,133,138,Gene/Protein	Arp2,152,156,Gene/Protein	"[{""token"": ""PICK1"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""TSC1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""TSC2"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Arp2"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Data are presented as mean ± SEM ( n = 7 animals per genotype; * P < 0. 05, unpaired two - tailed Student ’ s t - test ). ( D) Western blot images show co - immunoprecipitation ( IP) of EGFP - Shank3, Rhes, WAVE1, and Homer1b / c proteins from the Shank3 TG, but not WT, synaptosomal lysate.	animals,41,48,Organism/Species	EGFP,186,190,Gene/Protein	Shank3,193,199,Gene/Protein	Rhes,201,205,Gene/Protein	WAVE1,207,212,Gene/Protein	Homer1b / c,218,229,Gene/Protein	Shank3,248,254,Gene/Protein	"[{""token"": ""animals"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""EGFP"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""Rhes"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""WAVE1"", ""start_span"": 207, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""Homer1b / c"", ""start_span"": 218, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 248, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
One possibility is that Shank3 overexpression might shift or sequester TSC1 / TSC2 and Rhes proteins from mTORC1 regulatory complex to actin filaments - related complex and thereby disturb the maintenance of normal mTORC1 activity.	Shank3,24,30,Gene/Protein	TSC1,71,75,Gene/Protein	TSC2,78,82,Gene/Protein	Rhes,87,91,Gene/Protein	mTORC1,106,112,Gene/Protein	actin,135,140,Gene/Protein	mTORC1,215,221,Gene/Protein	"[{""token"": ""Shank3"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""TSC1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""TSC2"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Rhes"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 215, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Despite normal Akt activity in the Shank3 TG striatum, however, treatments with certain molecules that increase Akt activity such as IGF1, might possibly rescue the decreased striatal mTORC1 activity and some behavioral abnormalities in the Shank3 TG mice.	Akt,15,18,Gene/Protein	Shank3,35,41,Gene/Protein	Akt,112,115,Gene/Protein	IGF1,133,137,Gene/Protein	mTORC1,184,190,Gene/Protein	Shank3,241,247,Gene/Protein	mice,251,255,Organism/Species	"[{""token"": ""Akt"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""Akt"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""IGF1"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 241, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Organism/Species""}]"	train
The graph shows the results of qRT - PCR experiments validating an increase in the expression of Shank3, Gpr85 and Clic6, and a decrease in the expression of Plk5 in the striatum of Shank3 TG mice compared to WT mice.	Shank3,97,103,Gene/Protein	Gpr85,105,110,Gene/Protein	Clic6,115,120,Gene/Protein	Plk5,158,162,Gene/Protein	Shank3,182,188,Gene/Protein	mice,192,196,Organism/Species	mice,212,216,Organism/Species	"[{""token"": ""Shank3"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Gpr85"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""Clic6"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Plk5"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Organism/Species""}]"	train
Recently a large number of HER4 antibodies were screened using both cell lines transfected with HER1, HER2, HER3, and HER4; and breast carcinoma samples [ 29 ].	HER4,27,31,Gene/Protein	antibodies,32,42,Gene/Protein	HER1,96,100,Gene/Protein	HER2,102,106,Gene/Protein	HER3,108,112,Gene/Protein	HER4,118,122,Gene/Protein	breast carcinoma,128,144,Disease/Disorder	"[{""token"": ""HER4"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""HER1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""HER3"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""breast carcinoma"", ""start_span"": 128, ""end_span"": 144, ""type"": ""Disease/Disorder""}]"	train
These findings demonstrate the clinical value of addition of HER4 expression data in the context of other standard markers including HER2, estrogen receptor ( ER ), progesterone receptor ( PR) and Ki - 67.	HER4,61,65,Gene/Protein	HER2,133,137,Gene/Protein	estrogen receptor,139,156,Gene/Protein	ER,159,161,Gene/Protein	progesterone receptor,165,186,Gene/Protein	PR,189,191,Gene/Protein	Ki - 67,197,204,Gene/Protein	"[{""token"": ""HER4"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""estrogen receptor"", ""start_span"": 139, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""ER"", ""start_span"": 159, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""progesterone receptor"", ""start_span"": 165, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""PR"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""Ki - 67"", ""start_span"": 197, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
In the neoadjuvant cohort, ER expression was observed in 11 out of 12 cases that over - expressed HER4 ( HER2 - Pos and HER4 - Pos) and 13 out of 24 cases that lacked HER4 over - expression ( HER2 - Pos and HER4 - Neg ).	ER,27,29,Gene/Protein	HER4,98,102,Gene/Protein	HER2,105,109,Gene/Protein	HER4,120,124,Gene/Protein	HER4,167,171,Gene/Protein	HER2,192,196,Gene/Protein	HER4,207,211,Gene/Protein	"[{""token"": ""ER"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Similarly, in the metastatic cohort, ER expression was observed in 10 out of 11 cases that over - expressed HER4 ( HER2 - Pos and HER4 - Pos) and 8 out of 16 cases that lacked HER4 over - expression ( HER2 - Pos and HER4 - Neg) ( Supplemental Table 2 ).	ER,37,39,Gene/Protein	HER4,108,112,Gene/Protein	HER2,115,119,Gene/Protein	HER4,130,134,Gene/Protein	HER4,176,180,Gene/Protein	HER2,201,205,Gene/Protein	HER4,216,220,Gene/Protein	"[{""token"": ""ER"", ""start_span"": 37, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
Briefly, 4 μm formalin fixed paraffin embedded ( FFPE) tissue sections were used for automated staining carried out on the Ventana Benchmark XT system ( Ventana Medical Systems, Tucson, AZ) using the PATHWAY ® anti - HER2 / neu ( 4B5) rabbit monoclonal primary antibody ( Ventana Medical Systems, Tucson, AZ ), Anti - HER4 ( E200) rabbit monoclonal primary antibody ( Epitomics, Burlingame, CA) and ultraVIEW DAB detection kit ( Ventana Medical Systems, Tucson, AZ ).	HER2,217,221,Gene/Protein	neu,224,227,Gene/Protein	rabbit,235,241,Organism/Species	antibody,261,269,Gene/Protein	HER4,318,322,Gene/Protein	rabbit,331,337,Organism/Species	antibody,357,365,Gene/Protein	"[{""token"": ""HER2"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""neu"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 235, ""end_span"": 241, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 261, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 318, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 331, ""end_span"": 337, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 357, ""end_span"": 365, ""type"": ""Gene/Protein""}]"	train
We conclude that there is a basal oscillation mechanism of the BMP - induced expression of id1 and smad6. Oscillating target gene transcription is supported by the fact that hes1 expression, which is controlled by BMP2 in embryonic stem cells, has been found to oscillate and a hes1 - promoter driven Luciferase mimics this oscillatory expression [ 35 ].	BMP,63,66,Gene/Protein	id1,91,94,Gene/Protein	smad6,99,104,Gene/Protein	hes1,174,178,Gene/Protein	BMP2,214,218,Gene/Protein	hes1,278,282,Gene/Protein	Luciferase,301,311,Gene/Protein	"[{""token"": ""BMP"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""id1"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""smad6"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""hes1"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""BMP2"", ""start_span"": 214, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""hes1"", ""start_span"": 278, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""Luciferase"", ""start_span"": 301, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	train
The prevalence of HPV 26, 53, 66, 73, 82 is underestimated because these HPV types are detected by the “ Consensus High Risk HPV genotyping ” assay, but they are not targeted by HR - HC2 test; the detection of HPV 26, 53, 66, 73, 82 is due to an occasional cross - hybridization of HR - HC2 method or co - infection with HPV - targeted types, therefore they could more likely appear in multiple than single infections.	HPV,18,21,Organism/Species	HPV,73,76,Organism/Species	HPV,125,128,Organism/Species	HPV,210,213,Organism/Species	co - infection,301,315,Disease/Disorder	HPV,321,324,Organism/Species	infections,407,417,Disease/Disorder	"[{""token"": ""HPV"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Organism/Species""}, {""token"": ""HPV"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Organism/Species""}, {""token"": ""HPV"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""HPV"", ""start_span"": 210, ""end_span"": 213, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 301, ""end_span"": 315, ""type"": ""Disease/Disorder""}, {""token"": ""HPV"", ""start_span"": 321, ""end_span"": 324, ""type"": ""Organism/Species""}, {""token"": ""infections"", ""start_span"": 407, ""end_span"": 417, ""type"": ""Disease/Disorder""}]"	train
The effect of the nasal challenge with CpG DNA against serum immunoglobulins ( IgG, IgA, IgM, and IgA – IgG ICs) and urinary albumin were not different in each dietary group ( data not shown ).	immunoglobulins,61,76,Gene/Protein	IgG,79,82,Gene/Protein	IgA,84,87,Gene/Protein	IgM,89,92,Gene/Protein	IgA,98,101,Gene/Protein	IgG,104,107,Gene/Protein	albumin,125,132,Gene/Protein	"[{""token"": ""immunoglobulins"", ""start_span"": 61, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IgA"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""IgM"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""IgA"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""albumin"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
MyD88 induces inflammatory responses by activating NF - κB and MAPK, whereas TRIF recruits TRADD, TRAF6, and TRAF3.	MyD88,0,5,Gene/Protein	NF - κB,51,58,Gene/Protein	MAPK,63,67,Gene/Protein	TRIF,77,81,Gene/Protein	TRADD,91,96,Gene/Protein	TRAF6,98,103,Gene/Protein	TRAF3,109,114,Gene/Protein	"[{""token"": ""MyD88"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""TRIF"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""TRAF6"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	train
On the other hand, TRAF3 activates some kinases, such as TBK1 and IKKi, and subsequently, IRF3, which is a key transcriptional factor for interferon - β [ 29 ].	TRAF3,19,24,Gene/Protein	kinases,40,47,Gene/Protein	TBK1,57,61,Gene/Protein	IKKi,66,70,Gene/Protein	IRF3,90,94,Gene/Protein	transcriptional factor,111,133,Gene/Protein	interferon - β,138,152,Gene/Protein	"[{""token"": ""TRAF3"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""kinases"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""TBK1"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IKKi"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IRF3"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional factor"", ""start_span"": 111, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""interferon - \u03b2"", ""start_span"": 138, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
The following eight families are provided in the figure: ligand - dependent nuclear receptor, peptidase, phosphatase, transporter, ion channel, kinase, transcription regulator, enzymes and others.	ligand - dependent nuclear receptor,57,92,Gene/Protein	peptidase,94,103,Gene/Protein	phosphatase,105,116,Gene/Protein	transporter,118,129,Gene/Protein	ion channel,131,142,Gene/Protein	kinase,144,150,Gene/Protein	transcription regulator,152,175,Gene/Protein	"[{""token"": ""ligand - dependent nuclear receptor"", ""start_span"": 57, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""peptidase"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""phosphatase"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""transporter"", ""start_span"": 118, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""ion channel"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""transcription regulator"", ""start_span"": 152, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
In addition, CADM2 ( cell adhesion molecule 2 ), HIST1H2AG ( histone cluster 1, H2ag ), NEBL ( nebulette) and IGHA1 play roles in junction organization, nucleosome assembly, actin filament length and immune response, respectively.	CADM2,13,18,Gene/Protein	cell adhesion molecule 2,21,45,Gene/Protein	HIST1H2AG,49,58,Gene/Protein	NEBL,88,92,Gene/Protein	nebulette,95,104,Gene/Protein	IGHA1,110,115,Gene/Protein	actin,174,179,Gene/Protein	"[{""token"": ""CADM2"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""cell adhesion molecule 2"", ""start_span"": 21, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""HIST1H2AG"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""NEBL"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""nebulette"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IGHA1"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Furthermore, in this study, we show that many of the genes activated at 24 h encode for chemokines that play central roles in inflammation ( i. e ., IL - 8, IL - 10, IL - 22, IL - 15 and JAK family kinases ).	chemokines,88,98,Gene/Protein	IL - 8,149,155,Gene/Protein	IL - 10,157,164,Gene/Protein	IL - 22,166,173,Gene/Protein	IL - 15,175,182,Gene/Protein	JAK,187,190,Gene/Protein	kinases,198,205,Gene/Protein	"[{""token"": ""chemokines"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""IL - 22"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""kinases"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
In corticosteroid - resistant patients, they reported an increase in the proportion of sequences of microorganisms in the phyla Actinobacteria and Proteobacteria, and reduced sequences for the genera Prevotella and Veillonella, and Phylum Fusobacteria compared to normal control subjects [ 23 ].	corticosteroid,3,17,Chemical/Drug	microorganisms,100,114,Organism/Species	Actinobacteria,128,142,Organism/Species	Proteobacteria,147,161,Organism/Species	Prevotella,200,210,Organism/Species	Veillonella,215,226,Organism/Species	Fusobacteria,239,251,Organism/Species	"[{""token"": ""corticosteroid"", ""start_span"": 3, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""microorganisms"", ""start_span"": 100, ""end_span"": 114, ""type"": ""Organism/Species""}, {""token"": ""Actinobacteria"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Organism/Species""}, {""token"": ""Proteobacteria"", ""start_span"": 147, ""end_span"": 161, ""type"": ""Organism/Species""}, {""token"": ""Prevotella"", ""start_span"": 200, ""end_span"": 210, ""type"": ""Organism/Species""}, {""token"": ""Veillonella"", ""start_span"": 215, ""end_span"": 226, ""type"": ""Organism/Species""}, {""token"": ""Fusobacteria"", ""start_span"": 239, ""end_span"": 251, ""type"": ""Organism/Species""}]"	train
The coral community at Pulau Satumu is dominated by coral genera with foliose, encrusting, massive and sub - massive growth forms including Montipora, Merulina, Platygyra, Echinopora and Pachyseris66.	coral,4,9,Organism/Species	coral,52,57,Organism/Species	foliose,70,77,Organism/Species	Montipora,140,149,Organism/Species	Merulina,151,159,Organism/Species	Platygyra,161,170,Organism/Species	Echinopora,172,182,Organism/Species	"[{""token"": ""coral"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organism/Species""}, {""token"": ""coral"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""foliose"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""Montipora"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Organism/Species""}, {""token"": ""Merulina"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Organism/Species""}, {""token"": ""Platygyra"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Organism/Species""}, {""token"": ""Echinopora"", ""start_span"": 172, ""end_span"": 182, ""type"": ""Organism/Species""}]"	train
Since CUL4A is an E3 ligase that targets LATS1 protein for ubiquitination and degradation, we performed an immunoprecipitation assay using either anti - LATS1 antibody or anti - CUL4A antibody to precipitate CUL4A or LATS1, respectively.	CUL4A,6,11,Gene/Protein	E3 ligase,18,27,Gene/Protein	LATS1,41,46,Gene/Protein	LATS1,153,158,Gene/Protein	CUL4A,178,183,Gene/Protein	CUL4A,208,213,Gene/Protein	LATS1,217,222,Gene/Protein	"[{""token"": ""CUL4A"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""E3 ligase"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""LATS1"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""LATS1"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""CUL4A"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""CUL4A"", ""start_span"": 208, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""LATS1"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
Moreover, we performed a Western blot analysis, which showed that uc. 134 overexpression reversed the CUL4A - mediated decrease in LATS1 expression and inactivation of Hippo kinase signaling ( Fig. 4f ). Fig. 4LncRNA uc. 134 inhibits the CUL4A - mediated ubiquitination of LATS1 to regulate Hippo kinase signaling. a – b Hierarchical clustering analysis ( a) and GO analysis ( b) of microarray data for HCC cells overexpressing uc. 134 and control cells.	CUL4A,102,107,Gene/Protein	LATS1,131,136,Gene/Protein	Hippo kinase,168,180,Gene/Protein	CUL4A,238,243,Gene/Protein	LATS1,273,278,Gene/Protein	Hippo kinase,291,303,Gene/Protein	HCC,403,406,Disease/Disorder	"[{""token"": ""CUL4A"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""LATS1"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Hippo kinase"", ""start_span"": 168, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""CUL4A"", ""start_span"": 238, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""LATS1"", ""start_span"": 273, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""Hippo kinase"", ""start_span"": 291, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 403, ""end_span"": 406, ""type"": ""Disease/Disorder""}]"	train
Regarding the area under the receiver operating characteristics curve ( AUC ), no statistically significant differences ( p > 0. 01) between COPD and non - COPD groups were found in both settings, particularly for severe OSAS ( AHI ≥ 30 events / h ): 0. 97 ( 0. 92 – 0. 99 CI95 %) non - COPD vs. 0. 98 ( 0. 92 – 1. 0 CI95 %) COPD in the hospital, and 0. 87 ( 0. 79 – 0. 92 CI95 %) non - COPD vs. 0. 86 ( 0. 75 – 0. 93 CI95 %) COPD at home.	COPD,141,145,Disease/Disorder	COPD,156,160,Disease/Disorder	OSAS,221,225,Disease/Disorder	COPD,287,291,Disease/Disorder	COPD,325,329,Disease/Disorder	COPD,387,391,Disease/Disorder	COPD,426,430,Disease/Disorder	"[{""token"": ""COPD"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Disease/Disorder""}, {""token"": ""COPD"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Disease/Disorder""}, {""token"": ""OSAS"", ""start_span"": 221, ""end_span"": 225, ""type"": ""Disease/Disorder""}, {""token"": ""COPD"", ""start_span"": 287, ""end_span"": 291, ""type"": ""Disease/Disorder""}, {""token"": ""COPD"", ""start_span"": 325, ""end_span"": 329, ""type"": ""Disease/Disorder""}, {""token"": ""COPD"", ""start_span"": 387, ""end_span"": 391, ""type"": ""Disease/Disorder""}, {""token"": ""COPD"", ""start_span"": 426, ""end_span"": 430, ""type"": ""Disease/Disorder""}]"	train
Inflammatory bowel disease ( IBD) including Crohn ' s disease ( CD) and ulcerative colitis ( UC) is a chronic and disabling disease with unknown etiology.	Inflammatory bowel disease,0,26,Disease/Disorder	IBD,29,32,Disease/Disorder	Crohn ' s disease,44,61,Disease/Disorder	CD,64,66,Chemical/Drug	ulcerative colitis,72,90,Disease/Disorder	UC,93,95,Disease/Disorder	disabling disease,114,131,Disease/Disorder	"[{""token"": ""Inflammatory bowel disease"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Disease/Disorder""}, {""token"": ""IBD"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Disease/Disorder""}, {""token"": ""Crohn ' s disease"", ""start_span"": 44, ""end_span"": 61, ""type"": ""Disease/Disorder""}, {""token"": ""CD"", ""start_span"": 64, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""ulcerative colitis"", ""start_span"": 72, ""end_span"": 90, ""type"": ""Disease/Disorder""}, {""token"": ""UC"", ""start_span"": 93, ""end_span"": 95, ""type"": ""Disease/Disorder""}, {""token"": ""disabling disease"", ""start_span"": 114, ""end_span"": 131, ""type"": ""Disease/Disorder""}]"	train
Inflammatory Bowel Disease ( IBD) describes a group of chronic gastrointestinal tract diseases that are relapsing and remitting; the term primarily comprises Crohn ' s disease ( CD) and Ulcerative Colitis ( UC ).	Inflammatory Bowel Disease,0,26,Disease/Disorder	IBD,29,32,Disease/Disorder	chronic gastrointestinal tract diseases,55,94,Disease/Disorder	Crohn ' s disease,158,175,Disease/Disorder	CD,178,180,Chemical/Drug	Ulcerative Colitis,186,204,Disease/Disorder	UC,207,209,Disease/Disorder	"[{""token"": ""Inflammatory Bowel Disease"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Disease/Disorder""}, {""token"": ""IBD"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Disease/Disorder""}, {""token"": ""chronic gastrointestinal tract diseases"", ""start_span"": 55, ""end_span"": 94, ""type"": ""Disease/Disorder""}, {""token"": ""Crohn ' s disease"", ""start_span"": 158, ""end_span"": 175, ""type"": ""Disease/Disorder""}, {""token"": ""CD"", ""start_span"": 178, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""Ulcerative Colitis"", ""start_span"": 186, ""end_span"": 204, ""type"": ""Disease/Disorder""}, {""token"": ""UC"", ""start_span"": 207, ""end_span"": 209, ""type"": ""Disease/Disorder""}]"	train
However, Kurina et al. [ 66 ], using a database of linked hospital records abstracts, in a retrospective nested case - control study on 12499 patients ( 7268 UC and 5231 CD) and 800000 controls with minor medical conditions not related to the conditions of interest, found that both depression and anxiety preceded UC ( but not CD) significantly more often than would be predicted by chance; the relationships were strongest when the mental conditions were diagnosed shortly before UC.	UC,158,160,Disease/Disorder	CD,170,172,Chemical/Drug	depression,283,293,Disease/Disorder	anxiety,298,305,Disease/Disorder	UC,315,317,Disease/Disorder	CD,328,330,Chemical/Drug	UC,482,484,Disease/Disorder	"[{""token"": ""UC"", ""start_span"": 158, ""end_span"": 160, ""type"": ""Disease/Disorder""}, {""token"": ""CD"", ""start_span"": 170, ""end_span"": 172, ""type"": ""Chemical/Drug""}, {""token"": ""depression"", ""start_span"": 283, ""end_span"": 293, ""type"": ""Disease/Disorder""}, {""token"": ""anxiety"", ""start_span"": 298, ""end_span"": 305, ""type"": ""Disease/Disorder""}, {""token"": ""UC"", ""start_span"": 315, ""end_span"": 317, ""type"": ""Disease/Disorder""}, {""token"": ""CD"", ""start_span"": 328, ""end_span"": 330, ""type"": ""Chemical/Drug""}, {""token"": ""UC"", ""start_span"": 482, ""end_span"": 484, ""type"": ""Disease/Disorder""}]"	train
Amino acid sequences of the NACHT domains ( between the GxxGxGKS / T motif and the ' FAAFY ' signature of human NOD2 or equivalent region in other NLRs) of vertebrate NLRs were aligned using CLUSTALW.	Amino acid,0,10,Chemical/Drug	NACHT,28,33,Gene/Protein	human,106,111,Organism/Species	NOD2,112,116,Gene/Protein	NLRs,147,151,Gene/Protein	vertebrate,156,166,Organism/Species	NLRs,167,171,Gene/Protein	"[{""token"": ""Amino acid"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""NACHT"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""NOD2"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""NLRs"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""vertebrate"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Organism/Species""}, {""token"": ""NLRs"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Although the N - terminal end of NOD3 ( NLR - A3) was not recognized by the CDD, it shares some similarity with the human NOD3 effector domain with two conserved sequence signatures, MRK and EAG ( amino acids 59 – 61 and 69 – 71 of DR - NLR - A3 respectively ).	NOD3,33,37,Gene/Protein	NLR - A3,40,48,Gene/Protein	human,116,121,Organism/Species	NOD3,122,126,Gene/Protein	amino acids,197,208,Chemical/Drug	DR,232,234,Organism/Species	NLR - A3,237,245,Gene/Protein	"[{""token"": ""NOD3"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A3"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""NOD3"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""amino acids"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Chemical/Drug""}, {""token"": ""DR"", ""start_span"": 232, ""end_span"": 234, ""type"": ""Organism/Species""}, {""token"": ""NLR - A3"", ""start_span"": 237, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
Since RICK is also present in fish genomes ( see zebrafish RIPK2, Q4V958 ), it would appear that this inflammatory cascade was established prior to the divergence of teleost fish from the tetrapod lineage, assuming that the same interaction occurs between these molecules in fish.	RICK,6,10,Gene/Protein	fish,30,34,Organism/Species	zebrafish,49,58,Organism/Species	RIPK2,59,64,Gene/Protein	teleost fish,166,178,Organism/Species	tetrapod,188,196,Organism/Species	fish,275,279,Organism/Species	"[{""token"": ""RICK"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""fish"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""zebrafish"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Organism/Species""}, {""token"": ""RIPK2"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""teleost fish"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Organism/Species""}, {""token"": ""tetrapod"", ""start_span"": 188, ""end_span"": 196, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 275, ""end_span"": 279, ""type"": ""Organism/Species""}]"	train
Six genes were identified in zebrafish ( Zv6) for NALP - like molecules ( NLR - B1 to - B6 ), and ten predicted NALP - like genes ( nicknamed NALPa to NALPj) were found for Xenopus.	zebrafish,29,38,Organism/Species	NALP - like,50,61,Gene/Protein	NLR - B1,74,82,Gene/Protein	NALP - like,112,123,Gene/Protein	NALPa,142,147,Gene/Protein	NALPj,151,156,Gene/Protein	Xenopus,173,180,Organism/Species	"[{""token"": ""zebrafish"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Organism/Species""}, {""token"": ""NALP - like"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NLR - B1"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""NALP - like"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""NALPa"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""NALPj"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""Xenopus"", ""start_span"": 173, ""end_span"": 180, ""type"": ""Organism/Species""}]"	train
Secondly, these genes all possess a central NACHT domain that is highly similar to the NACHT domain of NOD3 ( NLR - A3) suggesting they evolved from a NLR - A3 - like molecule, yet many of these genes possess a PYRIN domain at their N - terminus making them more structurally similar to mammalian NALP molecules.	NACHT,44,49,Gene/Protein	NACHT,87,92,Gene/Protein	NOD3,103,107,Gene/Protein	NLR - A3,110,118,Gene/Protein	NLR - A3 - like,151,166,Gene/Protein	PYRIN,211,216,Gene/Protein	NALP,297,301,Gene/Protein	"[{""token"": ""NACHT"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""NACHT"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""NOD3"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A3"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A3 - like"", ""start_span"": 151, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""PYRIN"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""NALP"", ""start_span"": 297, ""end_span"": 301, ""type"": ""Gene/Protein""}]"	train
However, neither NAIP nor IPAF was identified in the fish genomes at this time, although IPAF was evident in the frog genome, suggesting that the genes for these molecules may have been lost from the fish genomes during the teleost - specific genome duplication event.	NAIP,17,21,Gene/Protein	IPAF,26,30,Gene/Protein	fish,53,57,Organism/Species	IPAF,89,93,Gene/Protein	frog,113,117,Organism/Species	fish,200,204,Organism/Species	teleost,224,231,Organism/Species	"[{""token"": ""NAIP"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IPAF"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""fish"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""IPAF"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""frog"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Organism/Species""}, {""token"": ""teleost"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Organism/Species""}]"	train
Also, breast cancer cell leucocyte receptor, vascular cell adhesion molecule 1 ( VCAM1) binding to TAM α4 - integrin explains the increased survival of VCAM1 + tumor cells in leucocyte - rich environments [ 13 ].	breast cancer,6,19,Disease/Disorder	leucocyte receptor,25,43,Gene/Protein	vascular cell adhesion molecule 1,45,78,Gene/Protein	VCAM1,81,86,Gene/Protein	α4 - integrin,103,116,Gene/Protein	VCAM1,152,157,Gene/Protein	tumor,160,165,Disease/Disorder	"[{""token"": ""breast cancer"", ""start_span"": 6, ""end_span"": 19, ""type"": ""Disease/Disorder""}, {""token"": ""leucocyte receptor"", ""start_span"": 25, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule 1"", ""start_span"": 45, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""VCAM1"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""\u03b14 - integrin"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""VCAM1"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Disease/Disorder""}]"	train
The difference in mean increase between both the groups was 3. 95 ( 95% CI 3. 19, 4. 69) which was statistically significant ( p < 0. 0001 ). Table 3Level of 25 ( OH) D in Healthy Subjects and Patients with malabsorption syndrome after 30 day administration of vitamin D3 buccal spray and soft gelatin capsuleParametersMean baseline value in ng / mlMean value in ng / ml after 30 day of treatmentDifference of meanPercentage mean increase from baselineHealthy SubjectsSoft gelatin Capsule Formulation Mean18. 69 ± 5. 8822. 75 ± 6. 754. 0621. 72% Range9. 25, 30. 0512. 75, 35. 522. 5, 5. 615. 36, 37. 79 n13131313 95% CI15. 14 to 22. 2418. 67 to 24. 423. 41 to 4. 7116. 42 to 24. 42Buccal Spray Formulation Mean18. 91 ± 4. 326. 91 ± 5. 727. 99542. 99% Range13. 36, 26. 8219. 6, 38. 54. 5, 11. 6729. 21, 68. 71 n13131313 95% CI16. 31 to 21. 5123. 45 to 30. 366. 86 to 9. 1337. 19 to 48. 79Patients with intestinal malabsorption syndromeSoft gelatin Capsule Formulation Mean11. 01 ± 6. 4314. 97 ± 9. 013. 96536. 02% Range2. 9, 26. 54. 6, 36. 891. 06, 10. 3924. 62, 58. 73 n13131313 95% CI7. 12 to 14. 899. 52 to 20. 422. 37 to 5. 5630. 42 to 41. 62Buccal Spray Formulation Mean10. 01 ± 4. 2920. 47 ± 7. 8910. 46117. 8% Range4. 6, 18. 859. 8, 34. 644. 25, 27. 4461. 31, 381. 1 n13131313 95% CI7. 42 to 12. 615. 7 to 25. 246. 89 to 14. 0364. 71 to 170. 8	malabsorption syndrome,207,229,Disease/Disorder	vitamin D3,261,271,Chemical/Drug	n13131313,603,612,Chemical/Drug	n13131313,809,818,Chemical/Drug	gelatin,939,946,Chemical/Drug	n13131313,1069,1078,Chemical/Drug	n13131313,1273,1282,Chemical/Drug	"[{""token"": ""malabsorption syndrome"", ""start_span"": 207, ""end_span"": 229, ""type"": ""Disease/Disorder""}, {""token"": ""vitamin D3"", ""start_span"": 261, ""end_span"": 271, ""type"": ""Chemical/Drug""}, {""token"": ""n13131313"", ""start_span"": 603, ""end_span"": 612, ""type"": ""Chemical/Drug""}, {""token"": ""n13131313"", ""start_span"": 809, ""end_span"": 818, ""type"": ""Chemical/Drug""}, {""token"": ""gelatin"", ""start_span"": 939, ""end_span"": 946, ""type"": ""Chemical/Drug""}, {""token"": ""n13131313"", ""start_span"": 1069, ""end_span"": 1078, ""type"": ""Chemical/Drug""}, {""token"": ""n13131313"", ""start_span"": 1273, ""end_span"": 1282, ""type"": ""Chemical/Drug""}]"	train
Briefly, the epicellular Goussia ( Fig. 1) forms a distinct group, positioned as basal in relation to other Goussia groups [ 7 ], and members of Caryospora, Isospora ( both Eimeriidae) and Schellakia ( Schellakiadae) are closely related [ 27 – 29 ].	Goussia,25,32,Organism/Species	Goussia,108,115,Organism/Species	Caryospora,145,155,Organism/Species	Isospora,157,165,Organism/Species	Eimeriidae,173,183,Organism/Species	Schellakia,189,199,Organism/Species	Schellakiadae,202,215,Organism/Species	"[{""token"": ""Goussia"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""Goussia"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Organism/Species""}, {""token"": ""Caryospora"", ""start_span"": 145, ""end_span"": 155, ""type"": ""Organism/Species""}, {""token"": ""Isospora"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Organism/Species""}, {""token"": ""Eimeriidae"", ""start_span"": 173, ""end_span"": 183, ""type"": ""Organism/Species""}, {""token"": ""Schellakia"", ""start_span"": 189, ""end_span"": 199, ""type"": ""Organism/Species""}, {""token"": ""Schellakiadae"", ""start_span"": 202, ""end_span"": 215, ""type"": ""Organism/Species""}]"	train
The genotypes sequenced from Pagrus caeruleostictus were recovered in the present phylogenetic analysis as sister to the genus Calyptospora. To the best of our knowledge, the only coccidians known to infect this fish belong to Eimeria ( e. g. [ 52 ]). Although the divergence between the genotypes found in P. caeruleostictus and Calysptospora spp. ranges between 0. 9 – 11. 0 %, i. e. above the observed divergence between Calyptospora spp.	Pagrus caeruleostictus,29,51,Organism/Species	Calyptospora,127,139,Organism/Species	coccidians,180,190,Organism/Species	fish,212,216,Organism/Species	Eimeria,227,234,Organism/Species	Calysptospora spp,330,347,Organism/Species	Calyptospora spp,424,440,Organism/Species	"[{""token"": ""Pagrus caeruleostictus"", ""start_span"": 29, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""Calyptospora"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""coccidians"", ""start_span"": 180, ""end_span"": 190, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Organism/Species""}, {""token"": ""Eimeria"", ""start_span"": 227, ""end_span"": 234, ""type"": ""Organism/Species""}, {""token"": ""Calysptospora spp"", ""start_span"": 330, ""end_span"": 347, ""type"": ""Organism/Species""}, {""token"": ""Calyptospora spp"", ""start_span"": 424, ""end_span"": 440, ""type"": ""Organism/Species""}]"	train
The Apicomplexa infecting Scyliorhinus canicula are closely related with the Eimeriidae and Schellakiidae infecting reptiles, amphibians and birds	Apicomplexa,4,15,Organism/Species	Scyliorhinus canicula,26,47,Organism/Species	Eimeriidae,77,87,Organism/Species	Schellakiidae,92,105,Organism/Species	reptiles,116,124,Organism/Species	amphibians,126,136,Organism/Species	birds,141,146,Organism/Species	"[{""token"": ""Apicomplexa"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""Scyliorhinus canicula"", ""start_span"": 26, ""end_span"": 47, ""type"": ""Organism/Species""}, {""token"": ""Eimeriidae"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Organism/Species""}, {""token"": ""Schellakiidae"", ""start_span"": 92, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""reptiles"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""amphibians"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Organism/Species""}]"	train
Another group was related to the genera Caryospora ( Eimeriidae ), Schellakia ( Schellakiidae) and Isospora ( Eimeriidae ), which typically infect terrestrial vertebrates ( e. g. [ 55 ]).	Caryospora,40,50,Organism/Species	Eimeriidae,53,63,Organism/Species	Schellakia,67,77,Organism/Species	Schellakiidae,80,93,Organism/Species	Isospora,99,107,Organism/Species	Eimeriidae,110,120,Organism/Species	vertebrates,159,170,Organism/Species	"[{""token"": ""Caryospora"", ""start_span"": 40, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""Eimeriidae"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""Schellakia"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""Schellakiidae"", ""start_span"": 80, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""Isospora"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""Eimeriidae"", ""start_span"": 110, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""vertebrates"", ""start_span"": 159, ""end_span"": 170, ""type"": ""Organism/Species""}]"	train
The phenotype displayed by Rev - erbα −/− mice is reminiscent of animals overexpressing Fgf21 ( Owen et al ., 2013 ), therefore, we tested whether Fgf21 expression is altered in Rev - erbα −/− mice.	Rev - erbα,27,37,Gene/Protein	mice,42,46,Organism/Species	animals,65,72,Organism/Species	Fgf21,88,93,Gene/Protein	Fgf21,147,152,Gene/Protein	Rev - erbα,178,188,Gene/Protein	mice,193,197,Organism/Species	"[{""token"": ""Rev - erb\u03b1"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""animals"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""Fgf21"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""Rev - erb\u03b1"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Organism/Species""}]"	train
Transactivation experiments in Hepa - 1c1c7 cells revealed that REV - ERBα suppresses the Bmal1 :: luc reporter in an HNF6 independent manner, because Hnf6 shRNA did not affect this repression ( Fig. 2E ); although Hnf6 mRNA and protein was strongly repressed with Rev - erbα expression unaffected ( Fig. S1 ).	REV - ERBα,64,74,Gene/Protein	Bmal1,90,95,Gene/Protein	luc,99,102,Gene/Protein	HNF6,118,122,Gene/Protein	Hnf6,151,155,Gene/Protein	Hnf6,215,219,Gene/Protein	Rev - erbα,265,275,Gene/Protein	"[{""token"": ""REV - ERB\u03b1"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""HNF6"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Hnf6"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Hnf6"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""Rev - erb\u03b1"", ""start_span"": 265, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	train
Chromatin from livers of female mice was isolated and antibodies against REV - ERBα, HNF6 and PPARα were used to identify the promoter sequences in Fgf21 bound by these transcription factors.	mice,32,36,Organism/Species	antibodies,54,64,Gene/Protein	REV - ERBα,73,83,Gene/Protein	HNF6,85,89,Gene/Protein	PPARα,94,99,Gene/Protein	Fgf21,148,153,Gene/Protein	transcription factors,169,190,Gene/Protein	"[{""token"": ""mice"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""REV - ERB\u03b1"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""HNF6"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b1"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 169, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
We observed that PER2 binds in a time - of - day dependent manner to both the Bmal1 and Fgf21 promoters in wild - type mice, however, only to the Bmal1 promoter in Rev - erbα −/− animals ( Fig. 3C ).	PER2,17,21,Gene/Protein	Bmal1,78,83,Gene/Protein	Fgf21,88,93,Gene/Protein	mice,119,123,Organism/Species	Bmal1,146,151,Gene/Protein	Rev - erbα,164,174,Gene/Protein	animals,179,186,Organism/Species	"[{""token"": ""PER2"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""Bmal1"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""Rev - erb\u03b1"", ""start_span"": 164, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Organism/Species""}]"	train
DNA fragments precipitated with anti - REV - ERBα antibody ( 1: 50 dilution; SAB2101632; Sigma - Aldrich ), with anti - HNF6 ( G - 10) ( 1: 30 dilution; sc - 376167, Santa Cruz Biotechnology ), with anti - PPARα ( 1: 25 dilution; 101710; Cayman Chemical Company, USA) or with anti - PER2 ( 1: 25 dilution; No. 611138; BD Transduction Laboratories) were detected with the reverse transcription PCR primers and probes enlisted in Table S2.	REV - ERBα,39,49,Gene/Protein	antibody,50,58,Gene/Protein	SAB2101632,77,87,Chemical/Drug	HNF6,120,124,Gene/Protein	sc - 376167,153,164,Chemical/Drug	PPARα,206,211,Gene/Protein	PER2,283,287,Gene/Protein	"[{""token"": ""REV - ERB\u03b1"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""SAB2101632"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""HNF6"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""sc - 376167"", ""start_span"": 153, ""end_span"": 164, ""type"": ""Chemical/Drug""}, {""token"": ""PPAR\u03b1"", ""start_span"": 206, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""PER2"", ""start_span"": 283, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
For instance, a difference of 20 genes within a single family may be remarkable between human and chimpanzee, but not between human and mouse, or human and dog.	human,88,93,Organism/Species	chimpanzee,98,108,Organism/Species	human,126,131,Organism/Species	mouse,136,141,Organism/Species	or,143,145,Gene/Protein	human,146,151,Organism/Species	dog,156,159,Organism/Species	"[{""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""chimpanzee"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Organism/Species""}, {""token"": ""or"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Organism/Species""}]"	train
Chimp, human, mouse, rat, and dog are observed values; whereas, Primate, Rodent, Ingroup, and MRCA values are inferred from our analysis.	Chimp,0,5,Organism/Species	human,7,12,Organism/Species	mouse,14,19,Organism/Species	rat,21,24,Organism/Species	dog,30,33,Organism/Species	Primate,64,71,Organism/Species	Rodent,73,79,Organism/Species	"[{""token"": ""Chimp"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 7, ""end_span"": 12, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Organism/Species""}, {""token"": ""Primate"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""Rodent"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Organism/Species""}]"	train
However, the largest family in the mammalian MRCA to eventually go extinct in any lineage ( 11 genes) is a V2R vomeronasal receptor gene family that has > 100 genes in each rodent lineage but is absent from the dog, human, and chimpanzee genomes ( it is, however, present in the preliminary assembly of the rhesus macaque genome; see Materials and Methods ).	V2R,107,110,Gene/Protein	vomeronasal receptor,111,131,Gene/Protein	rodent,173,179,Organism/Species	dog,211,214,Organism/Species	human,216,221,Organism/Species	chimpanzee,227,237,Organism/Species	rhesus macaque,307,321,Organism/Species	"[{""token"": ""V2R"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""vomeronasal receptor"", ""start_span"": 111, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""rodent"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 216, ""end_span"": 221, ""type"": ""Organism/Species""}, {""token"": ""chimpanzee"", ""start_span"": 227, ""end_span"": 237, ""type"": ""Organism/Species""}, {""token"": ""rhesus macaque"", ""start_span"": 307, ""end_span"": 321, ""type"": ""Organism/Species""}]"	train
Ingroup creations are those that are present in 3 or 4 of the mouse, rat, human, chimpanzee group, but absent in dog and the other 14 eukaryotes.	or,50,52,Gene/Protein	mouse,62,67,Organism/Species	rat,69,72,Organism/Species	human,74,79,Organism/Species	chimpanzee,81,91,Organism/Species	dog,113,116,Organism/Species	eukaryotes,134,144,Organism/Species	"[{""token"": ""or"", ""start_span"": 50, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""chimpanzee"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""eukaryotes"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Organism/Species""}]"	train
To identify GABA - ergic interneurons we utilized GAD 67 GFP + mice, engineered to co - express green fluorescent protein ( GFP) with the GABA - synthesising 67 kDa γ - amino decarboxylase ( GAD 67) enzyme ( Tamamaki et al.	GAD 67,50,56,Gene/Protein	GFP,57,60,Gene/Protein	mice,63,67,Organism/Species	green fluorescent protein,96,121,Gene/Protein	GFP,124,127,Gene/Protein	67 kDa γ - amino decarboxylase,158,188,Gene/Protein	GAD 67,191,197,Gene/Protein	"[{""token"": ""GAD 67"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""green fluorescent protein"", ""start_span"": 96, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""67 kDa \u03b3 - amino decarboxylase"", ""start_span"": 158, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""GAD 67"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Yeast lipids are mostly present in the cells in the form of triacylglycerols; some of these lipids are constituted by monounsaturated and polyunsaturated fatty acids ( PUFA) [ 15 ], whose production might be exploitable due to the ability of these microorganisms to synthesize in high quantities lipids rarely found in the plant or animal kingdom ( i. e ., lipids presenting composition similarities with the cocoa butter or other exotic fats ).	Yeast,0,5,Organism/Species	triacylglycerols,60,76,Chemical/Drug	monounsaturated and polyunsaturated fatty acids,118,165,Chemical/Drug	microorganisms,248,262,Organism/Species	plant,323,328,Organism/Species	animal,332,338,Organism/Species	cocoa,409,414,Organism/Species	"[{""token"": ""Yeast"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""triacylglycerols"", ""start_span"": 60, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""monounsaturated and polyunsaturated fatty acids"", ""start_span"": 118, ""end_span"": 165, ""type"": ""Chemical/Drug""}, {""token"": ""microorganisms"", ""start_span"": 248, ""end_span"": 262, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 323, ""end_span"": 328, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 332, ""end_span"": 338, ""type"": ""Organism/Species""}, {""token"": ""cocoa"", ""start_span"": 409, ""end_span"": 414, ""type"": ""Organism/Species""}]"	train
Another interesting observation is the repeated acquisition of pathways on carbohydrate metabolism among intestinal ( e. g ., Enterobacteria and Bacteroides) and pathogenic ( e. g ., Pseudomonas, Xanthomonas, and Ralstonia) bacteria ( Figure 2, red symbols ).	carbohydrate,75,87,Chemical/Drug	Enterobacteria,126,140,Organism/Species	Bacteroides,145,156,Organism/Species	Pseudomonas,183,194,Organism/Species	Xanthomonas,196,207,Organism/Species	Ralstonia,213,222,Organism/Species	bacteria,224,232,Organism/Species	"[{""token"": ""carbohydrate"", ""start_span"": 75, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""Enterobacteria"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""Bacteroides"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""Pseudomonas"", ""start_span"": 183, ""end_span"": 194, ""type"": ""Organism/Species""}, {""token"": ""Xanthomonas"", ""start_span"": 196, ""end_span"": 207, ""type"": ""Organism/Species""}, {""token"": ""Ralstonia"", ""start_span"": 213, ""end_span"": 222, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 224, ""end_span"": 232, ""type"": ""Organism/Species""}]"	train
Breast cancer stem cells are classically defined by CD44 ( Cluster of Differentiation antigen - 44) positive and low or absent levels of CD24 ( Cluster of Differentiation antigen - 24) expression ( CD44 +/ CD24 −/ low ).	Breast cancer,0,13,Disease/Disorder	CD44,52,56,Gene/Protein	Cluster of Differentiation antigen - 44,59,98,Gene/Protein	CD24,137,141,Gene/Protein	Cluster of Differentiation antigen - 24,144,183,Gene/Protein	CD44,198,202,Gene/Protein	CD24,206,210,Gene/Protein	"[{""token"": ""Breast cancer"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Disease/Disorder""}, {""token"": ""CD44"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Cluster of Differentiation antigen - 44"", ""start_span"": 59, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""CD24"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Cluster of Differentiation antigen - 24"", ""start_span"": 144, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""CD44"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""CD24"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
NIK, a MAP kinase kinase kinase ( MAP3K14) protein, is essential for the activation of the non - canonical NF - κB pathway because it phosphorylates IκB Kinase - α ( IKKα) and participates in the processing of p10010.	NIK,0,3,Gene/Protein	MAP kinase kinase kinase,7,31,Gene/Protein	MAP3K14,34,41,Gene/Protein	NF - κB,107,114,Gene/Protein	IκB Kinase - α,149,163,Gene/Protein	IKKα,166,170,Gene/Protein	p10010,210,216,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinase kinase kinase"", ""start_span"": 7, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""MAP3K14"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""I\u03baB Kinase - \u03b1"", ""start_span"": 149, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""IKK\u03b1"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""p10010"", ""start_span"": 210, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
Surprisingly, 89. 4% of those tumors presented a cellular co - localization of both proteins as shown in Fig. 7D. Figure 7E represents tumors that express NIK and ALDH in different cells. Figure 7F – H represents tumors lacking either NIK or ALDH.	tumors,30,36,Disease/Disorder	tumors,135,141,Disease/Disorder	NIK,155,158,Gene/Protein	ALDH,163,167,Gene/Protein	tumors,213,219,Disease/Disorder	NIK,235,238,Gene/Protein	ALDH,242,246,Gene/Protein	"[{""token"": ""tumors"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Disease/Disorder""}, {""token"": ""tumors"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Disease/Disorder""}, {""token"": ""NIK"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""ALDH"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 213, ""end_span"": 219, ""type"": ""Disease/Disorder""}, {""token"": ""NIK"", ""start_span"": 235, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""ALDH"", ""start_span"": 242, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
In this article, we demonstrated that NIK overexpression induces NF - κB activation and enhances the expression of p52, p65, and RelB, suggesting that components of non - canonical and canonical NF - κB pathways are involved in NIK - mediated stem cell phenotype modulation.	NIK,38,41,Gene/Protein	NF - κB,65,72,Gene/Protein	p52,115,118,Gene/Protein	p65,120,123,Gene/Protein	RelB,129,133,Gene/Protein	NF - κB,195,202,Gene/Protein	NIK,228,231,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Immunofluorescence analysis was performed with the following primary antibodies: p52 ( 1: 500, sc848, Santa Cruz ); p65 ( 1: 500, sc372, Santa Cruz Biotechnologies ); RelB ( 1: 500, sc28689, Santa Cruz Biotechnology ); P50 ( 1: 250, sc1190, Santa Cruz Biotechnologies ), NIK ( 1: 1000, 4994, Cell Signaling ), phospho - p52 ( 1: 500, Cell Signaling ), phosphor - p65 ( 1: 500, 3036, Cell Signaling ).	p52,81,84,Gene/Protein	p65,116,119,Gene/Protein	RelB,167,171,Gene/Protein	P50,219,222,Gene/Protein	NIK,271,274,Gene/Protein	p52,320,323,Gene/Protein	p65,363,366,Gene/Protein	"[{""token"": ""p52"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""P50"", ""start_span"": 219, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 271, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 320, ""end_span"": 323, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 363, ""end_span"": 366, ""type"": ""Gene/Protein""}]"	train
Cells were washed and blocked with 5% Bovine serum albumin ( BSA) for 1 h and subsequently incubated with primary antibodies for 2 h at RT, followed by incubation with the secondary Cy3 - goat anti - mouse antibody ( Millipore) or Cy3 - goat anti - rabbit antibody ( Millipore) or Cy3 - rabbit - anti - goat ( 811615, Zymed) for 1 h.	albumin,51,58,Gene/Protein	goat,188,192,Organism/Species	mouse,200,205,Organism/Species	goat,237,241,Organism/Species	rabbit,249,255,Organism/Species	rabbit,287,293,Organism/Species	goat,303,307,Organism/Species	"[{""token"": ""albumin"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Organism/Species""}, {""token"": ""goat"", ""start_span"": 237, ""end_span"": 241, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 249, ""end_span"": 255, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 287, ""end_span"": 293, ""type"": ""Organism/Species""}, {""token"": ""goat"", ""start_span"": 303, ""end_span"": 307, ""type"": ""Organism/Species""}]"	train
A recent study on the effects of tadalafil 5mg in men with hypogonadism and LUTS - BPH showed that while tadalafil was effective in both men with and without hypogonadism, IPSS storage subscore and IPSS - QoL was appreciably greater in men without hypogonadism than those with low testosterone levels [ 41 ].	tadalafil,33,42,Chemical/Drug	hypogonadism,59,71,Disease/Disorder	BPH,83,86,Disease/Disorder	tadalafil,105,114,Chemical/Drug	hypogonadism,158,170,Disease/Disorder	hypogonadism,248,260,Disease/Disorder	testosterone,281,293,Chemical/Drug	"[{""token"": ""tadalafil"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""hypogonadism"", ""start_span"": 59, ""end_span"": 71, ""type"": ""Disease/Disorder""}, {""token"": ""BPH"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""tadalafil"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""hypogonadism"", ""start_span"": 158, ""end_span"": 170, ""type"": ""Disease/Disorder""}, {""token"": ""hypogonadism"", ""start_span"": 248, ""end_span"": 260, ""type"": ""Disease/Disorder""}, {""token"": ""testosterone"", ""start_span"": 281, ""end_span"": 293, ""type"": ""Chemical/Drug""}]"	train
NT - pro - BNP, estimated glomerular filtration rate ( eGFR ), urea nitrogen ( BUN) and 6 - minute walk distance of patients with PH were compared in those with AF ( PH - AF) and SR ( PH - SR ). * p < 0. 05.	NT - pro - BNP,0,14,Gene/Protein	urea,63,67,Chemical/Drug	PH,130,132,Disease/Disorder	AF,161,163,Disease/Disorder	PH,166,168,Disease/Disorder	AF,171,173,Disease/Disorder	PH,184,186,Disease/Disorder	"[{""token"": ""NT - pro - BNP"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""urea"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""PH"", ""start_span"": 130, ""end_span"": 132, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 161, ""end_span"": 163, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 166, ""end_span"": 168, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 171, ""end_span"": 173, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 184, ""end_span"": 186, ""type"": ""Disease/Disorder""}]"	train
Given the distinct pathopyhsiology of pre - versus postcapillary PH, in a subanalysis patients with PH due to left heart disease ( PH - HF, group 2) were separated from patients with PH due to any other cause ( PH - nonHF, groups 1, 3, 4, or 5 ).	PH,65,67,Disease/Disorder	PH,100,102,Disease/Disorder	heart disease,115,128,Disease/Disorder	PH,131,133,Disease/Disorder	HF,136,138,Disease/Disorder	PH,183,185,Disease/Disorder	PH,211,213,Disease/Disorder	"[{""token"": ""PH"", ""start_span"": 65, ""end_span"": 67, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 100, ""end_span"": 102, ""type"": ""Disease/Disorder""}, {""token"": ""heart disease"", ""start_span"": 115, ""end_span"": 128, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 131, ""end_span"": 133, ""type"": ""Disease/Disorder""}, {""token"": ""HF"", ""start_span"": 136, ""end_span"": 138, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 183, ""end_span"": 185, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 211, ""end_span"": 213, ""type"": ""Disease/Disorder""}]"	train
To determine the correlation of MARCH7 expression with cancer type and cancer stage, all cancer samples were grouped into histologic types ( serous papillary adenocarcinoma, mucinous adenocarcinoma, and endometrioid adenocarcinoma) ( Fig. 1A - H ).	MARCH7,32,38,Gene/Protein	cancer,55,61,Disease/Disorder	cancer,71,77,Disease/Disorder	cancer,89,95,Disease/Disorder	serous papillary adenocarcinoma,141,172,Disease/Disorder	mucinous adenocarcinoma,174,197,Disease/Disorder	endometrioid adenocarcinoma,203,230,Disease/Disorder	"[{""token"": ""MARCH7"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Disease/Disorder""}, {""token"": ""serous papillary adenocarcinoma"", ""start_span"": 141, ""end_span"": 172, ""type"": ""Disease/Disorder""}, {""token"": ""mucinous adenocarcinoma"", ""start_span"": 174, ""end_span"": 197, ""type"": ""Disease/Disorder""}, {""token"": ""endometrioid adenocarcinoma"", ""start_span"": 203, ""end_span"": 230, ""type"": ""Disease/Disorder""}]"	train
IHC revealed that the expression of MARCH7, P50, P65 and β - catenin in tumors from LV5 - MARCH7 infected group was increased than that in the LV5 - GFP infected group ( P < 0. 05) ( Fig. 6F and S2B ).	MARCH7,36,42,Gene/Protein	P50,44,47,Gene/Protein	P65,49,52,Gene/Protein	β - catenin,57,68,Gene/Protein	tumors,72,78,Disease/Disorder	MARCH7,90,96,Gene/Protein	GFP,149,152,Gene/Protein	"[{""token"": ""MARCH7"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""P50"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""P65"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""MARCH7"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
Our data also demonstrates that MARCH7 can regulate nuclear factor kB ( NF - kB) and Wnt / β - catenin pathway, and that MIR - 101 controls MARCH7 by targeting MATCH7 3 ′ UTR region.	MARCH7,32,38,Gene/Protein	nuclear factor kB,52,69,Gene/Protein	NF - kB,72,79,Gene/Protein	Wnt,85,88,Gene/Protein	β - catenin,91,102,Gene/Protein	MARCH7,140,146,Gene/Protein	MATCH7,160,166,Gene/Protein	"[{""token"": ""MARCH7"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kB"", ""start_span"": 52, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""MARCH7"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""MATCH7"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
In conclusion, this study confirms that MARCH7 is a tumor promoting gene in humans with ovarian cancer, which was involved in NFkB and Wnt / β - catenin pathway ( Fig.	MARCH7,40,46,Gene/Protein	tumor,52,57,Disease/Disorder	humans,76,82,Organism/Species	ovarian cancer,88,102,Disease/Disorder	NFkB,126,130,Gene/Protein	Wnt,135,138,Gene/Protein	β - catenin,141,152,Gene/Protein	"[{""token"": ""MARCH7"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Disease/Disorder""}, {""token"": ""humans"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Organism/Species""}, {""token"": ""ovarian cancer"", ""start_span"": 88, ""end_span"": 102, ""type"": ""Disease/Disorder""}, {""token"": ""NFkB"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
Interstitial lung diseases ( ILDs ), also called interstitial lung abnormalities ( ILA) or interstitial pneumonia ( IP ), are characterized by diffuse pulmonary interstitial abnormalities that often lead to fibrosis ( Borchers et al. 2011 ).	Interstitial lung diseases,0,26,Disease/Disorder	ILDs,29,33,Disease/Disorder	interstitial lung abnormalities,49,80,Disease/Disorder	ILA,83,86,Disease/Disorder	interstitial pneumonia,91,113,Disease/Disorder	IP,116,118,Disease/Disorder	diffuse pulmonary interstitial abnormalities,143,187,Disease/Disorder	"[{""token"": ""Interstitial lung diseases"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Disease/Disorder""}, {""token"": ""ILDs"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Disease/Disorder""}, {""token"": ""interstitial lung abnormalities"", ""start_span"": 49, ""end_span"": 80, ""type"": ""Disease/Disorder""}, {""token"": ""ILA"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""interstitial pneumonia"", ""start_span"": 91, ""end_span"": 113, ""type"": ""Disease/Disorder""}, {""token"": ""IP"", ""start_span"": 116, ""end_span"": 118, ""type"": ""Disease/Disorder""}, {""token"": ""diffuse pulmonary interstitial abnormalities"", ""start_span"": 143, ""end_span"": 187, ""type"": ""Disease/Disorder""}]"	train
In patients with IPF, median PFS ( 92 days, P < 0. 0001) and OS ( 223 days, P = 0. 0002) were even shorter ( Fig. 2 ). Fig. 1Kaplan – Meier curves of ( a) progression - free survival and ( b) overall survival in advanced NSCLC patients with interstitial lung disease ( ILD) who received chemotherapy and / or molecular targeted therapyFig. 2Kaplan – Meier curves of ( a) progression - free survival and ( b) overall survival in advanced NSCLC patients with idiopathic pulmonary fibrosis ( IPF) who received chemotherapy and / or molecular targeted therapy	IPF,17,20,Disease/Disorder	NSCLC,221,226,Disease/Disorder	interstitial lung disease,241,266,Disease/Disorder	ILD,269,272,Disease/Disorder	NSCLC,437,442,Disease/Disorder	idiopathic pulmonary fibrosis,457,486,Disease/Disorder	IPF,489,492,Disease/Disorder	"[{""token"": ""IPF"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Disease/Disorder""}, {""token"": ""NSCLC"", ""start_span"": 221, ""end_span"": 226, ""type"": ""Disease/Disorder""}, {""token"": ""interstitial lung disease"", ""start_span"": 241, ""end_span"": 266, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 269, ""end_span"": 272, ""type"": ""Disease/Disorder""}, {""token"": ""NSCLC"", ""start_span"": 437, ""end_span"": 442, ""type"": ""Disease/Disorder""}, {""token"": ""idiopathic pulmonary fibrosis"", ""start_span"": 457, ""end_span"": 486, ""type"": ""Disease/Disorder""}, {""token"": ""IPF"", ""start_span"": 489, ""end_span"": 492, ""type"": ""Disease/Disorder""}]"	train
Median PFS was 180, 118, and 92 days for non - ILD, ILD, and IPF patients, respectively ( P = 0. 0301 for non - ILD vs. ILD and P = 0. 0018 for non - ILD vs. IPF ).	ILD,47,50,Disease/Disorder	ILD,52,55,Disease/Disorder	IPF,61,64,Disease/Disorder	ILD,112,115,Disease/Disorder	ILD,120,123,Disease/Disorder	ILD,150,153,Disease/Disorder	IPF,158,161,Disease/Disorder	"[{""token"": ""ILD"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Disease/Disorder""}, {""token"": ""IPF"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Disease/Disorder""}, {""token"": ""IPF"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Disease/Disorder""}]"	train
Median OS was 458, 258, and 223 days for non - ILD, ILD, and IPF patients, respectively ( P = 0. 0202 for non - ILD vs. ILD and P = 0. 0126 for non - ILD vs. IPF ).	ILD,47,50,Disease/Disorder	ILD,52,55,Disease/Disorder	IPF,61,64,Disease/Disorder	ILD,112,115,Disease/Disorder	ILD,120,123,Disease/Disorder	ILD,150,153,Disease/Disorder	IPF,158,161,Disease/Disorder	"[{""token"": ""ILD"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Disease/Disorder""}, {""token"": ""IPF"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Disease/Disorder""}, {""token"": ""IPF"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Disease/Disorder""}]"	train
RR and DCR in ILD / IPF patients were lower than that in non - ILD patients. EGFR mutation was not identified in any of the 34 IPF patients, whereas 32% of non - ILD patients harbored EGFR mutations.	ILD,14,17,Disease/Disorder	IPF,20,23,Disease/Disorder	ILD,63,66,Disease/Disorder	EGFR,77,81,Gene/Protein	IPF,127,130,Disease/Disorder	ILD,162,165,Disease/Disorder	EGFR,184,188,Gene/Protein	"[{""token"": ""ILD"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Disease/Disorder""}, {""token"": ""IPF"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""EGFR"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""IPF"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Disease/Disorder""}, {""token"": ""EGFR"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Negative control images ( inset) were obtained by substituting an isotype control antibody for the primary antibody. A: The bladder cancer microenvironment contains CD3 + T cells, FoxP3 + cells, CD68 + macrophages and CD15 + granulocytes. B: Representative images from two bladder cancer biopsies with high ( left) or low ( right) numbers of IL - 17 positive cells present.	bladder cancer,124,138,Disease/Disorder	CD3,165,168,Gene/Protein	FoxP3,180,185,Gene/Protein	CD68,195,199,Gene/Protein	CD15,218,222,Gene/Protein	bladder cancer,273,287,Disease/Disorder	IL - 17,342,349,Gene/Protein	"[{""token"": ""bladder cancer"", ""start_span"": 124, ""end_span"": 138, ""type"": ""Disease/Disorder""}, {""token"": ""CD3"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""FoxP3"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""CD68"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""CD15"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""bladder cancer"", ""start_span"": 273, ""end_span"": 287, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 17"", ""start_span"": 342, ""end_span"": 349, ""type"": ""Gene/Protein""}]"	train
The viability of the spores generated in spo5 - NLS - GFP cells was comparable to that of the control ( spo5 - GFP, 50% vs. spo5 - NLS - GFP 40 %), implying that the loss of Spo5 function did not affect the germination potential.	spo5,41,45,Gene/Protein	GFP,54,57,Gene/Protein	spo5,104,108,Gene/Protein	GFP,111,114,Gene/Protein	spo5,124,128,Gene/Protein	GFP,137,140,Gene/Protein	Spo5,174,178,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""spo5"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""spo5"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Spo5"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Immunoprecipitation by anti - GFP antibody indicated that pcr1 + mRNA formed a complex with Spo5 - GFP in vivo, but that the mRNAs of other ATF / CREB factors did not ( Figure 5B ).	GFP,30,33,Gene/Protein	antibody,34,42,Gene/Protein	pcr1,58,62,Gene/Protein	Spo5,92,96,Gene/Protein	GFP,99,102,Gene/Protein	ATF,140,143,Gene/Protein	CREB,146,150,Gene/Protein	"[{""token"": ""GFP"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""pcr1"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Spo5"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""ATF"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Recombinant GST and GST – Spo5C ( the C - terminal part of Spo5, aas 192 – 567) proteins were incubated with pcr1 + RNA including the coding region and both 5 ′- and 3 ′- UTRs ( lanes 3 and 4) or control GFP RNA ( lanes 1 and 2 ). ‘ G ’ indicates GST ( 50 ng ), and ‘ SpC ’ indicates GST - Spo5C ( 20 ng ).	GST,12,15,Gene/Protein	GST,20,23,Gene/Protein	Spo5,26,30,Gene/Protein	pcr1,109,113,Gene/Protein	GFP,204,207,Gene/Protein	GST,247,250,Gene/Protein	GST,284,287,Gene/Protein	"[{""token"": ""GST"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""GST"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Spo5"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""pcr1"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""GST"", ""start_span"": 247, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""GST"", ""start_span"": 284, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 - GFP - kan mei2 - mCherry - hph ade6 - M216 leu1	spo5,5,9,Gene/Protein	GFP,12,15,Gene/Protein	mei2,22,26,Gene/Protein	mCherry,29,36,Gene/Protein	hph,39,42,Gene/Protein	ade6,43,47,Gene/Protein	leu1,55,59,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""mei2"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""mCherry"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 :: ura4 + :: spo5 ( F427A )- GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	ura4,13,17,Gene/Protein	spo5,23,27,Gene/Protein	GFP,39,42,Gene/Protein	ade6,49,53,Gene/Protein	leu1,61,65,Gene/Protein	ura4,66,70,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""spo5"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 :: ura4 + :: spo5 ( F341A )- GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	ura4,13,17,Gene/Protein	spo5,23,27,Gene/Protein	GFP,39,42,Gene/Protein	ade6,49,53,Gene/Protein	leu1,61,65,Gene/Protein	ura4,66,70,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""spo5"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 :: ura4 + :: spo5 ( F341A, F427A )- GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	ura4,13,17,Gene/Protein	spo5,23,27,Gene/Protein	GFP,46,49,Gene/Protein	ade6,56,60,Gene/Protein	leu1,68,72,Gene/Protein	ura4,73,77,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""spo5"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 - GFP - kan cut11 - 4mRFP - hph rae1 - 167 ade6 - M216 leu1	spo5,5,9,Gene/Protein	GFP,12,15,Gene/Protein	cut11,22,27,Gene/Protein	hph,38,41,Gene/Protein	rae1,42,46,Gene/Protein	ade6,53,57,Gene/Protein	leu1,65,69,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""cut11"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""rae1"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}]"	train
To block the Crm1 / exportin - dependent nuclear export machinery, 100 ng / mL leptomycin B ( LMB) [ 28] was added to a culture of Spo5 - GFP Mei2 - mCherry cells.	Crm1,13,17,Gene/Protein	exportin,20,28,Gene/Protein	leptomycin B,79,91,Chemical/Drug	Spo5,131,135,Gene/Protein	GFP,138,141,Gene/Protein	Mei2,142,146,Gene/Protein	mCherry,149,156,Gene/Protein	"[{""token"": ""Crm1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""exportin"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""leptomycin B"", ""start_span"": 79, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""Spo5"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Mei2"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""mCherry"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
The purpose of this study was: ( a) to confirm the different proliferative behavior in response to αMSH in healthy and in melanoma condition; ( b) to verify whether the cAMP / PKA pathway and the PLC / PPARγ pathway could exert an antagonistic function in the control of proliferation; ( c) to deepen the knowledge of the molecular basis responsible for the down - proliferative response of melanoma cells after exposure to αMSH.	αMSH,99,103,Gene/Protein	melanoma,122,130,Disease/Disorder	PKA,176,179,Gene/Protein	PLC,196,199,Gene/Protein	PPARγ,202,207,Gene/Protein	melanoma,391,399,Disease/Disorder	αMSH,424,428,Gene/Protein	"[{""token"": ""\u03b1MSH"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""melanoma"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Disease/Disorder""}, {""token"": ""PKA"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""PLC"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b3"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""melanoma"", ""start_span"": 391, ""end_span"": 399, ""type"": ""Disease/Disorder""}, {""token"": ""\u03b1MSH"", ""start_span"": 424, ""end_span"": 428, ""type"": ""Gene/Protein""}]"	train
All together, these results underline the key role of PPARγ in mediating the αMSH dependent effect on proliferation slow down. Fig. 6The PPARγ acts as an effector element in determining the reduction of cell number induced by the activation of PI ( 4, 5) P2 / PLC pathway in B16 - F10 and Mel 13 melanoma cell lines. a Analysis of cell number performed on B16 - F10 and Mel 13, after treatment for 24 and 48 h with 15 μM 3 m3 or 10 − 7 M αMSH in the presence or absence of 3 μM GW9662.	PPARγ,54,59,Gene/Protein	αMSH,77,81,Gene/Protein	PPARγ,137,142,Gene/Protein	PLC,260,263,Gene/Protein	melanoma,296,304,Disease/Disorder	αMSH,438,442,Gene/Protein	GW9662,478,484,Chemical/Drug	"[{""token"": ""PPAR\u03b3"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1MSH"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b3"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""PLC"", ""start_span"": 260, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""melanoma"", ""start_span"": 296, ""end_span"": 304, ""type"": ""Disease/Disorder""}, {""token"": ""\u03b1MSH"", ""start_span"": 438, ""end_span"": 442, ""type"": ""Gene/Protein""}, {""token"": ""GW9662"", ""start_span"": 478, ""end_span"": 484, ""type"": ""Chemical/Drug""}]"	train
Data are mean values ± SD of three independent experiments performed in duplicate. * p < 0. 01 ( vs untreated cells ); $ p < 0. 01 ( vs 3 m3 - treated cells ); § p < 0. 01 ( vs αMSH - treated cells ). c Western blot analysis of p27 ( 4 h ), p21 ( 48 h ), cyclin D1 and cyclin E ( 6 h) protein expression on cell lysate of B16 - F10 and Mel 13, treated with 10 − 7 M αMSH in the presence or absence of 3 μM GW9662.	αMSH,177,181,Gene/Protein	p27,228,231,Gene/Protein	p21,241,244,Gene/Protein	cyclin D1,255,264,Gene/Protein	cyclin E,269,277,Gene/Protein	αMSH,366,370,Gene/Protein	GW9662,406,412,Chemical/Drug	"[{""token"": ""\u03b1MSH"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""p27"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""p21"", ""start_span"": 241, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D1"", ""start_span"": 255, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""cyclin E"", ""start_span"": 269, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1MSH"", ""start_span"": 366, ""end_span"": 370, ""type"": ""Gene/Protein""}, {""token"": ""GW9662"", ""start_span"": 406, ""end_span"": 412, ""type"": ""Chemical/Drug""}]"	train
For transient expression analysis, the fusion construct ( bHLH18 – YFP) or the control vector ( YFP) was co - transformed with a plasmid coding for a nuclear marker VirD2NLS fused to mCherry into tobacco ( Nicotiana benthamiana) leaves by Agrobacterium tumefaciens infiltration based on a previous description ( Kumar and Kirti, 2010 ).	bHLH18,58,64,Gene/Protein	YFP,67,70,Gene/Protein	YFP,96,99,Gene/Protein	mCherry,183,190,Gene/Protein	tobacco,196,203,Organism/Species	Nicotiana benthamiana,206,227,Organism/Species	Agrobacterium tumefaciens,239,264,Organism/Species	"[{""token"": ""bHLH18"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""YFP"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""YFP"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""mCherry"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""tobacco"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Organism/Species""}, {""token"": ""Nicotiana benthamiana"", ""start_span"": 206, ""end_span"": 227, ""type"": ""Organism/Species""}, {""token"": ""Agrobacterium tumefaciens"", ""start_span"": 239, ""end_span"": 264, ""type"": ""Organism/Species""}]"	train
Many plant TF families that participate in stress responses have been identified and characterized, such as the MYB, WRKY, CBF / DREB, and bZIPs.	plant,5,10,Organism/Species	TF,11,13,Gene/Protein	MYB,112,115,Gene/Protein	WRKY,117,121,Gene/Protein	CBF,123,126,Gene/Protein	DREB,129,133,Gene/Protein	bZIPs,139,144,Gene/Protein	"[{""token"": ""plant"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organism/Species""}, {""token"": ""TF"", ""start_span"": 11, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""MYB"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""WRKY"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""CBF"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""DREB"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""bZIPs"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
For example, Jiang et al. ( 2012) showed that overexpression of AtWKRY57 up - regulated RD29A, NCED3, and ABA3, but only two of these genes ( RD29A and NCED3) were confirmed to be directly regulated by AtWRKY57.	AtWKRY57,64,72,Gene/Protein	RD29A,88,93,Gene/Protein	NCED3,95,100,Gene/Protein	ABA3,106,110,Gene/Protein	RD29A,142,147,Gene/Protein	NCED3,152,157,Gene/Protein	AtWRKY57,202,210,Gene/Protein	"[{""token"": ""AtWKRY57"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""RD29A"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""NCED3"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""ABA3"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""RD29A"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""NCED3"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""AtWRKY57"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
We excluded patients with any of the following conditions: IgA - nephritis, lupus nephritis, other primary glomerulonephritides, neoplastic disease, active peptic ulcer, diabetes mellitus, and viral hepatitis.	IgA - nephritis,59,74,Disease/Disorder	lupus nephritis,76,91,Disease/Disorder	glomerulonephritides,107,127,Disease/Disorder	neoplastic disease,129,147,Disease/Disorder	active peptic ulcer,149,168,Disease/Disorder	diabetes mellitus,170,187,Disease/Disorder	viral hepatitis,193,208,Disease/Disorder	"[{""token"": ""IgA - nephritis"", ""start_span"": 59, ""end_span"": 74, ""type"": ""Disease/Disorder""}, {""token"": ""lupus nephritis"", ""start_span"": 76, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""glomerulonephritides"", ""start_span"": 107, ""end_span"": 127, ""type"": ""Disease/Disorder""}, {""token"": ""neoplastic disease"", ""start_span"": 129, ""end_span"": 147, ""type"": ""Disease/Disorder""}, {""token"": ""active peptic ulcer"", ""start_span"": 149, ""end_span"": 168, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes mellitus"", ""start_span"": 170, ""end_span"": 187, ""type"": ""Disease/Disorder""}, {""token"": ""viral hepatitis"", ""start_span"": 193, ""end_span"": 208, ""type"": ""Disease/Disorder""}]"	train
For the purpose of staining, we used PerCP - anti - CD19, PE - anti - CD38, APC - anti - CD86, or PerCP - anti - CD19, PE - anti - CD27, and APC - anti - CD95 or isotype - matched control IgG ( BD Biosciences, San Jose, CA, USA ).	CD19,52,56,Gene/Protein	CD38,70,74,Gene/Protein	CD86,89,93,Gene/Protein	CD19,113,117,Gene/Protein	CD27,131,135,Gene/Protein	CD95,154,158,Gene/Protein	IgG,188,191,Gene/Protein	"[{""token"": ""CD19"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""CD38"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""CD95"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Then, they were stained with PerCP - anti - CD19, PE - anti - CD38, APC - anti - CD86, or PerCP - anti - CD19, PE - anti - CD27, and APC - anti - CD95 ( Biolegend, San Diego, CA, USA ), or isotype - matched control IgG ( Beckton Dickinson, San Jose, CA, USA ).	CD19,44,48,Gene/Protein	CD38,62,66,Gene/Protein	CD86,81,85,Gene/Protein	CD19,105,109,Gene/Protein	CD27,123,127,Gene/Protein	CD95,146,150,Gene/Protein	IgG,215,218,Gene/Protein	"[{""token"": ""CD19"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CD38"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""CD95"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
In addition, there was no significant effect of age on the numbers of CD1d + CD5 + CD19 + Bregs or IL - 10 + CD1d + CD5 + CD19 + B cells ( data not shown ).	CD1d,70,74,Gene/Protein	CD5,77,80,Gene/Protein	CD19,83,87,Gene/Protein	IL - 10,99,106,Gene/Protein	CD1d,109,113,Gene/Protein	CD5,116,119,Gene/Protein	CD19,122,126,Gene/Protein	"[{""token"": ""CD1d"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
Then, we analyzed the correlation between the number of CD38 + CD19 + B cells and the serum IgA concentration in HSPN patients and found that the serum IgA concentration was positively correlated with the number of CD38 + CD19 + B cells ( Fig 6B, P = 0. 0303, R = 0. 4338 ).	CD38,56,60,Gene/Protein	CD19,63,67,Gene/Protein	IgA,92,95,Gene/Protein	HSPN,113,117,Disease/Disorder	IgA,152,155,Gene/Protein	CD38,215,219,Gene/Protein	CD19,222,226,Gene/Protein	"[{""token"": ""CD38"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""IgA"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""HSPN"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Disease/Disorder""}, {""token"": ""IgA"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""CD38"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
Because HSPN is mainly associated with glomerular deposits of an immune complex containing IgA, we also analyzed the serum level of IgA in patients with HSPN and found that the serum IgA concentration was positively correlated with the number of CD38 + CD19 + B cells.	HSPN,8,12,Disease/Disorder	IgA,91,94,Gene/Protein	IgA,132,135,Gene/Protein	HSPN,153,157,Disease/Disorder	IgA,183,186,Gene/Protein	CD38,246,250,Gene/Protein	CD19,253,257,Gene/Protein	"[{""token"": ""HSPN"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Disease/Disorder""}, {""token"": ""IgA"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""IgA"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""HSPN"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Disease/Disorder""}, {""token"": ""IgA"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""CD38"", ""start_span"": 246, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 253, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	train
They, identified eQTL in six of the genes that were that were differentially expressed in our study ( SERPING1, DDX24, OAS3, MX1, ZDHHC18, and NUP214; Fehrmann et al ., 2011 ), but of these only SERPING1 shows a significant eQTL in our Atlanta study.	SERPING1,102,110,Gene/Protein	DDX24,112,117,Gene/Protein	OAS3,119,123,Gene/Protein	MX1,125,128,Gene/Protein	ZDHHC18,130,137,Gene/Protein	NUP214,143,149,Gene/Protein	SERPING1,195,203,Gene/Protein	"[{""token"": ""SERPING1"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""DDX24"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""OAS3"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""MX1"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""ZDHHC18"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""NUP214"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""SERPING1"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
Similarly, we found that mRNA and protein levels of adhesion molecules VCAM ‐ 1 and ICAM ‐ 1 and chemokine MCP ‐ 1 in HFD mice treated with L6H21 were comparable to mice on control diet ( Fig. 3G – I and Fig. S9 ).	adhesion molecules,52,70,Gene/Protein	VCAM ‐ 1,71,79,Gene/Protein	ICAM ‐ 1,84,92,Gene/Protein	chemokine,97,106,Gene/Protein	MCP ‐ 1,107,114,Gene/Protein	mice,122,126,Organism/Species	mice,165,169,Organism/Species	"[{""token"": ""adhesion molecules"", ""start_span"": 52, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""VCAM \u2010 1"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""ICAM \u2010 1"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""chemokine"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""MCP \u2010 1"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Organism/Species""}]"	train
A number of pro - inflammatory mediators, such as TNF - α, were also elevated in D8 – 10 mice; others, such as IL - 12 and MIP - 1α, were elevated in D3 – 5, often demonstrating an age - dependent decrease. Error bars depict standard error of the mean. Asterisk indicates that the group has significantly greater levels than bracketed comparison ( p < 0. 05 ). b Photomicrographs depicting CTB ( first column) and elevated immunostaining for FGF - 2 ( second column) and GFAP ( third column) in representative DBA / 2J retina whole mount compared to a D2G.	TNF - α,50,57,Gene/Protein	mice,89,93,Organism/Species	IL - 12,111,118,Gene/Protein	MIP - 1α,123,131,Gene/Protein	CTB,390,393,Gene/Protein	FGF - 2,442,449,Gene/Protein	GFAP,471,475,Gene/Protein	"[{""token"": ""TNF - \u03b1"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""IL - 12"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1\u03b1"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""CTB"", ""start_span"": 390, ""end_span"": 393, ""type"": ""Gene/Protein""}, {""token"": ""FGF - 2"", ""start_span"": 442, ""end_span"": 449, ""type"": ""Gene/Protein""}, {""token"": ""GFAP"", ""start_span"": 471, ""end_span"": 475, ""type"": ""Gene/Protein""}]"	train
No significant differences were seen between old and young D2G pON in the following cytokines: FGF - 2 ( t ( 10) = − 1. 921, p = 0. 084 ), IL - 1β ( t ( 4) = 1. 633, p = 0. 178 ), IL - 6 ( t ( 9) = 0. 003, p = 0. 998 ), IL - 12 ( no IL - 12 was detected in D2Gs, so t test not computed ), MIP - 1α ( t ( 10) = 0. 450, p = 0. 662 ).	cytokines,84,93,Gene/Protein	FGF - 2,95,102,Gene/Protein	IL - 1β,139,146,Gene/Protein	IL - 6,180,186,Gene/Protein	IL - 12,220,227,Gene/Protein	IL - 12,233,240,Gene/Protein	MIP - 1α,289,297,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""FGF - 2"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 220, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 233, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1\u03b1"", ""start_span"": 289, ""end_span"": 297, ""type"": ""Gene/Protein""}]"	train
No significant differences in cerebellar cytokine levels were observed in DBA / 2J and D2G mice across ages ( Table 2) indicating that differences in cytokine levels are not generalizable to the nervous system in these mice. Table 1Summary of group nomenclature and N valuesStrainAgeGroup nomenclatureMice per group ( N) Projections analyzed ( n) D2G3 – 5 monthsD2Ga 48D2G12 – 15 months46DBA / 2J3 – 5 monthsD3 – 5510DBA / 2J8 – 10 monthsD8 – 10612DBA / 2J12 – 15 monthsD12 – 15510 aYoung and old D2G mice were combined into a single control group in order to simplify results when possible; independent samples t tests indicated that young and old D2G mice showed few differences in their cytokines levels.	cytokine,41,49,Gene/Protein	mice,91,95,Organism/Species	cytokine,150,158,Gene/Protein	mice,219,223,Organism/Species	mice,501,505,Organism/Species	mice,653,657,Organism/Species	cytokines,690,699,Gene/Protein	"[{""token"": ""cytokine"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""cytokine"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 501, ""end_span"": 505, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 653, ""end_span"": 657, ""type"": ""Organism/Species""}, {""token"": ""cytokines"", ""start_span"": 690, ""end_span"": 699, ""type"": ""Gene/Protein""}]"	train
Early elevations of classically categorized pro - inflammatory cytokines — specifically IFNγ, MIG, KC, TNF - α, and MIP - 1α — observed in the retina and SC may signal the progression of pathological changes in the visual projection of DBA / 2J mice prior to functional transport loss and RGC death.	pro - inflammatory cytokines,44,72,Gene/Protein	IFNγ,88,92,Gene/Protein	MIG,94,97,Gene/Protein	KC,99,101,Gene/Protein	TNF - α,103,110,Gene/Protein	MIP - 1α,116,124,Gene/Protein	DBA / 2J mice,236,249,Organism/Species	"[{""token"": ""pro - inflammatory cytokines"", ""start_span"": 44, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IFN\u03b3"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""MIG"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""KC"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1\u03b1"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""DBA / 2J mice"", ""start_span"": 236, ""end_span"": 249, ""type"": ""Organism/Species""}]"	train
pDARPP - 32 ( Thr34) immunoreactivity was used to provide a marker of DA - related signal transduction activity, because evidence indicates that DA acting through the D1 receptor and the G proteins Gs / Golf activates adenylate cyclase activity, thereby stimulating PKA - mediated phosphorylation of DARPP - 32 at the Thr34 site [ 45 ], [ 46 ], [ 47 ], [ 48 ].	D1 receptor,167,178,Gene/Protein	G proteins,187,197,Gene/Protein	Gs,198,200,Gene/Protein	Golf,203,207,Gene/Protein	adenylate cyclase,218,235,Gene/Protein	PKA,266,269,Gene/Protein	DARPP - 32,300,310,Gene/Protein	"[{""token"": ""D1 receptor"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""G proteins"", ""start_span"": 187, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""Gs"", ""start_span"": 198, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""Golf"", ""start_span"": 203, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""adenylate cyclase"", ""start_span"": 218, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 266, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""DARPP - 32"", ""start_span"": 300, ""end_span"": 310, ""type"": ""Gene/Protein""}]"	train
pDARPP - 32 ( Thr34) immunoreactivity was used to provide a marker of signal transduction activity, and evidence indicates that DA acting through the D1 receptor and related G proteins ( Gs / Golf) activates adenylate cyclase activity, thereby stimulating PKA - mediated phosphorylation of DARPP - 32 at the Thr34 site [ 45 ]–[ 48 ].	D1 receptor,150,161,Gene/Protein	G proteins,174,184,Gene/Protein	Gs,187,189,Gene/Protein	Golf,192,196,Gene/Protein	adenylate cyclase,208,225,Gene/Protein	PKA,256,259,Gene/Protein	DARPP - 32,290,300,Gene/Protein	"[{""token"": ""D1 receptor"", ""start_span"": 150, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""G proteins"", ""start_span"": 174, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""Gs"", ""start_span"": 187, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""Golf"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""adenylate cyclase"", ""start_span"": 208, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 256, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""DARPP - 32"", ""start_span"": 290, ""end_span"": 300, ""type"": ""Gene/Protein""}]"	train
Evidence from epidemiological studies indicates an inverse relationship between the incidence of helminth infections and the occurrence of immune - related diseases including allergies, multiple sclerosis ( MS) and inflammatory bowel disease ( IBD) [ 3, 4, 5 ].	helminth infections,97,116,Disease/Disorder	immune - related diseases,139,164,Disease/Disorder	allergies,175,184,Disease/Disorder	multiple sclerosis,186,204,Disease/Disorder	MS,207,209,Disease/Disorder	inflammatory bowel disease,215,241,Disease/Disorder	IBD,244,247,Disease/Disorder	"[{""token"": ""helminth infections"", ""start_span"": 97, ""end_span"": 116, ""type"": ""Disease/Disorder""}, {""token"": ""immune - related diseases"", ""start_span"": 139, ""end_span"": 164, ""type"": ""Disease/Disorder""}, {""token"": ""allergies"", ""start_span"": 175, ""end_span"": 184, ""type"": ""Disease/Disorder""}, {""token"": ""multiple sclerosis"", ""start_span"": 186, ""end_span"": 204, ""type"": ""Disease/Disorder""}, {""token"": ""MS"", ""start_span"": 207, ""end_span"": 209, ""type"": ""Disease/Disorder""}, {""token"": ""inflammatory bowel disease"", ""start_span"": 215, ""end_span"": 241, ""type"": ""Disease/Disorder""}, {""token"": ""IBD"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Disease/Disorder""}]"	train
In experimental autoimmune encephalomyelitis, a mouse model for MS, eggs of Schistosoma mansoni, a parasitic trematode bloodfluke, reduced disease severity in established disease, while pre - established infection with live S. mansoni delayed onset and significantly reduced incidence of the disease [ 6 ].	experimental autoimmune encephalomyelitis,3,44,Disease/Disorder	mouse,48,53,Organism/Species	MS,64,66,Disease/Disorder	Schistosoma mansoni,76,95,Organism/Species	trematode,109,118,Organism/Species	bloodfluke,119,129,Organism/Species	infection,204,213,Disease/Disorder	"[{""token"": ""experimental autoimmune encephalomyelitis"", ""start_span"": 3, ""end_span"": 44, ""type"": ""Disease/Disorder""}, {""token"": ""mouse"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Organism/Species""}, {""token"": ""MS"", ""start_span"": 64, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""Schistosoma mansoni"", ""start_span"": 76, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""trematode"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""bloodfluke"", ""start_span"": 119, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 204, ""end_span"": 213, ""type"": ""Disease/Disorder""}]"	train
In TNBS and DSS colitis models, two mouse models for IBD, S. mansoni was shown to ameliorate colitis [ 7, 8] and infection with S. mansoni has beneficial effects in collagen - induced arthritis [ 9 ].	colitis,16,23,Disease/Disorder	mouse,36,41,Organism/Species	IBD,53,56,Disease/Disorder	colitis,93,100,Disease/Disorder	infection,113,122,Disease/Disorder	collagen,165,173,Gene/Protein	arthritis,184,193,Disease/Disorder	"[{""token"": ""colitis"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Disease/Disorder""}, {""token"": ""mouse"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""IBD"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""colitis"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Disease/Disorder""}, {""token"": ""infection"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""collagen"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""arthritis"", ""start_span"": 184, ""end_span"": 193, ""type"": ""Disease/Disorder""}]"	train
SEA was coated to wells of an ELISA plate, and the plate was washed before DCs were added, A - C The production of the cytokines TNFα ( A ), IL - 12p70 ( B) and IL - 6 ( C) was determined in the DC supernatants after 4h ( IL - 6 and TNFα) or 24h ( IL - 12p70 ).	cytokines,119,128,Gene/Protein	TNFα,129,133,Gene/Protein	IL - 12p70,141,151,Gene/Protein	IL - 6,161,167,Gene/Protein	IL - 6,222,228,Gene/Protein	TNFα,233,237,Gene/Protein	IL - 12p70,248,258,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 119, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""TNF\u03b1"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12p70"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""TNF\u03b1"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12p70"", ""start_span"": 248, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
The cytokine production of LPS - activated DCs was set at 100% in each experiment and varied for TNFα from 40 – 200 ng / ml, for IL - 6 from 2 – 10 ng / ml and for IL - 12 from 50 – 200 ng / ml, dependent on the blood donor used. D - E Relative mRNA levels of SOCS1 ( D) and SHP1 ( E) were determined in the cells after 4h by quantitative real - time PCR using GAPDH as reference gene.	cytokine,4,12,Gene/Protein	TNFα,97,101,Gene/Protein	IL - 6,129,135,Gene/Protein	IL - 12,164,171,Gene/Protein	SOCS1,260,265,Gene/Protein	SHP1,275,279,Gene/Protein	GAPDH,361,366,Gene/Protein	"[{""token"": ""cytokine"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""TNF\u03b1"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""SOCS1"", ""start_span"": 260, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 275, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""GAPDH"", ""start_span"": 361, ""end_span"": 366, ""type"": ""Gene/Protein""}]"	train
To discriminate between the putative involvement of DC - SIGN and the MR in the SEA - induced expression of SOCS1 and SHP1, DCs were incubated with blocking antibodies for the MR or DC - SIGN prior to SEA stimulation.	DC - SIGN,52,61,Gene/Protein	MR,70,72,Gene/Protein	SOCS1,108,113,Gene/Protein	SHP1,118,122,Gene/Protein	antibodies,157,167,Gene/Protein	MR,176,178,Gene/Protein	DC - SIGN,182,191,Gene/Protein	"[{""token"": ""DC - SIGN"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""MR"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""SOCS1"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 157, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""MR"", ""start_span"": 176, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""DC - SIGN"", ""start_span"": 182, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Possibly, the MR blockade by antibody is not sufficiently efficient to obtain an effect on the level of cytokine secretion, since a complete block of both SOCS1 and SHP1 expression by immobilization of SEA did reverse the suppression of TLR4 - induced TNFα production.	MR,14,16,Gene/Protein	antibody,29,37,Gene/Protein	cytokine,104,112,Gene/Protein	SOCS1,155,160,Gene/Protein	SHP1,165,169,Gene/Protein	TLR4,237,241,Gene/Protein	TNFα,252,256,Gene/Protein	"[{""token"": ""MR"", ""start_span"": 14, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""SOCS1"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 237, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""TNF\u03b1"", ""start_span"": 252, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
Blinded digital images of the fetal rhesus skin ( 5 non - overlapping, random fields per animal) were quantified for the total number of inflammatory cells, and immunostaining for IL - 6, IL - 8, neutrophil ( MPO ), monocyte / macrophage ( CD68 ), and T - cells ( CD3 ).	rhesus,36,42,Organism/Species	animal,89,95,Organism/Species	IL - 6,180,186,Gene/Protein	IL - 8,188,194,Gene/Protein	MPO,209,212,Gene/Protein	CD68,240,244,Gene/Protein	CD3,264,267,Gene/Protein	"[{""token"": ""rhesus"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""IL - 6"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 188, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""MPO"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""CD68"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 264, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	train
The Neighbor - Joining tree ( NJ) based on the external contour of the eggs revealed ( i) remarkable difference between Triatomini and Rhodniini eggs; ( ii) correct clustering of three species belonging to two genera, Panstrongylus and Triatoma; and ( iii) distinction between two geographic populations within R. ecuadoriensis ( Fig. 8 ). Fig. 8Neighbor - joining trees derived from egg shape variation based on Mahalanobis distances for egg shape between P. chinai, P. howardi, T. carrioni and two populations of R. ecuadoriensis ( Loja and Manabí ). Abbreviations: P, Panstrongylus; T, Triatoma; R, Rhodnius; L, Loja; M, Manabí	Triatomini,120,130,Organism/Species	Rhodniini,135,144,Organism/Species	Panstrongylus,218,231,Organism/Species	Triatoma,236,244,Organism/Species	Panstrongylus,571,584,Organism/Species	Triatoma,589,597,Organism/Species	Rhodnius,602,610,Organism/Species	"[{""token"": ""Triatomini"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""Rhodniini"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Organism/Species""}, {""token"": ""Panstrongylus"", ""start_span"": 218, ""end_span"": 231, ""type"": ""Organism/Species""}, {""token"": ""Triatoma"", ""start_span"": 236, ""end_span"": 244, ""type"": ""Organism/Species""}, {""token"": ""Panstrongylus"", ""start_span"": 571, ""end_span"": 584, ""type"": ""Organism/Species""}, {""token"": ""Triatoma"", ""start_span"": 589, ""end_span"": 597, ""type"": ""Organism/Species""}, {""token"": ""Rhodnius"", ""start_span"": 602, ""end_span"": 610, ""type"": ""Organism/Species""}]"	train
The Melanoma, Breast Cancer 2, Gastric Tumor and Pancreatic Cancer datasets contain a large number of genes, the Breast Cancer 1, Brain Cancer and Lymphoma datasets involve a relatively small number of genes and the gene numbers in the other datasets are intermediate.	Melanoma,4,12,Disease/Disorder	Breast Cancer,14,27,Disease/Disorder	Gastric Tumor,31,44,Disease/Disorder	Pancreatic Cancer,49,66,Disease/Disorder	Breast Cancer,113,126,Disease/Disorder	Brain Cancer,130,142,Disease/Disorder	Lymphoma,147,155,Disease/Disorder	"[{""token"": ""Melanoma"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Disease/Disorder""}, {""token"": ""Breast Cancer"", ""start_span"": 14, ""end_span"": 27, ""type"": ""Disease/Disorder""}, {""token"": ""Gastric Tumor"", ""start_span"": 31, ""end_span"": 44, ""type"": ""Disease/Disorder""}, {""token"": ""Pancreatic Cancer"", ""start_span"": 49, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""Breast Cancer"", ""start_span"": 113, ""end_span"": 126, ""type"": ""Disease/Disorder""}, {""token"": ""Brain Cancer"", ""start_span"": 130, ""end_span"": 142, ""type"": ""Disease/Disorder""}, {""token"": ""Lymphoma"", ""start_span"": 147, ""end_span"": 155, ""type"": ""Disease/Disorder""}]"	train
Following sonication and boiling, aliquots were resolved by 12% SDS – PAGE according to Laemmli, transferred to a PVDF membrane ( Thermo Scientific) and hybridized with a mouse monoclonal antibody against RAD51 at the 1: 1000 dilution ( clone 3C10, Invitrogen) or against RAD52 at the 1: 1000 dilution ( Thermo Scientific) followed by a peroxidase - labeled anti - mouse antibody ( Sigma) at the 1: 10000 dilution.	mouse,171,176,Organism/Species	antibody,188,196,Gene/Protein	RAD51,205,210,Gene/Protein	RAD52,272,277,Gene/Protein	peroxidase,337,347,Gene/Protein	mouse,365,370,Organism/Species	antibody,371,379,Gene/Protein	"[{""token"": ""mouse"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 188, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""RAD51"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""RAD52"", ""start_span"": 272, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""peroxidase"", ""start_span"": 337, ""end_span"": 347, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 365, ""end_span"": 370, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 371, ""end_span"": 379, ""type"": ""Gene/Protein""}]"	train
In this paper, we present the results of mercury concentration in soils, buds and leaves of maple ( Acer platanoides — Ap) and linden ( Tilia platyphyllos — Tp) collected in four periods of the growing season of trees, i. e. in April ( IV ), June ( VI ), August ( VIII) and November ( IX) in 2013, from the area of Poznań city ( Poland ).	maple,92,97,Organism/Species	Acer platanoides,100,116,Organism/Species	Ap,119,121,Organism/Species	linden,127,133,Organism/Species	Tilia platyphyllos,136,154,Organism/Species	Tp,157,159,Organism/Species	trees,212,217,Organism/Species	"[{""token"": ""maple"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organism/Species""}, {""token"": ""Acer platanoides"", ""start_span"": 100, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""Ap"", ""start_span"": 119, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""linden"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Organism/Species""}, {""token"": ""Tilia platyphyllos"", ""start_span"": 136, ""end_span"": 154, ""type"": ""Organism/Species""}, {""token"": ""Tp"", ""start_span"": 157, ""end_span"": 159, ""type"": ""Organism/Species""}, {""token"": ""trees"", ""start_span"": 212, ""end_span"": 217, ""type"": ""Organism/Species""}]"	train
The effects of losartan ( Los ), metformin ( Met ), compound C ( CC ), Nω - nitro - L - arginine methyl ester ( L - NAME) or splitomicin ( SP) on phospho - AMPK ( P - AMPK, A and B) and total - AMPK ( T - AMPK, C and D) in cell hypertrophy.	losartan,15,23,Chemical/Drug	metformin,33,42,Chemical/Drug	splitomicin,125,136,Chemical/Drug	AMPK,156,160,Gene/Protein	AMPK,167,171,Gene/Protein	AMPK,194,198,Gene/Protein	AMPK,205,209,Gene/Protein	"[{""token"": ""losartan"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Chemical/Drug""}, {""token"": ""metformin"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""splitomicin"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""AMPK"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""AMPK"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""AMPK"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""AMPK"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
On the other hand, metformin - or losartan - induced AMPK activation can increase NAD +/ NADH, which, in turn, stimulates the NAD +- dependent deacetylases sirtuins, including SIRT1, a regulator of p53 activity.	metformin,19,28,Chemical/Drug	losartan,34,42,Chemical/Drug	AMPK,53,57,Gene/Protein	NAD +- dependent deacetylases,126,155,Gene/Protein	sirtuins,156,164,Gene/Protein	SIRT1,176,181,Gene/Protein	p53,198,201,Gene/Protein	"[{""token"": ""metformin"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""losartan"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""AMPK"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""NAD +- dependent deacetylases"", ""start_span"": 126, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""sirtuins"", ""start_span"": 156, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""SIRT1"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
SEX4, LSF2 and Laforin are classified in the family of atypical Dual - Specificity Phosphatases ( DSPs ), which belongs to the Protein Tyrosine Phosphatase ( PTP) superfamily.	SEX4,0,4,Gene/Protein	LSF2,6,10,Gene/Protein	Laforin,15,22,Gene/Protein	Dual - Specificity Phosphatases,64,95,Gene/Protein	DSPs,98,102,Gene/Protein	Protein Tyrosine Phosphatase,127,155,Gene/Protein	PTP,158,161,Gene/Protein	"[{""token"": ""SEX4"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""LSF2"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""Laforin"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Dual - Specificity Phosphatases"", ""start_span"": 64, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""DSPs"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""Protein Tyrosine Phosphatase"", ""start_span"": 127, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""PTP"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
Accordingly, the various PDHA2 reporter plasmids and the parental pGL2 - Basic vector were transfected into HeLa ( cervix adenocarcinoma ), NT2 ( human teratocarcinoma) and SH - SY5Y ( human neuroblastoma) cells, which do not normally express PDHA2 mRNA.	PDHA2,25,30,Gene/Protein	cervix adenocarcinoma,115,136,Disease/Disorder	human,146,151,Organism/Species	teratocarcinoma,152,167,Disease/Disorder	human,185,190,Organism/Species	neuroblastoma,191,204,Disease/Disorder	PDHA2,243,248,Gene/Protein	"[{""token"": ""PDHA2"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""cervix adenocarcinoma"", ""start_span"": 115, ""end_span"": 136, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""teratocarcinoma"", ""start_span"": 152, ""end_span"": 167, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 185, ""end_span"": 190, ""type"": ""Organism/Species""}, {""token"": ""neuroblastoma"", ""start_span"": 191, ""end_span"": 204, ""type"": ""Disease/Disorder""}, {""token"": ""PDHA2"", ""start_span"": 243, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	train
SH - SY5Y ( human neuroblastoma, ATCC CRL - 2266) cell line was maintained in low glucose Dulbecco ' s modified Eagle ' s medium ( Sigma - Aldrich Inc ., St. Louis, MO, USA ), while HeLa ( human cervix adenocarcinoma, ATCC CCL - 2) and NT2 ( human teratocarcinoma, ATCC CRL - 1973) cell lines were cultured in high glucose Dulbecco ' s modified Eagle ' s medium ( Sigma ).	human,12,17,Organism/Species	neuroblastoma,18,31,Disease/Disorder	glucose,82,89,Chemical/Drug	human,189,194,Organism/Species	cervix adenocarcinoma,195,216,Disease/Disorder	human,242,247,Organism/Species	teratocarcinoma,248,263,Disease/Disorder	"[{""token"": ""human"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""neuroblastoma"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Disease/Disorder""}, {""token"": ""glucose"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""human"", ""start_span"": 189, ""end_span"": 194, ""type"": ""Organism/Species""}, {""token"": ""cervix adenocarcinoma"", ""start_span"": 195, ""end_span"": 216, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 242, ""end_span"": 247, ""type"": ""Organism/Species""}, {""token"": ""teratocarcinoma"", ""start_span"": 248, ""end_span"": 263, ""type"": ""Disease/Disorder""}]"	train
Meanwhile, the network 2 ( Figure 5B) associated with high birth weight group (> 75th percentile) was related to inflammatory disease pathway ( highest score) with increased CRP ( red ), down - regulated MMP - 9 ( green) and interaction seen between ET - 1 and ET [ B] receptor ( EDNRB ), where ET - 1 potentially binds to ET [ B] receptor and can upregulate VEGF ( red ), as seen under hypoxic condition ( Spinella et al ., 2014 ).	inflammatory disease,113,133,Disease/Disorder	CRP,174,177,Gene/Protein	MMP - 9,204,211,Gene/Protein	ET - 1,250,256,Gene/Protein	EDNRB,280,285,Gene/Protein	ET - 1,295,301,Gene/Protein	VEGF,359,363,Gene/Protein	"[{""token"": ""inflammatory disease"", ""start_span"": 113, ""end_span"": 133, ""type"": ""Disease/Disorder""}, {""token"": ""CRP"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""ET - 1"", ""start_span"": 250, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""EDNRB"", ""start_span"": 280, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""ET - 1"", ""start_span"": 295, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""VEGF"", ""start_span"": 359, ""end_span"": 363, ""type"": ""Gene/Protein""}]"	train
Three transcription factors created all of the links from the regulatory network into the intersecting genes ( MZF1, TEF and SMAD4) while an additional two transcription factors were present within the intersecting landscape via their connection to other genes made by epistatic interactions ( MAML2 and SP3 ).	transcription factors,6,27,Gene/Protein	MZF1,111,115,Gene/Protein	TEF,117,120,Gene/Protein	SMAD4,125,130,Gene/Protein	transcription factors,156,177,Gene/Protein	MAML2,294,299,Gene/Protein	SP3,304,307,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 6, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""MZF1"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""TEF"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""SMAD4"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 156, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""MAML2"", ""start_span"": 294, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""SP3"", ""start_span"": 304, ""end_span"": 307, ""type"": ""Gene/Protein""}]"	train
These viruses encode wild - type active Cre - recombinase ( WT - Cre, active) or mutated defective Cre - recombinase ( Δ - Cre, control) respectively and green fluorescent protein ( GFP) and are known to be taken up by all types of cells in the injected region [ 61 ].	viruses,6,13,Organism/Species	Cre - recombinase,40,57,Gene/Protein	Cre,65,68,Gene/Protein	Cre - recombinase,99,116,Gene/Protein	Cre,123,126,Gene/Protein	green fluorescent protein,154,179,Gene/Protein	GFP,182,185,Gene/Protein	"[{""token"": ""viruses"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Organism/Species""}, {""token"": ""Cre - recombinase"", ""start_span"": 40, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Cre"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Cre - recombinase"", ""start_span"": 99, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Cre"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""green fluorescent protein"", ""start_span"": 154, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
Primary antibodies, mouse anti - NDUFS4 ( Santa Cruz; dilution 1: 50 ), mouse anti - cytochrome C ( MitoSciences; dilution 1: 300) and goat anti - GFP ( Abcam; dilution 1: 200) were incubated overnight at 4 ° C.	antibodies,8,18,Gene/Protein	mouse,20,25,Organism/Species	NDUFS4,33,39,Gene/Protein	mouse,72,77,Organism/Species	cytochrome C,85,97,Gene/Protein	goat,135,139,Organism/Species	GFP,147,150,Gene/Protein	"[{""token"": ""antibodies"", ""start_span"": 8, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Organism/Species""}, {""token"": ""NDUFS4"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""cytochrome C"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""GFP"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
TLF contains apolipoprotein A - I ( ApoA - 1 ), a protein found in all subclasses of HDL, and two proteins, haptoglobin - related protein ( Hpr) and apolipoprotein L - 1 ( ApoL - 1) that are unique to primates [ 8 – 19 ].	apolipoprotein A - I,13,33,Gene/Protein	ApoA - 1,36,44,Gene/Protein	haptoglobin - related protein,108,137,Gene/Protein	Hpr,140,143,Gene/Protein	apolipoprotein L - 1,149,169,Gene/Protein	ApoL - 1,172,180,Gene/Protein	primates,201,209,Organism/Species	"[{""token"": ""apolipoprotein A - I"", ""start_span"": 13, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""ApoA - 1"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""haptoglobin - related protein"", ""start_span"": 108, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""apolipoprotein L - 1"", ""start_span"": 149, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""ApoL - 1"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""primates"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Organism/Species""}]"	train
Nevertheless, MS analysis failed to detect Hb as a component of purified TLF, most likely because the low levels of Hb that are released into the plasma of individuals with normal erythrocyte turnover are instantly bound by Hp, which is present in large excess compared to Hpr ( the concentration of Hp is roughly 10 - to 100 - fold higher than Hpr in normal human serum) [ 12, 31 ].	Hb,43,45,Gene/Protein	Hb,116,118,Gene/Protein	Hp,224,226,Gene/Protein	Hpr,273,276,Gene/Protein	Hp,300,302,Gene/Protein	Hpr,345,348,Gene/Protein	human,359,364,Organism/Species	"[{""token"": ""Hb"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 116, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Hp"", ""start_span"": 224, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""Hp"", ""start_span"": 300, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 345, ""end_span"": 348, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 359, ""end_span"": 364, ""type"": ""Organism/Species""}]"	train
While Hp initially binds all free Hb, the clearance of the Hp – Hb complex would result in a significant drop in Hp levels to the point where Hpr would become a major Hb - binding protein.	Hp,6,8,Gene/Protein	Hb,34,36,Gene/Protein	Hp,59,61,Gene/Protein	Hb,64,66,Gene/Protein	Hp,113,115,Gene/Protein	Hpr,142,145,Gene/Protein	Hb,167,169,Gene/Protein	"[{""token"": ""Hp"", ""start_span"": 6, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 34, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""Hp"", ""start_span"": 59, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 64, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""Hp"", ""start_span"": 113, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 167, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
Because MTAP is linked to polyamine metabolism and adenine and methionine salvage [ 16, 17 ], examining whether MTAP inactivation promotes angiogenesis by perturbing the metabolic balance of sarcoma cells is conceivable, similar to the scenario involved in deregulated ASS1.	MTAP,8,12,Gene/Protein	polyamine,26,35,Chemical/Drug	adenine,51,58,Chemical/Drug	methionine,63,73,Chemical/Drug	MTAP,112,116,Gene/Protein	sarcoma,191,198,Disease/Disorder	ASS1,269,273,Gene/Protein	"[{""token"": ""MTAP"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""polyamine"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""adenine"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""methionine"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""MTAP"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""sarcoma"", ""start_span"": 191, ""end_span"": 198, ""type"": ""Disease/Disorder""}, {""token"": ""ASS1"", ""start_span"": 269, ""end_span"": 273, ""type"": ""Gene/Protein""}]"	train
Histologically, control xenografts ( upper panel) comprise MTAP - deficient high - grade pleomorphic sarcoma cells that exhibit frequent mitotic figures, the increased expression of cyclin D1, cyclin E, Ki - 67, and MMP - 9, and an increased microvascular density based on CD31 staining.	MTAP,59,63,Gene/Protein	sarcoma,101,108,Disease/Disorder	cyclin D1,182,191,Gene/Protein	cyclin E,193,201,Gene/Protein	Ki - 67,203,210,Gene/Protein	MMP - 9,216,223,Gene/Protein	CD31,273,277,Gene/Protein	"[{""token"": ""MTAP"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""sarcoma"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Disease/Disorder""}, {""token"": ""cyclin D1"", ""start_span"": 182, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""cyclin E"", ""start_span"": 193, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""Ki - 67"", ""start_span"": 203, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 216, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""CD31"", ""start_span"": 273, ""end_span"": 277, ""type"": ""Gene/Protein""}]"	train
Recently, we reported that the antiangiogenic function of ASS1, a rate - limiting enzyme converting citrulline into arginine in the urea cycle, was also attributable to the inhibition of ASS1 on MMP - 9 expression in myxofibrosarcomas [ 15 ].	ASS1,58,62,Gene/Protein	citrulline,100,110,Chemical/Drug	arginine,116,124,Chemical/Drug	urea,132,136,Chemical/Drug	ASS1,187,191,Gene/Protein	MMP - 9,195,202,Gene/Protein	myxofibrosarcomas,217,234,Disease/Disorder	"[{""token"": ""ASS1"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""citrulline"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Chemical/Drug""}, {""token"": ""arginine"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""ASS1"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""myxofibrosarcomas"", ""start_span"": 217, ""end_span"": 234, ""type"": ""Disease/Disorder""}]"	train
Whole sections of xenografted specimens were stained with MTAP ( 1: 50, Proteintech ), cyclin D1 ( 1: 100, Epitomics ), cyclin E ( 1: 20, Abcam ), Ki - 67 ( 1: 200, abcam ), MMP - 9 ( 1: 50, Epitomics ), CD31 ( 1: 50, BD Pharmingen ), and TUNEL ( Roche) for labeling apoptotic cells.	MTAP,58,62,Gene/Protein	cyclin D1,87,96,Gene/Protein	cyclin E,120,128,Gene/Protein	Ki - 67,147,154,Gene/Protein	MMP - 9,174,181,Gene/Protein	CD31,204,208,Gene/Protein	TUNEL,239,244,Gene/Protein	"[{""token"": ""MTAP"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D1"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""cyclin E"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Ki - 67"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""CD31"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""TUNEL"", ""start_span"": 239, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
Indeed, bi - directional development is a unique biological characteristic of E. granulosus and our previous study showed that some protein - coding genes, with high homology to the bile acid receptors and transporters, were located in the E. granulosus genome, and that nuclear hormone receptors, including the farnesoid X receptor ( FXR) and VDR, may play a key role in stimulating the PSC to develop into adult worms [ 16 ].	bile acid receptors,182,201,Gene/Protein	transporters,206,218,Gene/Protein	nuclear hormone receptors,271,296,Gene/Protein	farnesoid X receptor,312,332,Gene/Protein	FXR,335,338,Gene/Protein	VDR,344,347,Gene/Protein	worms,414,419,Organism/Species	"[{""token"": ""bile acid receptors"", ""start_span"": 182, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""transporters"", ""start_span"": 206, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""nuclear hormone receptors"", ""start_span"": 271, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""farnesoid X receptor"", ""start_span"": 312, ""end_span"": 332, ""type"": ""Gene/Protein""}, {""token"": ""FXR"", ""start_span"": 335, ""end_span"": 338, ""type"": ""Gene/Protein""}, {""token"": ""VDR"", ""start_span"": 344, ""end_span"": 347, ""type"": ""Gene/Protein""}, {""token"": ""worms"", ""start_span"": 414, ""end_span"": 419, ""type"": ""Organism/Species""}]"	train
The expression of both MRC2 and transforming growth factor ( TGFβ1) was detected in tumor tissues and adjacent liver tissues from 96 HCCs by immunohistochemistry staining, and it was found that MRC2 expression in HCC tissues was significantly higher than in adjacent liver tissues.	MRC2,23,27,Gene/Protein	transforming growth factor,32,58,Gene/Protein	TGFβ1,61,66,Gene/Protein	tumor,84,89,Disease/Disorder	HCCs,133,137,Disease/Disorder	MRC2,194,198,Gene/Protein	HCC,213,216,Disease/Disorder	"[{""token"": ""MRC2"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""transforming growth factor"", ""start_span"": 32, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""TGF\u03b21"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Disease/Disorder""}, {""token"": ""HCCs"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Disease/Disorder""}, {""token"": ""MRC2"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 213, ""end_span"": 216, ""type"": ""Disease/Disorder""}]"	train
A growing body of evidences showed that TGFβ1 functions as either a tumor suppressor or a tumor promoter [ 7, 8, 9, 10, 11, 12] via both SMAD ( drosophila mothers against decapentaplegic protein )- dependent and SMAD - independent cascades.	TGFβ1,40,45,Gene/Protein	tumor,68,73,Disease/Disorder	tumor,90,95,Disease/Disorder	SMAD,137,141,Gene/Protein	drosophila,144,154,Organism/Species	mothers against decapentaplegic protein,155,194,Gene/Protein	SMAD,212,216,Gene/Protein	"[{""token"": ""TGF\u03b21"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Disease/Disorder""}, {""token"": ""SMAD"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""drosophila"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Organism/Species""}, {""token"": ""mothers against decapentaplegic protein"", ""start_span"": 155, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""SMAD"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
TypA are widely distributed in plants and are present in green algae, mosses, liverworts, gymnosperms, and angiosperms ( Barak and Trebitsh, 2007 ).	TypA,0,4,Gene/Protein	plants,31,37,Organism/Species	green algae,57,68,Organism/Species	mosses,70,76,Organism/Species	liverworts,78,88,Organism/Species	gymnosperms,90,101,Organism/Species	angiosperms,107,118,Organism/Species	"[{""token"": ""TypA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Organism/Species""}, {""token"": ""green algae"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Organism/Species""}, {""token"": ""mosses"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Organism/Species""}, {""token"": ""liverworts"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Organism/Species""}, {""token"": ""gymnosperms"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""angiosperms"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Organism/Species""}]"	train
For analysis of the chloroplast transit peptide in TaTypA, the partial coding sequence ( positions 1 – 240, 240 nt) at N - terminal was fused into pCaMV35S :: GFP vector by PCR using primers TaTyPA - 163 - F and TaTyPA - 163 - RN ( Supplementary Table S1; pCaMV35S :: TaTypA - N1 - 80 :: GFP ).	TaTypA,51,57,Gene/Protein	at,116,118,Organism/Species	GFP,159,162,Gene/Protein	TaTyPA,191,197,Gene/Protein	TaTyPA,212,218,Gene/Protein	TaTypA,268,274,Gene/Protein	GFP,288,291,Gene/Protein	"[{""token"": ""TaTypA"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""at"", ""start_span"": 116, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""GFP"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""TaTyPA"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""TaTyPA"", ""start_span"": 212, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 268, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 288, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
Capped in vitro transcripts of BSMV RNAs were prepared from the linearized plasmids ( Petty et al ., 1990) γ - TaPDS - as, γ - TaTypA - as, γ, α, β using a Message T7 in vitro transcription kit ( Ambion, Austin, TX, USA) according to the manufacturer ’ s protocol; 2. 5 μl of each transcript, including BSMV RNAs α, β and genetically modified γ, were added to 42. 5 μl of FES buffer ( 0. 1 M glycine, 0. 06 M K2HPO4, 1% w / v tetrasodium pyrophosphate, 1% w / v bentonite, and 1% w / v celite, pH 8. 5) and inoculated into the second leaves of two - leaf wheat seedlings by gentle rubbing of the surface with a gloved finger ( Scofield et al ., 2005 ).	BSMV,31,35,Organism/Species	TaPDS,111,116,Gene/Protein	TaTypA,127,133,Gene/Protein	BSMV,303,307,Organism/Species	glycine,392,399,Chemical/Drug	celite,486,492,Chemical/Drug	wheat,555,560,Organism/Species	"[{""token"": ""BSMV"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Organism/Species""}, {""token"": ""TaPDS"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""BSMV"", ""start_span"": 303, ""end_span"": 307, ""type"": ""Organism/Species""}, {""token"": ""glycine"", ""start_span"": 392, ""end_span"": 399, ""type"": ""Chemical/Drug""}, {""token"": ""celite"", ""start_span"": 486, ""end_span"": 492, ""type"": ""Chemical/Drug""}, {""token"": ""wheat"", ""start_span"": 555, ""end_span"": 560, ""type"": ""Organism/Species""}]"	train
To determine the subcellular localization of TaTypA in wheat, recombinant pCaMV35S :: TaTypA :: GFP and pCaMV35S :: TaTypA - N1 - 80 :: GFP were transfected into wheat mesophyll protoplasts by transfection.	TaTypA,45,51,Gene/Protein	wheat,55,60,Organism/Species	TaTypA,86,92,Gene/Protein	GFP,96,99,Gene/Protein	TaTypA,116,122,Gene/Protein	GFP,136,139,Gene/Protein	wheat,162,167,Organism/Species	"[{""token"": ""TaTypA"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""wheat"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Organism/Species""}, {""token"": ""TaTypA"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""wheat"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Organism/Species""}]"	train
For example, wheat stripe rust resistance protein WKS1 localized in chloroplasts and reduced the ability of the thylakoid - associated ascorbate peroxidase to detoxify ROS ( Gou et al ., 2015 ), and the chloroplastic / cytoplasmic protein NRIP1, which associated with the NB - LRR immune receptor “ N ”, was shown to be responsible for tobacco mosaic virus recognition and resistance in Nicotiana ( Caplan et al ., 2008 ).	wheat stripe rust resistance protein,13,49,Gene/Protein	WKS1,50,54,Gene/Protein	thylakoid - associated ascorbate peroxidase,112,155,Gene/Protein	NRIP1,239,244,Gene/Protein	NB - LRR immune receptor,272,296,Gene/Protein	tobacco mosaic virus,336,356,Organism/Species	Nicotiana,387,396,Organism/Species	"[{""token"": ""wheat stripe rust resistance protein"", ""start_span"": 13, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""WKS1"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""thylakoid - associated ascorbate peroxidase"", ""start_span"": 112, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""NRIP1"", ""start_span"": 239, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""NB - LRR immune receptor"", ""start_span"": 272, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""tobacco mosaic virus"", ""start_span"": 336, ""end_span"": 356, ""type"": ""Organism/Species""}, {""token"": ""Nicotiana"", ""start_span"": 387, ""end_span"": 396, ""type"": ""Organism/Species""}]"	train
The scale - eaters were placed individually with a single prey fish ( platy fish, Xiphophorus maculatus, for three - month old fish and goldfish, Carassius auratus auratus, for two - and seven - month old fish) in the trial tanks.	fish,63,67,Organism/Species	platy fish,70,80,Organism/Species	Xiphophorus maculatus,82,103,Organism/Species	fish,127,131,Organism/Species	goldfish,136,144,Organism/Species	Carassius auratus auratus,146,171,Organism/Species	fish,205,209,Organism/Species	"[{""token"": ""fish"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""platy fish"", ""start_span"": 70, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""Xiphophorus maculatus"", ""start_span"": 82, ""end_span"": 103, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""goldfish"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Organism/Species""}, {""token"": ""Carassius auratus auratus"", ""start_span"": 146, ""end_span"": 171, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Organism/Species""}]"	train
Total PFN1 levels were unaffected by these treatments as indicated by immunostaining with a generic PFN1 antibody ( PFN1 in green and DAPI in blue) ( d – l ). E, HEK293 cells were treated with or without 50 µM hydroxyfasudil ( OH - fasudil) for 2 hr, followed by immunostaining with P3490 ( a – b) or the generic PFN1 antibody ( c – d) ( both in green) and counterstaining with DAPI ( blue ).	PFN1,6,10,Gene/Protein	PFN1,100,104,Gene/Protein	antibody,105,113,Gene/Protein	PFN1,116,120,Gene/Protein	P3490,283,288,Chemical/Drug	PFN1,313,317,Gene/Protein	antibody,318,326,Gene/Protein	"[{""token"": ""PFN1"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""P3490"", ""start_span"": 283, ""end_span"": 288, ""type"": ""Chemical/Drug""}, {""token"": ""PFN1"", ""start_span"": 313, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 318, ""end_span"": 326, ""type"": ""Gene/Protein""}]"	train
Only cells expressing the phosphomimetic Myc - PFN1 ( S137D) stained positive with P3490 ( g – i ), but not Myc - PFN1 ( wt) ( a – c) or Myc - PFN1 ( S137A) ( d – f ).	Myc,41,44,Gene/Protein	PFN1,47,51,Gene/Protein	P3490,83,88,Chemical/Drug	Myc,108,111,Gene/Protein	PFN1,114,118,Gene/Protein	Myc,137,140,Gene/Protein	PFN1,143,147,Gene/Protein	"[{""token"": ""Myc"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""P3490"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""Myc"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
Arrowheads indicate two cells that expressed Myc - PFN1 ( S137D) and stained positive with P3490. E, Western blot confirmed comparable levels of Myc - PFN1 over - expression ( wt, S137A and S137D) in transiently transfected HEK293 cells, as compared to cells transfected with an empty vector ( pcDNA3 ). F, cells transfected ( as in E) with pcDNA3 or various PFN1 constructs were immunostained with P3490, and quantified on a fluorescence plate reader with normalization vs. DAPI.	Myc,45,48,Gene/Protein	PFN1,51,55,Gene/Protein	P3490,91,96,Chemical/Drug	Myc,145,148,Gene/Protein	PFN1,151,155,Gene/Protein	PFN1,359,363,Gene/Protein	P3490,399,404,Chemical/Drug	"[{""token"": ""Myc"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""P3490"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""Myc"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 359, ""end_span"": 363, ""type"": ""Gene/Protein""}, {""token"": ""P3490"", ""start_span"": 399, ""end_span"": 404, ""type"": ""Chemical/Drug""}]"	train
A, HEK293 cells were co - transfected with an untagged PFN1 along with either an empty vector ( pcDNA3) ( Lane 1 ), or Myc - tagged PP1Cα ( Lane 2 ), or PP2ACα ( Lane 3 ), followed by immunoprecipitation with an anti - Myc antibody and Western blot for PFN1.	PFN1,55,59,Gene/Protein	Myc,119,122,Gene/Protein	PP1Cα,132,137,Gene/Protein	PP2ACα,153,159,Gene/Protein	Myc,219,222,Gene/Protein	antibody,223,231,Gene/Protein	PFN1,253,257,Gene/Protein	"[{""token"": ""PFN1"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""PP2AC\u03b1"", ""start_span"": 153, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 219, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 223, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 253, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	train
PFN1 co - immunoprecipitated specifically with PP1Cα, but not PP2ACα. B, HA - PFN1 constructs ( wt, S137A or S137D) were co - transfected into HEK293 cells with pcDNA3 ( Lanes 1 – 3) or Myc - PP1Cα ( Lanes 4 – 6 ).	PFN1,0,4,Gene/Protein	PP1Cα,47,52,Gene/Protein	PP2ACα,62,68,Gene/Protein	HA,73,75,Gene/Protein	PFN1,78,82,Gene/Protein	Myc,186,189,Gene/Protein	PP1Cα,192,197,Gene/Protein	"[{""token"": ""PFN1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""PP2AC\u03b1"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""HA"", ""start_span"": 73, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
By using a phospho - antibody against pSer - 137 of PFN1, we found that pharmacologic inhibition and genetic knockdown of the catalytic subunit of PP1 ( PP1Cα ), but not PP2A ( PP2ACα ), increased pS137 - PFN1 levels in cultured cells.	antibody,21,29,Gene/Protein	PFN1,52,56,Gene/Protein	PP1,147,150,Gene/Protein	PP1Cα,153,158,Gene/Protein	PP2A,170,174,Gene/Protein	PP2ACα,177,183,Gene/Protein	PFN1,205,209,Gene/Protein	"[{""token"": ""antibody"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""PP2AC\u03b1"", ""start_span"": 177, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
Secondary antibodies for immunofluorescence staining include Alexa Fluor ® 488 - conjugated goat anti - rabbit IgG ( Invitrogen, A - 11034) and Alexa Fluor ® 546 - conjugated goat anti - mouse IgG ( Invitrogen, A - 11030 ).	antibodies,10,20,Gene/Protein	goat,92,96,Organism/Species	rabbit,104,110,Organism/Species	IgG,111,114,Gene/Protein	goat,175,179,Organism/Species	mouse,187,192,Organism/Species	IgG,193,196,Gene/Protein	"[{""token"": ""antibodies"", ""start_span"": 10, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
The Glyma15g34770 network in PlaNet lists 37 genes co - expressed with WRI1, and there are 33 genes in our network, and seven of them overlap with results from PlaNet, and form the ‘ band 7 family ’, ‘ LACS9 ’, ‘ DREB2A ’, ‘ AREB3 ’, ‘ CYP76G1 ’ and so on.	Glyma15g34770,4,17,Gene/Protein	WRI1,71,75,Gene/Protein	band 7,183,189,Gene/Protein	LACS9,202,207,Gene/Protein	DREB2A,213,219,Gene/Protein	AREB3,225,230,Gene/Protein	CYP76G1,236,243,Gene/Protein	"[{""token"": ""Glyma15g34770"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""WRI1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""band 7"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""LACS9"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""DREB2A"", ""start_span"": 213, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""AREB3"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""CYP76G1"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
It has been reported that activation of rat CD163 on peritoneal macrophages induces the production of pro - inflammatory mediators including TNF [ 31 ]; TNF directly interacts with TNFRSF1B [ 32] and is a mediator of TNF function in the mouse ovary [ 33 ].	rat,40,43,Organism/Species	CD163,44,49,Gene/Protein	TNF,141,144,Gene/Protein	TNF,153,156,Gene/Protein	TNFRSF1B,181,189,Gene/Protein	TNF,217,220,Gene/Protein	mouse,237,242,Organism/Species	"[{""token"": ""rat"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Organism/Species""}, {""token"": ""CD163"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""TNFRSF1B"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Organism/Species""}]"	train
A transcription factor, octamer - binding transcription factor - 1 ( POU2F1, also known as Oct - 1) has been predicted to bind promoter region of VCAM1, LAIR1 and CTSL ( hypergeometric p - value 0. 012 ).	transcription factor,2,22,Gene/Protein	octamer - binding transcription factor - 1,24,66,Gene/Protein	POU2F1,69,75,Gene/Protein	Oct - 1,91,98,Gene/Protein	VCAM1,146,151,Gene/Protein	LAIR1,153,158,Gene/Protein	CTSL,163,167,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 2, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""octamer - binding transcription factor - 1"", ""start_span"": 24, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""POU2F1"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""VCAM1"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""LAIR1"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""CTSL"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
The dosage used was 3. 07 – 3. 27 µg g − 1 for Acanthodoras spinosissimus, 3. 99 – 5. 38 µg g − 1 for Agamyxis pectinifrons, 0. 86 – 3. 26 µg g − 1 for Amblydoras affinis, 1. 73 – 2. 82 µg g − 1 for Hemidoras morrisi, 3. 8 – 7. 01 µg g − 1 for Megalodoras uranoscopus, and 1. 73 – 2. 06 µg g − 1 for Oxydoras niger. The lowest dosage that immobilized fish while enabling slight movement of the opercula during the experiments was applied.	Acanthodoras spinosissimus,47,73,Organism/Species	Agamyxis pectinifrons,102,123,Organism/Species	Amblydoras affinis,152,170,Organism/Species	Hemidoras morrisi,199,216,Organism/Species	Megalodoras uranoscopus,244,267,Organism/Species	Oxydoras niger,300,314,Organism/Species	fish,351,355,Organism/Species	"[{""token"": ""Acanthodoras spinosissimus"", ""start_span"": 47, ""end_span"": 73, ""type"": ""Organism/Species""}, {""token"": ""Agamyxis pectinifrons"", ""start_span"": 102, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""Amblydoras affinis"", ""start_span"": 152, ""end_span"": 170, ""type"": ""Organism/Species""}, {""token"": ""Hemidoras morrisi"", ""start_span"": 199, ""end_span"": 216, ""type"": ""Organism/Species""}, {""token"": ""Megalodoras uranoscopus"", ""start_span"": 244, ""end_span"": 267, ""type"": ""Organism/Species""}, {""token"": ""Oxydoras niger"", ""start_span"": 300, ""end_span"": 314, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 351, ""end_span"": 355, ""type"": ""Organism/Species""}]"	train
Averaged hearing thresholds of thorny catfish species with large ( Acanthodoras spinosissimus, Agamyxis pectinifrons, Megalodoras uranoscopus) and small ( Amblydoras affinis, Hemidoras morrisi, Oxydoras niger) swim bladders.	thorny catfish,31,45,Organism/Species	Acanthodoras spinosissimus,67,93,Organism/Species	Agamyxis pectinifrons,95,116,Organism/Species	Megalodoras uranoscopus,118,141,Organism/Species	Amblydoras affinis,155,173,Organism/Species	Hemidoras morrisi,175,192,Organism/Species	Oxydoras niger,194,208,Organism/Species	"[{""token"": ""thorny catfish"", ""start_span"": 31, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""Acanthodoras spinosissimus"", ""start_span"": 67, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""Agamyxis pectinifrons"", ""start_span"": 95, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""Megalodoras uranoscopus"", ""start_span"": 118, ""end_span"": 141, ""type"": ""Organism/Species""}, {""token"": ""Amblydoras affinis"", ""start_span"": 155, ""end_span"": 173, ""type"": ""Organism/Species""}, {""token"": ""Hemidoras morrisi"", ""start_span"": 175, ""end_span"": 192, ""type"": ""Organism/Species""}, {""token"": ""Oxydoras niger"", ""start_span"": 194, ""end_span"": 208, ""type"": ""Organism/Species""}]"	train
Auchenipterids possessed either cordiform swim bladders with smooth walls ( Glanidium, Pseudauchenipterus ), almost apple - shaped bladders ( Centromochlus spp .) or bladders reduced in size and partially or completely ossified ( Ageneiosus inermis ). Tocantinsia piresi and Asterophysus batrachus had distinctive - looking bladders with either two or many diverticula.	Auchenipterids,0,14,Organism/Species	Glanidium,76,85,Organism/Species	Pseudauchenipterus,87,105,Organism/Species	Centromochlus spp,142,159,Organism/Species	Ageneiosus inermis,230,248,Organism/Species	Tocantinsia piresi,252,270,Organism/Species	Asterophysus batrachus,275,297,Organism/Species	"[{""token"": ""Auchenipterids"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Organism/Species""}, {""token"": ""Glanidium"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""Pseudauchenipterus"", ""start_span"": 87, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""Centromochlus spp"", ""start_span"": 142, ""end_span"": 159, ""type"": ""Organism/Species""}, {""token"": ""Ageneiosus inermis"", ""start_span"": 230, ""end_span"": 248, ""type"": ""Organism/Species""}, {""token"": ""Tocantinsia piresi"", ""start_span"": 252, ""end_span"": 270, ""type"": ""Organism/Species""}, {""token"": ""Asterophysus batrachus"", ""start_span"": 275, ""end_span"": 297, ""type"": ""Organism/Species""}]"	train
Future in vivo rodent experiments could use a diet representing the more varied human diet for non - heme Fe ( e. g ., mixed Fe ( II )- Fe ( III) salts that undergo gastric dissolution, plus ferritin - protein) and then establish, in the Slc11a2int / int mouse, whether or not there is enterocyte lysosomal accumulation of Fe ( i. e. initial apical uptake due to a non DMT - 1 pathway for the hydrolysed Fe ( III) and possibly ferritin - protein fractions, but accumulation due to export failure with lack of lysosomal DMT - 1 ).	human,80,85,Organism/Species	heme,101,105,Chemical/Drug	ferritin,191,199,Gene/Protein	mouse,255,260,Organism/Species	DMT - 1,369,376,Gene/Protein	ferritin,427,435,Gene/Protein	DMT - 1,519,526,Gene/Protein	"[{""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""heme"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""ferritin"", ""start_span"": 191, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 255, ""end_span"": 260, ""type"": ""Organism/Species""}, {""token"": ""DMT - 1"", ""start_span"": 369, ""end_span"": 376, ""type"": ""Gene/Protein""}, {""token"": ""ferritin"", ""start_span"": 427, ""end_span"": 435, ""type"": ""Gene/Protein""}, {""token"": ""DMT - 1"", ""start_span"": 519, ""end_span"": 526, ""type"": ""Gene/Protein""}]"	train
The excised fragments were then ligated to a NdeI - SacII adaptor ( Supplementary Table 1 ), providing the NdeI - compatible end required for in - frame incorporation of the SacII / NotI - digested inserts into NdeI / NotI - digested pET28b (+) recombinant expression vector ( Novagen ).	NdeI,45,49,Gene/Protein	SacII,52,57,Gene/Protein	NdeI,107,111,Gene/Protein	SacII,174,179,Gene/Protein	NotI,182,186,Gene/Protein	NdeI,211,215,Gene/Protein	NotI,218,222,Gene/Protein	"[{""token"": ""NdeI"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""SacII"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""NdeI"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""SacII"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""NotI"", ""start_span"": 182, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""NdeI"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""NotI"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
In this study, to investigate the functional relationship between the HR factor Rad54 and Parp - 1 in development and oncogenesis in vivo, we introduced single or combined Rad54 and Parp - 1 inactivating mutations in a well characterized cancer model, the Ptc1 heterozygous mice.	Rad54,80,85,Gene/Protein	Parp - 1,90,98,Gene/Protein	Rad54,172,177,Gene/Protein	Parp - 1,182,190,Gene/Protein	cancer,238,244,Disease/Disorder	Ptc1,256,260,Gene/Protein	mice,274,278,Organism/Species	"[{""token"": ""Rad54"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Disease/Disorder""}, {""token"": ""Ptc1"", ""start_span"": 256, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 274, ""end_span"": 278, ""type"": ""Organism/Species""}]"	train
Mice in which one copy the Ptc1 gene has been inactivated ( Ptc1 +/-) are developmentally nearly normal, but show a marked predisposition to tumor development, including medulloblastoma ( MB ), a frequent pediatric malignant tumor of the cerebellum [ 17, 18 ].	Mice,0,4,Organism/Species	Ptc1,27,31,Gene/Protein	Ptc1,60,64,Gene/Protein	tumor,141,146,Disease/Disorder	medulloblastoma,170,185,Disease/Disorder	MB,188,190,Disease/Disorder	malignant tumor of the cerebellum,215,248,Disease/Disorder	"[{""token"": ""Mice"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism/Species""}, {""token"": ""Ptc1"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Disease/Disorder""}, {""token"": ""medulloblastoma"", ""start_span"": 170, ""end_span"": 185, ""type"": ""Disease/Disorder""}, {""token"": ""MB"", ""start_span"": 188, ""end_span"": 190, ""type"": ""Disease/Disorder""}, {""token"": ""malignant tumor of the cerebellum"", ""start_span"": 215, ""end_span"": 248, ""type"": ""Disease/Disorder""}]"	train
To this aim, Rad54 +/-/ Parp - 1 +/-/ Ptc1 +/- and Rad54 +/-/ Parp - 1 +/-/ Ptc1 +/+ mice were intercrossed, and the progeny genotyped.	Rad54,13,18,Gene/Protein	Parp - 1,24,32,Gene/Protein	Ptc1,38,42,Gene/Protein	Rad54,51,56,Gene/Protein	Parp - 1,62,70,Gene/Protein	Ptc1,76,80,Gene/Protein	mice,85,89,Organism/Species	"[{""token"": ""Rad54"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Organism/Species""}]"	train
Because only Ptc1 +/- mice are prone to MB, the effects of Rad54 and Parp - 1 inactivation was evaluated only in mice with Ptc1 +/- genotype.	Ptc1,13,17,Gene/Protein	mice,22,26,Organism/Species	MB,40,42,Disease/Disorder	Rad54,59,64,Gene/Protein	Parp - 1,69,77,Gene/Protein	mice,113,117,Organism/Species	Ptc1,123,127,Gene/Protein	"[{""token"": ""Ptc1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Organism/Species""}, {""token"": ""MB"", ""start_span"": 40, ""end_span"": 42, ""type"": ""Disease/Disorder""}, {""token"": ""Rad54"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Organism/Species""}, {""token"": ""Ptc1"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	train
This was reflected in decreased incidence of late occurring tumors, including sarcomas and other tumors ( Figure 1F ), with exception of Parp - 1 -/-/ Ptc1 +/- mice, in which MB mortality was already high and did not significantly increase with irradiation.	tumors,60,66,Disease/Disorder	sarcomas,78,86,Disease/Disorder	tumors,97,103,Disease/Disorder	Parp - 1,137,145,Gene/Protein	Ptc1,151,155,Gene/Protein	mice,160,164,Organism/Species	MB,175,177,Disease/Disorder	"[{""token"": ""tumors"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""sarcomas"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""tumors"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Disease/Disorder""}, {""token"": ""Parp - 1"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Organism/Species""}, {""token"": ""MB"", ""start_span"": 175, ""end_span"": 177, ""type"": ""Disease/Disorder""}]"	train
Quantification of Ki - 67 staining in the EGL revealed a high proliferation rate in Parp - 1 -/-/ Ptc1 +/- mice ( Figure 4A - 4E ), which is in keeping with the higher spontaneous MB tumorigenesis detected in Parp - 1 -/- mice.	Ki - 67,18,25,Gene/Protein	Parp - 1,84,92,Gene/Protein	Ptc1,98,102,Gene/Protein	mice,107,111,Organism/Species	MB,180,182,Disease/Disorder	Parp - 1,209,217,Gene/Protein	mice,222,226,Organism/Species	"[{""token"": ""Ki - 67"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""MB"", ""start_span"": 180, ""end_span"": 182, ""type"": ""Disease/Disorder""}, {""token"": ""Parp - 1"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Organism/Species""}]"	train
We immunostained several tissues ( thymus, lung, kidney, liver, intestine, skin) from Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/- and Ptc1 +/- mice at P1 with Ki - 67 and γ - H2AX.	Rad54,86,91,Gene/Protein	Parp - 1,97,105,Gene/Protein	Ptc1,111,115,Gene/Protein	Ptc1,124,128,Gene/Protein	mice,133,137,Organism/Species	Ki - 67,149,156,Gene/Protein	H2AX,165,169,Gene/Protein	"[{""token"": ""Rad54"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Organism/Species""}, {""token"": ""Ki - 67"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""H2AX"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
Important to our understanding of the underlying mechanisms of this novel genetic link, immunohistochemical analysis revealed a trend to high degree of granule cell proliferation in the EGL of Parp - 1 null mice ( Parp - 1 -/-/ Ptc1 +/-), which decreased significantly in age - matched double mutants ( Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/-).	Parp - 1,193,201,Gene/Protein	mice,207,211,Organism/Species	Parp - 1,214,222,Gene/Protein	Ptc1,228,232,Gene/Protein	Rad54,303,308,Gene/Protein	Parp - 1,314,322,Gene/Protein	Ptc1,328,332,Gene/Protein	"[{""token"": ""Parp - 1"", ""start_span"": 193, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Organism/Species""}, {""token"": ""Parp - 1"", ""start_span"": 214, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 228, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 303, ""end_span"": 308, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 314, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 328, ""end_span"": 332, ""type"": ""Gene/Protein""}]"	train
Because p53 phosphorylation is classically considered as the first crucial step of p53 stabilization, driven by several kinases, including ATM and DNA - PKcs, we analyzed phosphorylation of p53 at Ser18 [ 27] in P1 cerebella and did not detect significant differences among genotypes, despite accumulation of p53 only in double mutants.	p53,8,11,Gene/Protein	p53,83,86,Gene/Protein	kinases,120,127,Gene/Protein	ATM,139,142,Gene/Protein	DNA - PKcs,147,157,Gene/Protein	p53,190,193,Gene/Protein	p53,309,312,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""kinases"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""ATM"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""DNA - PKcs"", ""start_span"": 147, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 309, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	train
Besides p53 - dependent neuronal apoptosis, our findings that MEFs from compound Rad54 / Parp - 1 mutant mice display severe p53 - mediated accelerated senescent phenotypes, and that features of senescence were detected in several neonatal tissues, strongly argue for senescence as the mechanism underlying synthetic lethal interactions of Rad54 and Parp - 1 inactivation in vivo.	p53,8,11,Gene/Protein	Rad54,81,86,Gene/Protein	Parp - 1,89,97,Gene/Protein	mice,105,109,Organism/Species	p53,125,128,Gene/Protein	Rad54,340,345,Gene/Protein	Parp - 1,350,358,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""p53"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 340, ""end_span"": 345, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 350, ""end_span"": 358, ""type"": ""Gene/Protein""}]"	train
Notably, many of the DNA repair pathways found deregulated in the cerebellum of Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/- mutants have been reported to cause senescence; overexpression of Pttg1, the most upregulated gene in our settings, induces senescence in a p53 - dependent fashion in normal fibroblasts [ 45 ], and chemical inhibition of DNA - PKcs leads to p53 - dependent accelerated senescence after irradiation in vivo and in vitro [ 46 ].	Rad54,80,85,Gene/Protein	Parp - 1,91,99,Gene/Protein	Ptc1,105,109,Gene/Protein	Pttg1,180,185,Gene/Protein	p53,254,257,Gene/Protein	DNA - PKcs,335,345,Gene/Protein	p53,355,358,Gene/Protein	"[{""token"": ""Rad54"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""Pttg1"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 254, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""DNA - PKcs"", ""start_span"": 335, ""end_span"": 345, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 355, ""end_span"": 358, ""type"": ""Gene/Protein""}]"	train
Finally Rad54 +/-/ Parp - 1 +/-/ Ptc1 +/+/ and Rad54 +/-/ Parp - 1 +/-/ Ptc1 +/- mice were intercrossed.	Rad54,8,13,Gene/Protein	Parp - 1,19,27,Gene/Protein	Ptc1,33,37,Gene/Protein	Rad54,47,52,Gene/Protein	Parp - 1,58,66,Gene/Protein	Ptc1,72,76,Gene/Protein	mice,81,85,Organism/Species	"[{""token"": ""Rad54"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Organism/Species""}]"	train
This could mean that there exists a pathway leading to ERK phosphorylation which depends on EGFR ( since the effect is decreased in the presence of Tyrphostin ), but neither on p38MAPK ( since SB203580 is present in both conditions ), nor on MEK ( since the effect is not observed for MEK ).	ERK,55,58,Gene/Protein	EGFR,92,96,Gene/Protein	Tyrphostin,148,158,Chemical/Drug	p38MAPK,177,184,Gene/Protein	SB203580,193,201,Chemical/Drug	MEK,242,245,Gene/Protein	MEK,285,288,Gene/Protein	"[{""token"": ""ERK"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""EGFR"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Tyrphostin"", ""start_span"": 148, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""p38MAPK"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""SB203580"", ""start_span"": 193, ""end_span"": 201, ""type"": ""Chemical/Drug""}, {""token"": ""MEK"", ""start_span"": 242, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""MEK"", ""start_span"": 285, ""end_span"": 288, ""type"": ""Gene/Protein""}]"	train
In this line, we and other groups demonstrated the presence of cytokines such as IL - 1, IL - 6, IL - 23, TGFβ, etc, in BP skin lesions.	cytokines,63,72,Gene/Protein	IL - 1,81,87,Gene/Protein	IL - 6,89,95,Gene/Protein	IL - 23,97,104,Gene/Protein	TGFβ,106,110,Gene/Protein	BP,120,122,Disease/Disorder	skin lesions,123,135,Disease/Disorder	"[{""token"": ""cytokines"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IL - 23"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""TGF\u03b2"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""BP"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""skin lesions"", ""start_span"": 123, ""end_span"": 135, ""type"": ""Disease/Disorder""}]"	train
In BP patients without mucosal involvement, the serum concentration of anti - BP180 NC16A autoantibodies was well correlated with both the skin erythema / urticaria and the blisters / erosions BPDAI scores, which is in line with the fact that anti - BP180 autoantibody binding onto their target induced an inflammatory response leading to blister formation ( 14 – 18 ).	BP,3,5,Disease/Disorder	BP180,78,83,Gene/Protein	autoantibodies,90,104,Gene/Protein	erythema,144,152,Disease/Disorder	urticaria,155,164,Disease/Disorder	BP180,250,255,Gene/Protein	autoantibody,256,268,Gene/Protein	"[{""token"": ""BP"", ""start_span"": 3, ""end_span"": 5, ""type"": ""Disease/Disorder""}, {""token"": ""BP180"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""autoantibodies"", ""start_span"": 90, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""erythema"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Disease/Disorder""}, {""token"": ""urticaria"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Disease/Disorder""}, {""token"": ""BP180"", ""start_span"": 250, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""autoantibody"", ""start_span"": 256, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
While mutations in subunits of the Elongator complex ( Elp1 - Elp6 ), which disable mcm5 side chain formation, or removal of components of the thiolation pathway ( Ncs2 / Ncs6, Urm1, Uba4) are individually tolerated, the combination of both modification defects has been reported to have lethal effects on Saccharomyces cerevisiae.	Elp1,55,59,Gene/Protein	Elp6,62,66,Gene/Protein	Ncs2,164,168,Gene/Protein	Ncs6,171,175,Gene/Protein	Urm1,177,181,Gene/Protein	Uba4,183,187,Gene/Protein	Saccharomyces cerevisiae,306,330,Organism/Species	"[{""token"": ""Elp1"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Elp6"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""Ncs2"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""Ncs6"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""Urm1"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""Uba4"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""Saccharomyces cerevisiae"", ""start_span"": 306, ""end_span"": 330, ""type"": ""Organism/Species""}]"	train
To explore whether the negative genetic interaction of elp3 and urm1 / uba4 and its suppression by excess levels of tRNALys UUU applies to phenotypes other than TS, we analyzed growth responses to rapamycin, a TOR pathway inhibitor to which both, elp3 and urm1 / uba4 mutants show enhanced sensitivity [ 22, 26 ].	elp3,55,59,Gene/Protein	urm1,64,68,Gene/Protein	uba4,71,75,Gene/Protein	rapamycin,197,206,Chemical/Drug	elp3,247,251,Gene/Protein	urm1,256,260,Gene/Protein	uba4,263,267,Gene/Protein	"[{""token"": ""elp3"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""urm1"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""uba4"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""rapamycin"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Chemical/Drug""}, {""token"": ""elp3"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""urm1"", ""start_span"": 256, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""uba4"", ""start_span"": 263, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	train
Prior to LC - MS / MS analysis, 5 μg of each tRNA sample ( wt, elp3, uba4, elp3uba4) were digested into nucleosides according to the following protocol: samples were incubated in presence of 1 / 10 volume of 10x nuclease P1 buffer ( 0. 2 M NH4OAc pH 5. 0, ZnCl2 0. 2 mM ), 0. 3 U nuclease P1 ( Sigma Aldrich, Munich, Germany) and 0. 1 U snake venom phosphodiesterase ( Worthington, Lakewood, USA) at 37 ° C for 2 h.	elp3,63,67,Gene/Protein	uba4,69,73,Gene/Protein	nucleosides,104,115,Chemical/Drug	nuclease P1,212,223,Gene/Protein	nuclease P1,280,291,Gene/Protein	snake,337,342,Organism/Species	venom phosphodiesterase,343,366,Gene/Protein	"[{""token"": ""elp3"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""uba4"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""nucleosides"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""nuclease P1"", ""start_span"": 212, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""nuclease P1"", ""start_span"": 280, ""end_span"": 291, ""type"": ""Gene/Protein""}, {""token"": ""snake"", ""start_span"": 337, ""end_span"": 342, ""type"": ""Organism/Species""}, {""token"": ""venom phosphodiesterase"", ""start_span"": 343, ""end_span"": 366, ""type"": ""Gene/Protein""}]"	train
Based on the expressed sequence tag ( EST) sequences of several species ( human, mouse, rat, goat, cow and sheep ), a total of 334 transcripts were specifically expressed in ruminants ( S8 Table ).	human,74,79,Organism/Species	mouse,81,86,Organism/Species	rat,88,91,Organism/Species	goat,93,97,Organism/Species	cow,99,102,Organism/Species	sheep,107,112,Organism/Species	ruminants,174,183,Organism/Species	"[{""token"": ""human"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Organism/Species""}, {""token"": ""goat"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Organism/Species""}, {""token"": ""cow"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Organism/Species""}, {""token"": ""sheep"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""ruminants"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Organism/Species""}]"	train
Antibodies used were mouse anti - MLLC / HRX, clone 9 - 12 ( Upstate Cell Signaling Solutions, Temecula, CA ), which detects the C - terminal proteolytic fragment of MLL (~ 180 kDa ), and mouse anti - human β - actin as loading control ( Pan Actin Ab - 5 ( ACTN05) NeoMarkers, Fremont CA ).	mouse,21,26,Organism/Species	HRX,41,44,Gene/Protein	MLL,166,169,Gene/Protein	mouse,188,193,Organism/Species	human,201,206,Organism/Species	β - actin,207,216,Gene/Protein	Actin,242,247,Gene/Protein	"[{""token"": ""mouse"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Organism/Species""}, {""token"": ""HRX"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""MLL"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Organism/Species""}, {""token"": ""\u03b2 - actin"", ""start_span"": 207, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""Actin"", ""start_span"": 242, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
Suppression of HBV replication has been observed in patients with chronic HBV infection after acute infection with HCV; similarly, inhibition of HCV replication has been observed in patients with chronic HCV superinfected with HBV [ 8, 12 ].	HBV,15,18,Organism/Species	HBV infection,74,87,Disease/Disorder	acute infection,94,109,Disease/Disorder	HCV,115,118,Organism/Species	HCV,145,148,Organism/Species	HCV,204,207,Organism/Species	HBV,227,230,Organism/Species	"[{""token"": ""HBV"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Organism/Species""}, {""token"": ""HBV infection"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Disease/Disorder""}, {""token"": ""acute infection"", ""start_span"": 94, ""end_span"": 109, ""type"": ""Disease/Disorder""}, {""token"": ""HCV"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Organism/Species""}]"	train
In patients with chronic HBV - HCV co - infection, more rapid hepatitis B extracellular antigen ( HBeAg) seroconversion and hepatitis B virus surface antigen ( HBsAg) clearance have been documented [ 13, 14 ].	HBV,25,28,Organism/Species	HCV,31,34,Organism/Species	co - infection,35,49,Disease/Disorder	hepatitis B extracellular antigen,62,95,Gene/Protein	HBeAg,98,103,Gene/Protein	hepatitis B virus surface antigen,124,157,Gene/Protein	HBsAg,160,165,Gene/Protein	"[{""token"": ""HBV"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""hepatitis B extracellular antigen"", ""start_span"": 62, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""HBeAg"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""hepatitis B virus surface antigen"", ""start_span"": 124, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""HBsAg"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Compared to HBV mono - infected patients, HBsAg carriers with concurrent HCV infection have low - level HBV viremia, low titers of HBsAg in serum, and low - levels of intracellular HBsAg [ 15 ].	HBV,12,15,Organism/Species	HBsAg,42,47,Gene/Protein	HCV,73,76,Organism/Species	infection,77,86,Disease/Disorder	HBV viremia,104,115,Disease/Disorder	HBsAg,131,136,Gene/Protein	HBsAg,181,186,Gene/Protein	"[{""token"": ""HBV"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""HBsAg"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""HCV"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 77, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""HBV viremia"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Disease/Disorder""}, {""token"": ""HBsAg"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""HBsAg"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
In this investigation, 13. 1% of patients with HCV mono - infection were negative for HCV RNA, while up to 46. 7% of patients with HBV - HCV co - infection had undetectable HCV RNA ( P < 0. 001, Table 2 ).	HCV,47,50,Organism/Species	infection,58,67,Disease/Disorder	HCV,86,89,Organism/Species	HBV,131,134,Organism/Species	HCV,137,140,Organism/Species	co - infection,141,155,Disease/Disorder	HCV,173,176,Organism/Species	"[{""token"": ""HCV"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Disease/Disorder""}, {""token"": ""HCV"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Disease/Disorder""}, {""token"": ""HCV"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Organism/Species""}]"	train
The virological patterns of HBV and HCV infections have been investigated in a large number of clinical studies [ 3, 26] Most of these studies were cross - sectional evaluations of HBV and HCV viral loads observed at a single time point, showing an apparent dominant role of HCV ( i. e ., high HCV RNA and low HBV DNA levels) in the majority of the cases.	HBV,28,31,Organism/Species	HCV infections,36,50,Disease/Disorder	HBV,181,184,Organism/Species	HCV,189,192,Organism/Species	HCV,275,278,Organism/Species	HCV,294,297,Organism/Species	HBV,310,313,Organism/Species	"[{""token"": ""HBV"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Organism/Species""}, {""token"": ""HCV infections"", ""start_span"": 36, ""end_span"": 50, ""type"": ""Disease/Disorder""}, {""token"": ""HBV"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 275, ""end_span"": 278, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 294, ""end_span"": 297, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 310, ""end_span"": 313, ""type"": ""Organism/Species""}]"	train
Other studies have also confirmed that HBV - HCV co - infection is associated with more advanced liver disease compared to HBV or HCV mono - infection [ 5, 8, 28, 33 – 36 ].	HBV,39,42,Organism/Species	HCV,45,48,Organism/Species	co - infection,49,63,Disease/Disorder	liver disease,97,110,Disease/Disorder	HBV,123,126,Organism/Species	HCV,130,133,Organism/Species	infection,141,150,Disease/Disorder	"[{""token"": ""HBV"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 49, ""end_span"": 63, ""type"": ""Disease/Disorder""}, {""token"": ""liver disease"", ""start_span"": 97, ""end_span"": 110, ""type"": ""Disease/Disorder""}, {""token"": ""HBV"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 141, ""end_span"": 150, ""type"": ""Disease/Disorder""}]"	train
Becoming significant for the dog for the moment meant caring for the dog by reacting to and approving of the dog ’ s behaviour in words to the dog and in play while having the dog ’ s attention; understanding that one is important for the dog ’ s well - being in that shared moment with the dog. Mrs Carlson: Hey you, hey you, little doggy!	dog,29,32,Organism/Species	dog,69,72,Organism/Species	dog,109,112,Organism/Species	dog,143,146,Organism/Species	dog,176,179,Organism/Species	dog,239,242,Organism/Species	dog,291,294,Organism/Species	"[{""token"": ""dog"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 239, ""end_span"": 242, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 291, ""end_span"": 294, ""type"": ""Organism/Species""}]"	train
Bd0881 and Bd0743 predicted proteins show significant homology ( 28. 6% and 31. 8% identity respectively) to the rpoE gene product of E. coli which encodes a sigma factor of the ECF type that is responsive to extra - cytoplasmic, periplasmic events; RpoE in E. coli is sequestered at the inner membrane by an RseA RseB pair of proteins, until inducing - events, in the shape of abnormally folded proteins in the periplasm, cause it to be released and active [ 6 ].	Bd0881,0,6,Gene/Protein	Bd0743,11,17,Gene/Protein	rpoE,113,117,Gene/Protein	sigma factor,158,170,Gene/Protein	RpoE,250,254,Gene/Protein	RseA,309,313,Gene/Protein	RseB,314,318,Gene/Protein	"[{""token"": ""Bd0881"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""Bd0743"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""rpoE"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""sigma factor"", ""start_span"": 158, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""RpoE"", ""start_span"": 250, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""RseA"", ""start_span"": 309, ""end_span"": 313, ""type"": ""Gene/Protein""}, {""token"": ""RseB"", ""start_span"": 314, ""end_span"": 318, ""type"": ""Gene/Protein""}]"	train
The Bdellovibrio genome, like that of other delta - proteobacteria, does not contain rseAB genes, suggesting that the RpoE - like sigma factors encoded by bd0881 and bd0743 belong more generally to the Group IV - type sigma factors.	Bdellovibrio,4,16,Organism/Species	delta - proteobacteria,44,66,Organism/Species	RpoE - like,118,129,Gene/Protein	sigma factors,130,143,Gene/Protein	bd0881,155,161,Gene/Protein	bd0743,166,172,Gene/Protein	sigma factors,218,231,Gene/Protein	"[{""token"": ""Bdellovibrio"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Organism/Species""}, {""token"": ""delta - proteobacteria"", ""start_span"": 44, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""RpoE - like"", ""start_span"": 118, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""sigma factors"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""bd0881"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""bd0743"", ""start_span"": 166, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""sigma factors"", ""start_span"": 218, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Viable knock - out mutants capable of predation were obtained for bd0743 and bd0881, but they could not be obtained for bd3314, despite extensive screening in axenic ( prey - independent) and predatory conditions well beyond the bacterial numbers from which the other two mutants were isolated, suggesting that Bd3314 may be essential ( a total of 287 isolates were screened from 4 separate conjugation experiments, yielding only bd3314 merodiploids, compared to 10 and 29 isolates yielding 6 and 1 knock - out mutants for bd0743 and bd0881 respectively ).	bd0743,66,72,Gene/Protein	bd0881,77,83,Gene/Protein	bd3314,120,126,Gene/Protein	Bd3314,311,317,Gene/Protein	bd3314,430,436,Gene/Protein	bd0743,523,529,Gene/Protein	bd0881,534,540,Gene/Protein	"[{""token"": ""bd0743"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""bd0881"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""bd3314"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Bd3314"", ""start_span"": 311, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""bd3314"", ""start_span"": 430, ""end_span"": 436, ""type"": ""Gene/Protein""}, {""token"": ""bd0743"", ""start_span"": 523, ""end_span"": 529, ""type"": ""Gene/Protein""}, {""token"": ""bd0881"", ""start_span"": 534, ""end_span"": 540, ""type"": ""Gene/Protein""}]"	train
Bd3314 is larger than the other RpoE - like sigma factors ( predicted 373 amino acids compared to 162 and 206) with homology to regions 1. 2, 2, 3 and 4 of sigma 70 and so this may be acting as an alternative sigma 70 factor guiding the transcription of housekeeping genes which would explain why generating a knock - out mutant was not obtained.	Bd3314,0,6,Gene/Protein	RpoE - like,32,43,Gene/Protein	sigma factors,44,57,Gene/Protein	amino acids,74,85,Chemical/Drug	sigma 70,156,164,Gene/Protein	sigma 70,209,217,Gene/Protein	housekeeping genes,254,272,Gene/Protein	"[{""token"": ""Bd3314"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""RpoE - like"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""sigma factors"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""amino acids"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""sigma 70"", ""start_span"": 156, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""sigma 70"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""housekeeping genes"", ""start_span"": 254, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
We have shown that of three B. bacteriovorus HD100 sigma factor genes with at least partial rpoE homology, one - bd3314, is likely essential for Bdellovibrio cell life and cannot be deleted. bd0881 and bd0743 can be deleted with the Bdellovibrio retaining the ability to grow predatorily or prey - independently.	sigma factor,51,63,Gene/Protein	rpoE,92,96,Gene/Protein	bd3314,113,119,Gene/Protein	Bdellovibrio,145,157,Organism/Species	bd0881,191,197,Gene/Protein	bd0743,202,208,Gene/Protein	Bdellovibrio,233,245,Organism/Species	"[{""token"": ""sigma factor"", ""start_span"": 51, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""rpoE"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""bd3314"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Organism/Species""}, {""token"": ""bd0881"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""bd0743"", ""start_span"": 202, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 233, ""end_span"": 245, ""type"": ""Organism/Species""}]"	train
The bd0881 gene has an expression pattern across the predatory cycle that is similar to that of the flagellin genes whose expression is required for Bdellovibrio motility. That bd0881 expression is turned off and then resumes at a similar time to flagellin gene expression, during the predatory cycle, implies that Bd0881 may have a role associated with pre - septation developmental maturation of Bdellovibrio around the time that flagella are being built in newly dividing cells.	bd0881,4,10,Gene/Protein	flagellin,100,109,Gene/Protein	Bdellovibrio,149,161,Organism/Species	bd0881,177,183,Gene/Protein	flagellin,247,256,Gene/Protein	Bd0881,315,321,Gene/Protein	Bdellovibrio,398,410,Organism/Species	"[{""token"": ""bd0881"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""flagellin"", ""start_span"": 100, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 149, ""end_span"": 161, ""type"": ""Organism/Species""}, {""token"": ""bd0881"", ""start_span"": 177, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""flagellin"", ""start_span"": 247, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""Bd0881"", ""start_span"": 315, ""end_span"": 321, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 398, ""end_span"": 410, ""type"": ""Organism/Species""}]"	train
That the majority of GroES residues shown to interact with GroEL in E. coli [ 19] are conserved or have conserved substitutions in both of the GroES1 and GroES2 homologues of B. bacteriovorus HD100 supports the idea that they form genuine alternative chaperonin complexes, making GroEL protein folding chambers with different GroES “ lids ”.	GroES,21,26,Gene/Protein	GroEL,59,64,Gene/Protein	GroES1,143,149,Gene/Protein	GroES2,154,160,Gene/Protein	chaperonin,251,261,Gene/Protein	GroEL protein,280,293,Gene/Protein	GroES,326,331,Gene/Protein	"[{""token"": ""GroES"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""GroEL"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""GroES1"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""GroES2"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""chaperonin"", ""start_span"": 251, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""GroEL protein"", ""start_span"": 280, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""GroES"", ""start_span"": 326, ""end_span"": 331, ""type"": ""Gene/Protein""}]"	train
Transmissible spongiform encephalopathies ( TSE ), or prion diseases, are fatal neurological disorders of humans and other mammals that are characterized by accumulation of an abnormal, protease - resistant isoform of the prion protein ( PrPTSE) in the brain.	Transmissible spongiform encephalopathies,0,41,Disease/Disorder	TSE,44,47,Disease/Disorder	prion diseases,54,68,Disease/Disorder	neurological disorders,80,102,Disease/Disorder	humans,106,112,Organism/Species	mammals,123,130,Organism/Species	prion,222,227,Gene/Protein	"[{""token"": ""Transmissible spongiform encephalopathies"", ""start_span"": 0, ""end_span"": 41, ""type"": ""Disease/Disorder""}, {""token"": ""TSE"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Disease/Disorder""}, {""token"": ""prion diseases"", ""start_span"": 54, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""neurological disorders"", ""start_span"": 80, ""end_span"": 102, ""type"": ""Disease/Disorder""}, {""token"": ""humans"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""mammals"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""prion"", ""start_span"": 222, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
Cells were incubated for 1 h at room temperature with 10% goat serum and later EEA1 detection was performed using rabbit anti - EEA1 ( C45B10, Cell Signaling Technology) and secondary goat anti - rabbit AF546 - conjugated antibody ( Molecular Probes ).	goat,58,62,Organism/Species	EEA1,79,83,Gene/Protein	rabbit,114,120,Organism/Species	EEA1,128,132,Gene/Protein	goat,184,188,Organism/Species	rabbit,196,202,Organism/Species	antibody,222,230,Gene/Protein	"[{""token"": ""goat"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Organism/Species""}, {""token"": ""EEA1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""EEA1"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
48 h after infection and 72 h after transfection, cells were fixed in 3. 7% paraformaldehyde for 15 min, incubated for 1 h with 10% goat serum and then stained using antibodies for early endosomes ( rabbit anti - EEA1, C45B10, Cell Signaling Technology) and lysosomal markers ( mouse anti - LAMP1, D4O1S, Cell Signaling Technology ).	infection,11,20,Disease/Disorder	goat,132,136,Organism/Species	antibodies,166,176,Gene/Protein	rabbit,199,205,Organism/Species	EEA1,213,217,Gene/Protein	mouse,278,283,Organism/Species	LAMP1,291,296,Gene/Protein	"[{""token"": ""infection"", ""start_span"": 11, ""end_span"": 20, ""type"": ""Disease/Disorder""}, {""token"": ""goat"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 166, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 199, ""end_span"": 205, ""type"": ""Organism/Species""}, {""token"": ""EEA1"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 278, ""end_span"": 283, ""type"": ""Organism/Species""}, {""token"": ""LAMP1"", ""start_span"": 291, ""end_span"": 296, ""type"": ""Gene/Protein""}]"	train
Senescent BJ fibroblasts were infected with HPV - 2, HPV - 5, HPV - 16, HPV - 18 and HPV - 31 PsVs carrying a luciferase reporter plasmid and 24 h later transfected with control siRNA, or p53 siRNA.	HPV - 2,44,51,Organism/Species	HPV - 5,53,60,Organism/Species	HPV - 16,62,70,Organism/Species	HPV - 18,72,80,Organism/Species	HPV - 31,85,93,Organism/Species	luciferase,110,120,Gene/Protein	p53,188,191,Gene/Protein	"[{""token"": ""HPV - 2"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""HPV - 5"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Organism/Species""}, {""token"": ""HPV - 16"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""HPV - 18"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""HPV - 31"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""luciferase"", ""start_span"": 110, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
These data show MMTV - Wnt1 and MMTV - ΔN89β - catenin induce canonical signaling in distinct progenitors and that Hedgehog pathway activation is linked to melanocytic nevi and mammary tumor onset arising from excess Wnt1 ligand.	MMTV,16,20,Organism/Species	Wnt1,23,27,Gene/Protein	MMTV,32,36,Organism/Species	Hedgehog,115,123,Gene/Protein	melanocytic nevi,156,172,Disease/Disorder	mammary tumor,177,190,Disease/Disorder	Wnt1,217,221,Gene/Protein	"[{""token"": ""MMTV"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""MMTV"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""Hedgehog"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""melanocytic nevi"", ""start_span"": 156, ""end_span"": 172, ""type"": ""Disease/Disorder""}, {""token"": ""mammary tumor"", ""start_span"": 177, ""end_span"": 190, ""type"": ""Disease/Disorder""}, {""token"": ""Wnt1"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
Recent sorting studies of murine mammary cells have identified a subpopulation, with a lineage - depleted ( Lin −)/ CD24low / CD29 / 49fhigh / Sca - 1 −/ keratin ( K) 14 + profile, that are enriched in “ mammary repopulating units ” ( MRUs ), which have a parent - progeny relationship with a second Lin −/ CD24high / CD29 / 49flow subpopulation of alveolar - limited progenitors expressing a predominantly luminal K18 + profile [ 21 ], [ 27 ].	Lin,108,111,Gene/Protein	CD29,126,130,Gene/Protein	Sca - 1,143,150,Gene/Protein	keratin,154,161,Gene/Protein	Lin,300,303,Gene/Protein	CD29,318,322,Gene/Protein	K18,415,418,Gene/Protein	"[{""token"": ""Lin"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""CD29"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Sca - 1"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""keratin"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""Lin"", ""start_span"": 300, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""CD29"", ""start_span"": 318, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""K18"", ""start_span"": 415, ""end_span"": 418, ""type"": ""Gene/Protein""}]"	train
These data show that Hh pathway activation is linked to Wnt - 1 - induced mammary tumor onset and nevi formation and suggest that Hedgehog pathway activation maybe a critical component and useful marker of breast tumors arising from unopposed Wnt1 ligand.	Hh,21,23,Gene/Protein	Wnt - 1,56,63,Gene/Protein	mammary tumor,74,87,Disease/Disorder	nevi,98,102,Disease/Disorder	Hedgehog,130,138,Gene/Protein	breast tumors,206,219,Disease/Disorder	Wnt1,243,247,Gene/Protein	"[{""token"": ""Hh"", ""start_span"": 21, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Wnt - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""mammary tumor"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Disease/Disorder""}, {""token"": ""nevi"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Disease/Disorder""}, {""token"": ""Hedgehog"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""breast tumors"", ""start_span"": 206, ""end_span"": 219, ""type"": ""Disease/Disorder""}, {""token"": ""Wnt1"", ""start_span"": 243, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
Tumors from MMTV - Wnt1 mice displayed bi - layered papillary arrays of cells, showed an equal ratio of K14 +/ K18 + cells and expressed hormone receptors ( Fig. 2G – I ).	Tumors,0,6,Disease/Disorder	MMTV,12,16,Organism/Species	Wnt1,19,23,Gene/Protein	mice,24,28,Organism/Species	K14,104,107,Gene/Protein	K18,111,114,Gene/Protein	hormone receptors,137,154,Gene/Protein	"[{""token"": ""Tumors"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Disease/Disorder""}, {""token"": ""MMTV"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Organism/Species""}, {""token"": ""K14"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""K18"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""hormone receptors"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
To determine which cell - types respond to the expression of these transgenes via activation of the canonical pathway, we crossed MMTV - ΔN89β - catenin and MMTV - Wnt1 mice to Axin2 - d2EGFP transgenic and Conductin +/ lz heterozygous lacZ knock - in reporter lines.	MMTV,130,134,Organism/Species	MMTV,157,161,Organism/Species	Wnt1,164,168,Gene/Protein	mice,169,173,Organism/Species	Axin2,177,182,Gene/Protein	Conductin,207,216,Gene/Protein	lacZ,236,240,Gene/Protein	"[{""token"": ""MMTV"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""MMTV"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Organism/Species""}, {""token"": ""Axin2"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""Conductin"", ""start_span"": 207, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""lacZ"", ""start_span"": 236, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
In tumors from MMTV - ΔN89β - catenin mice, Conductin - lacZ was expressed within cells expressing the luminal marker K18 and absent from K14 + cells ( Fig. 4A – C ).	tumors,3,9,Disease/Disorder	MMTV,15,19,Organism/Species	mice,38,42,Organism/Species	Conductin,44,53,Gene/Protein	lacZ,56,60,Gene/Protein	K18,118,121,Gene/Protein	K14,138,141,Gene/Protein	"[{""token"": ""tumors"", ""start_span"": 3, ""end_span"": 9, ""type"": ""Disease/Disorder""}, {""token"": ""MMTV"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Organism/Species""}, {""token"": ""Conductin"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""lacZ"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""K18"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""K14"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
Wnt1 tumors showed the converse expression pattern; Conductin - lacZ expressing cells were restricted to a single K14 +/ K18 − layer of the bilayered papillary tumors ( Fig. 4D – F ).	Wnt1,0,4,Gene/Protein	tumors,5,11,Disease/Disorder	Conductin,52,61,Gene/Protein	lacZ,64,68,Gene/Protein	K14,114,117,Gene/Protein	K18,121,124,Gene/Protein	papillary tumors,150,166,Disease/Disorder	"[{""token"": ""Wnt1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 5, ""end_span"": 11, ""type"": ""Disease/Disorder""}, {""token"": ""Conductin"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""lacZ"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""K14"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""K18"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""papillary tumors"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Disease/Disorder""}]"	train
Conductin - lacZ is expressed in K18 + subpopulations in MMTV - ΔN89β - catenin and K14 + subpopulations in MMTV - Wnt1 hyperplasia.	Conductin,0,9,Gene/Protein	lacZ,12,16,Gene/Protein	K18,33,36,Gene/Protein	MMTV,57,61,Organism/Species	K14,84,87,Gene/Protein	MMTV,108,112,Organism/Species	Wnt1,115,119,Gene/Protein	"[{""token"": ""Conductin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""lacZ"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""K18"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""MMTV"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Organism/Species""}, {""token"": ""K14"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""MMTV"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene/Protein""}]"	train
In sections of MMTV - Wnt1; Gli1 +/ lz tumors ( D) Gli1 - lacZ expression is found within stromal cells and occasional p63 + cells ( arrow ).	MMTV,15,19,Organism/Species	Wnt1,22,26,Gene/Protein	Gli1,28,32,Gene/Protein	tumors,39,45,Disease/Disorder	Gli1,51,55,Gene/Protein	lacZ,58,62,Gene/Protein	p63,119,122,Gene/Protein	"[{""token"": ""MMTV"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""Gli1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Disease/Disorder""}, {""token"": ""Gli1"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""lacZ"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""p63"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene/Protein""}]"	train
Of note, stromal hyperplasia ( see Fig. 2L and 3E) is prominent within the early hyperplastic glands and tumors of MMTV - Wnt1 mice but is absent from glands and tumors of MMTV - ΔN89β - catenin mice.	tumors,105,111,Disease/Disorder	MMTV,115,119,Organism/Species	Wnt1,122,126,Gene/Protein	mice,127,131,Organism/Species	tumors,162,168,Disease/Disorder	MMTV,172,176,Organism/Species	mice,195,199,Organism/Species	"[{""token"": ""tumors"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Disease/Disorder""}, {""token"": ""MMTV"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""tumors"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Disease/Disorder""}, {""token"": ""MMTV"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Organism/Species""}]"	train
As MMTV - Wnt1 tumors recapitulate the pattern of activity reported for human breast tumors they may provide as a useful genetic model to dissect the contribution of Hedgehog signaling within these different cell types to tumor onset and progression.	MMTV,3,7,Organism/Species	Wnt1,10,14,Gene/Protein	tumors,15,21,Disease/Disorder	human,72,77,Organism/Species	breast tumors,78,91,Disease/Disorder	Hedgehog,166,174,Gene/Protein	tumor,222,227,Disease/Disorder	"[{""token"": ""MMTV"", ""start_span"": 3, ""end_span"": 7, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""breast tumors"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""Hedgehog"", ""start_span"": 166, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 222, ""end_span"": 227, ""type"": ""Disease/Disorder""}]"	train
The MetS is defined by having three or more of the following traits: waist circumference > 40 inches (> 102 cm) for men and 35 inches (> 89 cm) inches for women; fasting plasma TAG ≥ 150 mg / dl (≥ 1 · 70 mmol / l ); fasting plasma HDL - cholesterol < 40 mg / dl (< 1 · 04 mmol / l) for men and < 50 mg / dl (< 1 · 30 mmol / l) for women; blood pressure ≥ 130 / 85 mmHg; and fasting glucose ≥ 100 mg / dl (≥ 5 · 56 mmol / l )( 29 ).	MetS,4,8,Disease/Disorder	men,116,119,Organism/Species	women,155,160,Organism/Species	cholesterol,238,249,Chemical/Drug	men,287,290,Organism/Species	women,332,337,Organism/Species	glucose,383,390,Chemical/Drug	"[{""token"": ""MetS"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Disease/Disorder""}, {""token"": ""men"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""women"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""cholesterol"", ""start_span"": 238, ""end_span"": 249, ""type"": ""Chemical/Drug""}, {""token"": ""men"", ""start_span"": 287, ""end_span"": 290, ""type"": ""Organism/Species""}, {""token"": ""women"", ""start_span"": 332, ""end_span"": 337, ""type"": ""Organism/Species""}, {""token"": ""glucose"", ""start_span"": 383, ""end_span"": 390, ""type"": ""Chemical/Drug""}]"	train
In response to the PO + MFGM test meal, TAG concentration increased by 104% from 0 to 3 h and non - HDL - cholesterol concentration increased by 22% from 0 to 1 h. Table 3. Concentrations of metabolic markers with significant interaction effects ( Mean values and standard deviations) Time point0 h1 h3 h6 hMean sd Mean sd Mean sd Mean sd Time × treatment: PTotal cholesterol ( mg / dl) 0 · 04 PO meal194 · 938 · 5204 · 2 * 40 · 8201 · 4 * 39 · 9203 · 9 * 39 · 6 PO + MFGM meal198 · 737 · 6199 · 737 · 6207 · 137 · 4203 · 735 · 8Total cholesterol ( mmol / l) 0 · 04 PO meal5 · 051 · 005 · 29 * 1 · 065 · 22 * 1 · 035 · 28 * 1 · 03 PO + MFGM meal5 · 150 · 975 · 170 · 975 · 360 · 975 · 280 · 93HDL - cholesterol ( mg / dl) 0 · 01 PO meal49 · 614 · 551 · 6 * 15 · 349 · 3 † 15 · 349 · 9 † 15 · 3 PO + MFGM meal50 · 214 · 050 · 614 · 550 · 414 · 549 · 714 · 4HDL - cholesterol ( mmol / l) 0 · 01 PO meal1 · 280 · 371 · 34 * 0 · 401 · 28 † 0 · 401 · 29 † 0 · 40 PO + MFGM meal1 · 300 · 361 · 310 · 381 · 300 · 371 · 290 · 37TAG ( mg / dl )< 0 · 0005 PO meal126 · 656 · 5182 · 9 * 77 · 9223 · 9 *† 114 · 4209 · 6 *‡ 82 · 9 PO + MFGM meal130 · 170 · 6174 · 958 · 2265 · 1119 · 8210 · 4111 · 8TAG ( mmol / l )< 0 · 0005 PO meal1 · 430 · 642 · 07 * 0 · 882 · 53 *† 1 · 292 · 37 *‡ 0 · 94 PO + MFGM meal1 · 470 · 801 · 980 · 663 · 001 · 352 · 381 · 26Non - HDL - cholesterol ( mg / dl) 0 · 04 PO meal145 · 435 · 3152 · 6 * 36 · 5152 · 2 * 36 · 3154 · 0 * 37 · 2 PO + MFGM meal148 · 534 · 9180 · 5166 · 6157 · 034 · 5154 · 033 · 8Non - HDL - cholesterol ( mmol / l) 0 · 04 PO meal3 · 770 · 913 · 95 * 0 · 953 · 94 * 0 · 943 · 99 * 0 · 96 PO + MFGM meal3 · 850 · 904 · 674 · 324 · 070 · 893 · 990 · 88Insulin ( μIU / ml )< 0 · 0005 PO meal14 · 06 · 181 · 7 * 69 · 334 · 4 *† 28 · 6Not measured PO + MFGM meal16 · 410 · 654 · 846 · 139 · 625 · 9Not measuredInsulin ( pmol / l )< 0 · 0005 PO meal100 · 744 · 1586 · 4 * 497 · 4246 · 5 *† 205 · 5Not measured PO + MFGM meal117 · 575 · 9392 · 9330 · 4283 · 8186 · 0Not measuredPO, palm oil; PO + MFGM, palm oil + milk fat globule membrane .* Significantly different from 0 h when both treatments analysed together ( P < 0 · 05 ).† Significantly different from 1 h when both treatments analysed together ( P < 0 · 05 ).‡ Significantly different from 3 h when both treatments analysed together ( P < 0 · 05 ).	cholesterol,106,117,Chemical/Drug	cholesterol,364,375,Chemical/Drug	cholesterol,535,546,Chemical/Drug	cholesterol,699,710,Chemical/Drug	cholesterol,862,873,Chemical/Drug	cholesterol,1354,1365,Chemical/Drug	cholesterol,1532,1543,Chemical/Drug	"[{""token"": ""cholesterol"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 364, ""end_span"": 375, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 535, ""end_span"": 546, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 699, ""end_span"": 710, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 862, ""end_span"": 873, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 1354, ""end_span"": 1365, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 1532, ""end_span"": 1543, ""type"": ""Chemical/Drug""}]"	train
We compared the incidence of such records in starling and Common blackbird ( Turdus merula) to ascertain whether starlings were particularly susceptible to this cause of mortality, as the blackbird is another passerine of similar body size to the starling that is numerous within garden habitats.	starling,45,53,Organism/Species	Common blackbird,58,74,Organism/Species	Turdus merula,77,90,Organism/Species	starlings,113,122,Organism/Species	blackbird,188,197,Organism/Species	passerine,209,218,Organism/Species	starling,247,255,Organism/Species	"[{""token"": ""starling"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Organism/Species""}, {""token"": ""Common blackbird"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""Turdus merula"", ""start_span"": 77, ""end_span"": 90, ""type"": ""Organism/Species""}, {""token"": ""starlings"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Organism/Species""}, {""token"": ""blackbird"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Organism/Species""}, {""token"": ""passerine"", ""start_span"": 209, ""end_span"": 218, ""type"": ""Organism/Species""}, {""token"": ""starling"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Organism/Species""}]"	train
Starlings were classified as having drowned in a significantly greater proportion of ring recoveries than blackbirds, both when the entire dataset was considered ( starling 1. 22 %; blackbird 0. 87 %; χ21 = 27. 5, p < 0. 001) and when only those birds thought to have died as a result of natural consequences ( i. e. excluding shot, trapped, polluted and records of undetermined cause) were reviewed ( starling 5. 04 %; blackbird 3. 73 %; χ21 = 22. 12, p < 0. 001 ).	Starlings,0,9,Organism/Species	blackbirds,106,116,Organism/Species	starling,164,172,Organism/Species	blackbird,182,191,Organism/Species	birds,246,251,Organism/Species	starling,402,410,Organism/Species	blackbird,420,429,Organism/Species	"[{""token"": ""Starlings"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Organism/Species""}, {""token"": ""blackbirds"", ""start_span"": 106, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""starling"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""blackbird"", ""start_span"": 182, ""end_span"": 191, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 246, ""end_span"": 251, ""type"": ""Organism/Species""}, {""token"": ""starling"", ""start_span"": 402, ""end_span"": 410, ""type"": ""Organism/Species""}, {""token"": ""blackbird"", ""start_span"": 420, ""end_span"": 429, ""type"": ""Organism/Species""}]"	train
The propensity to invade the brain and the eye has given rise to particular concern in the human population, with ocular toxocariasis ( OT) a recognised syndrome ( Good et al ., 2004 ), and neurotoxocariasis ( NT) inferred from cognitive deficits, higher prevalence among epilepsy cases ( Quattrocchi et al ., 2012 ), and finding larvae in post - mortem brain samples ( Hill et al ., 1985 ).	human,91,96,Organism/Species	ocular toxocariasis,114,133,Disease/Disorder	OT,136,138,Disease/Disorder	neurotoxocariasis,190,207,Disease/Disorder	NT,210,212,Disease/Disorder	cognitive deficits,228,246,Disease/Disorder	epilepsy,272,280,Disease/Disorder	"[{""token"": ""human"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""ocular toxocariasis"", ""start_span"": 114, ""end_span"": 133, ""type"": ""Disease/Disorder""}, {""token"": ""OT"", ""start_span"": 136, ""end_span"": 138, ""type"": ""Disease/Disorder""}, {""token"": ""neurotoxocariasis"", ""start_span"": 190, ""end_span"": 207, ""type"": ""Disease/Disorder""}, {""token"": ""NT"", ""start_span"": 210, ""end_span"": 212, ""type"": ""Disease/Disorder""}, {""token"": ""cognitive deficits"", ""start_span"": 228, ""end_span"": 246, ""type"": ""Disease/Disorder""}, {""token"": ""epilepsy"", ""start_span"": 272, ""end_span"": 280, ""type"": ""Disease/Disorder""}]"	train
These authors went on to develop an IgG4 - specific diagnostic assay employing three recombinant antigens ( Tc - PEB - 1 or TES - 26, Tc - CTL - 1 or TES - 32 also named TES - 30USM, and Tc - MUC - 1 or TES120 ).	IgG4,36,40,Gene/Protein	PEB - 1,113,120,Gene/Protein	TES - 26,124,132,Gene/Protein	CTL - 1,139,146,Gene/Protein	TES - 32,150,158,Gene/Protein	MUC - 1,192,199,Gene/Protein	TES120,203,209,Gene/Protein	"[{""token"": ""IgG4"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""PEB - 1"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""TES - 26"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""CTL - 1"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""TES - 32"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""MUC - 1"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""TES120"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
By blocking Gαq via PAR - 1 and Gβi via P2Y12, combined inhibition of thrombin and P2Y12 receptors leads to a synergistic inhibitory effect on thrombin - induced platelet aggregation ( 10 ).	Gαq,12,15,Gene/Protein	PAR - 1,20,27,Gene/Protein	Gβi,32,35,Gene/Protein	P2Y12,40,45,Gene/Protein	thrombin,70,78,Gene/Protein	P2Y12 receptors,83,98,Gene/Protein	thrombin,143,151,Gene/Protein	"[{""token"": ""G\u03b1q"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""PAR - 1"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""G\u03b2i"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""P2Y12"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""P2Y12 receptors"", ""start_span"": 83, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 143, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
Thrombin binds to PAR - 1 receptor, which leads to shape change, phospholipase C ( PLC) activation, thromboxane A2 ( T × A2) generation, and activation of the glycoprotein ( GP) IIb / IIIa receptor, resulting in sustained platelet aggregation.	Thrombin,0,8,Gene/Protein	PAR - 1 receptor,18,34,Gene/Protein	phospholipase C,65,80,Gene/Protein	PLC,83,86,Gene/Protein	thromboxane A2,100,114,Chemical/Drug	glycoprotein,159,171,Gene/Protein	GP,174,176,Gene/Protein	"[{""token"": ""Thrombin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""PAR - 1 receptor"", ""start_span"": 18, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase C"", ""start_span"": 65, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""PLC"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""thromboxane A2"", ""start_span"": 100, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""glycoprotein"", ""start_span"": 159, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""GP"", ""start_span"": 174, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
Recent studies have suggested pro - inflammatory factors as key to keratoconus pathogenesis based on their findings of elevated interleukin ( IL )- 6, tumor necrosis factor ( TNF )- α and matrix metalloproteinase ( MMP )- 9 in the tear fluid of keratoconus patients [ 8 ], [ 9 ].	keratoconus,67,78,Disease/Disorder	interleukin,128,139,Gene/Protein	( IL )- 6,140,149,Gene/Protein	tumor necrosis factor,151,172,Gene/Protein	matrix metalloproteinase,188,212,Gene/Protein	( MMP )- 9,213,223,Gene/Protein	keratoconus,245,256,Disease/Disorder	"[{""token"": ""keratoconus"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""interleukin"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""( IL )- 6"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 151, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 188, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""( MMP )- 9"", ""start_span"": 213, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""keratoconus"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Disease/Disorder""}]"	train
The multiplex data implicate reductions in TH1 ( IL - 12, TNF - α, IFN - γ ), and possibly TH2 cytokines ( IL - 4 and IL - 13) in keratoconus.	IL - 12,49,56,Gene/Protein	TNF - α,58,65,Gene/Protein	IFN - γ,67,74,Gene/Protein	cytokines,95,104,Gene/Protein	IL - 4,107,113,Gene/Protein	IL - 13,118,125,Gene/Protein	keratoconus,130,141,Disease/Disorder	"[{""token"": ""IL - 12"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""keratoconus"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Disease/Disorder""}]"	train
IL - 4 is a key TH2 cell differentiation cytokine, and both IL - 4 and IL - 13 play crucial roles in amplification of the TH2 response through up regulation of STAT5, STAT6 and GATA3 transcription [ 14 ].	IL - 4,0,6,Gene/Protein	cytokine,41,49,Gene/Protein	IL - 4,60,66,Gene/Protein	IL - 13,71,78,Gene/Protein	STAT5,160,165,Gene/Protein	STAT6,167,172,Gene/Protein	GATA3,177,182,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""GATA3"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
Primary chicken embryo intestinal cells ( CEICs) were inoculated with C. jejuni chicken strain SC11 and human strain HM5040 at a MOI of 100: 1, total RNA was isolated, and the expression of ciaB, dnaJ and racR of C. jejuni in internalized / adhered ( IA) and suspended ( SU) bacteria were measured at various time points post inoculation ( p. i .) ( see Methods ).	chicken,8,15,Organism/Species	human,104,109,Organism/Species	HM5040,117,123,Chemical/Drug	ciaB,190,194,Gene/Protein	dnaJ,196,200,Gene/Protein	racR,205,209,Gene/Protein	bacteria,275,283,Organism/Species	"[{""token"": ""chicken"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""HM5040"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""ciaB"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""dnaJ"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""racR"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 275, ""end_span"": 283, ""type"": ""Organism/Species""}]"	train
Interleukin - 8 ( IL - 8 / CXCL - 8) is a prototype of the ELR + CXC chemokines that play an important role in the promotion and progression of many human cancers including breast cancer.	Interleukin - 8,0,15,Gene/Protein	IL - 8,18,24,Gene/Protein	CXCL - 8,27,35,Gene/Protein	CXC chemokines,65,79,Gene/Protein	human,149,154,Organism/Species	cancers,155,162,Disease/Disorder	breast cancer,173,186,Disease/Disorder	"[{""token"": ""Interleukin - 8"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""CXCL - 8"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CXC chemokines"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Organism/Species""}, {""token"": ""cancers"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Disease/Disorder""}, {""token"": ""breast cancer"", ""start_span"": 173, ""end_span"": 186, ""type"": ""Disease/Disorder""}]"	train
Our results indicated that the polymorphisms in IL - 8 and CXCR2 genes are associated with increased breast cancer risk, as well as disease progress, supporting our hypothesis for IL - 8 and ELR + CXC chemokine receptor ( CXCR2) involvement in breast cancer pathogenesis.	IL - 8,48,54,Gene/Protein	CXCR2,59,64,Gene/Protein	breast cancer,101,114,Disease/Disorder	IL - 8,180,186,Gene/Protein	CXC chemokine receptor,197,219,Gene/Protein	CXCR2,222,227,Gene/Protein	breast cancer,244,257,Disease/Disorder	"[{""token"": ""IL - 8"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""CXCR2"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 101, ""end_span"": 114, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 8"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""CXC chemokine receptor"", ""start_span"": 197, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""CXCR2"", ""start_span"": 222, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 244, ""end_span"": 257, ""type"": ""Disease/Disorder""}]"	train
The most abundant neurotrophin in the adult brain, brain - derived neurotrophic factor ( BDNF ), is first synthesized as a proBDNF precursor and recent studies have demonstrated that proBDNF can be secreted and that it functions as a ligand for a receptor complex containing p75NTR and sortilin.	neurotrophin,18,30,Gene/Protein	brain - derived neurotrophic factor,51,86,Gene/Protein	BDNF,89,93,Gene/Protein	proBDNF,123,130,Gene/Protein	proBDNF,183,190,Gene/Protein	p75NTR,275,281,Gene/Protein	sortilin,286,294,Gene/Protein	"[{""token"": ""neurotrophin"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""brain - derived neurotrophic factor"", ""start_span"": 51, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""p75NTR"", ""start_span"": 275, ""end_span"": 281, ""type"": ""Gene/Protein""}, {""token"": ""sortilin"", ""start_span"": 286, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
The effects of the neurotrophins are mediated by binding to TrkA, TrkB and TrkC receptor tyrosine kinases and to the p75 neurotrophin receptor ( p75NTR ).	neurotrophins,19,32,Gene/Protein	TrkA,60,64,Gene/Protein	TrkB,66,70,Gene/Protein	TrkC receptor,75,88,Gene/Protein	tyrosine kinases,89,105,Gene/Protein	p75 neurotrophin receptor,117,142,Gene/Protein	p75NTR,145,151,Gene/Protein	"[{""token"": ""neurotrophins"", ""start_span"": 19, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""TrkA"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""TrkB"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""TrkC receptor"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine kinases"", ""start_span"": 89, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""p75 neurotrophin receptor"", ""start_span"": 117, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""p75NTR"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
Briefly, 6 to 8 week - old C57BL / 6 mice were anaesthetized with ketamine: xylamine cocktail ( 60 mg / kg) and perfused with ice - cold choline chloride - based artificial cerebrospinal fluid ( ACSF) containing ( in mM ): 110 choline - Cl, 1. 25 NaH2PO4, 25 NaHCO3, 7 MgCl2, 0. 5 CaCl2, 2. 5 KCl, 7 glucose, 3 pyruvic acid and 1. 3 ascorbic acid, pH 7. 4 bubbled with carbogen ( O2 95 %, CO2 5 %).	C57BL / 6 mice,27,41,Organism/Species	ketamine,66,74,Chemical/Drug	xylamine,76,84,Chemical/Drug	choline,137,144,Chemical/Drug	glucose,300,307,Chemical/Drug	pyruvic acid,311,323,Chemical/Drug	ascorbic acid,333,346,Chemical/Drug	"[{""token"": ""C57BL / 6 mice"", ""start_span"": 27, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""ketamine"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""xylamine"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""choline"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 300, ""end_span"": 307, ""type"": ""Chemical/Drug""}, {""token"": ""pyruvic acid"", ""start_span"": 311, ""end_span"": 323, ""type"": ""Chemical/Drug""}, {""token"": ""ascorbic acid"", ""start_span"": 333, ""end_span"": 346, ""type"": ""Chemical/Drug""}]"	train
Moreover, a significant positive relationship was observed between detectable pVL and presence of anti - gp160 ( p < 0. 05 ), anti - gp120 ( p < 0. 05 ), anti - p68 ( p < 0. 0005 ), anti - p55 ( p < 0. 005 ), anti - p52 ( p < 0. 05 ), anti - gp41 ( p < 0. 005) and anti - gp34 ( p < 0. 0005) in erythrocytes.	gp160,105,110,Gene/Protein	gp120,133,138,Gene/Protein	p68,161,164,Gene/Protein	p55,189,192,Gene/Protein	p52,216,219,Gene/Protein	gp41,242,246,Gene/Protein	gp34,272,276,Gene/Protein	"[{""token"": ""gp160"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""gp120"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""p68"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""p55"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""gp41"", ""start_span"": 242, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""gp34"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
In order to establish whether erythrocytes from HIV - positive individuals are still capable to attach additional virus and / or antigen at the cell surface, we analyzed HIV capture by erythrocytes, pVL and IgG anti HIV - E in 48 blood samples from HIV - positive ( 48 of the 75 belonging to Table S1) and 15 from HIV - negative individuals.	HIV,48,51,Organism/Species	virus,114,119,Organism/Species	HIV,170,173,Organism/Species	IgG,207,210,Gene/Protein	HIV,216,219,Organism/Species	HIV,249,252,Organism/Species	HIV,314,317,Organism/Species	"[{""token"": ""HIV"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 207, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 249, ""end_span"": 252, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 314, ""end_span"": 317, ""type"": ""Organism/Species""}]"	train
( C) The 48 HIV - positive individuals are grouped according to the presence (+ IgG anti - HIV - E, N = 32) or absence (- IgG anti - HIV - E, N = 16) of at least one IgG anti - HIV associated to erythrocytes.	HIV,12,15,Organism/Species	IgG,80,83,Gene/Protein	HIV,91,94,Organism/Species	IgG,122,125,Gene/Protein	HIV,133,136,Organism/Species	IgG,166,169,Gene/Protein	HIV,177,180,Organism/Species	"[{""token"": ""HIV"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Organism/Species""}]"	train
( D) The 48 HIV - positive individuals are grouped according to the presence (+ IgG anti - gp160 - E, N = 25) or absence (- IgG anti - gp160 - E, N = 23) of IgG anti - gp160 associated to erythrocytes.	HIV,12,15,Organism/Species	IgG,80,83,Gene/Protein	gp160,91,96,Gene/Protein	IgG,124,127,Gene/Protein	gp160,135,140,Gene/Protein	IgG,157,160,Gene/Protein	gp160,168,173,Gene/Protein	"[{""token"": ""HIV"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Figure shows viral load ( copies / ml) of plasmas from 6 HIV - positive individuals ( Ig ), as a source of HIV - specific antibodies, incubated with HIV IIIB ( HIV) in presence of normal human serum as complement source ( C) and in presence (+ E) or absence of erythrocytes.	HIV,57,60,Organism/Species	Ig,86,88,Gene/Protein	HIV,107,110,Organism/Species	antibodies,122,132,Gene/Protein	HIV IIIB,149,157,Organism/Species	HIV,160,163,Organism/Species	human,187,192,Organism/Species	"[{""token"": ""HIV"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Organism/Species""}, {""token"": ""Ig"", ""start_span"": 86, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""HIV IIIB"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Organism/Species""}]"	train
With that purpose, erythrocytes from HIV - positive individuals were incubated with a known amount of virus in a similar way as that it was explained in the last section but in absence of immunoglobulins anti - HIV and complement. Figure 6 shows that HIV incubation with erythrocytes from HIV - positive individuals significantly decreased the HIV titer in the medium ( p < 0. 001 ).	HIV,37,40,Organism/Species	virus,102,107,Organism/Species	immunoglobulins,188,203,Gene/Protein	HIV,211,214,Organism/Species	HIV,251,254,Organism/Species	HIV,289,292,Organism/Species	HIV,344,347,Organism/Species	"[{""token"": ""HIV"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""immunoglobulins"", ""start_span"": 188, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 251, ""end_span"": 254, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 289, ""end_span"": 292, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 344, ""end_span"": 347, ""type"": ""Organism/Species""}]"	train
Altogether, the presence of IgG anti - HIV in erythrocytes from HIV - positive individuals, supported by previous data about p24 - antigen [ 1] and HIV - RNA [ 1 ], [ 11] detected in erythrocytes, suggests that virus and / or viral antigens bind to erythrocytes by immunoadherence in HIV - positive individuals.	IgG,28,31,Gene/Protein	HIV,39,42,Organism/Species	HIV,64,67,Organism/Species	p24,125,128,Gene/Protein	HIV,148,151,Organism/Species	virus,211,216,Organism/Species	HIV,284,287,Organism/Species	"[{""token"": ""IgG"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""p24"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 284, ""end_span"": 287, ""type"": ""Organism/Species""}]"	train
36 HNSCC cases from the ARCAGE study were selected based on carrying one or several mutations in their tumor samples in the 5 screened genes ( TP53, NOTCH1, CDKN2A, CASP8, PTEN) ( Figure 1 ).	HNSCC,3,8,Disease/Disorder	tumor,103,108,Disease/Disorder	TP53,143,147,Gene/Protein	NOTCH1,149,155,Gene/Protein	CDKN2A,157,163,Gene/Protein	CASP8,165,170,Gene/Protein	PTEN,172,176,Gene/Protein	"[{""token"": ""HNSCC"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Disease/Disorder""}, {""token"": ""TP53"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""NOTCH1"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""CDKN2A"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""CASP8"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""PTEN"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
The RNA - seq raw data were deposited in the Sequence Read Archive database ( http :// www. ncbi. nlm. nih. gov / Traces / sra /) under the accession numbers SRR4011621, SRR4011622, SRR4011623, SRR4011624, SRR4011625, SRR4011626, SRR4011627, and SRR4011628.	SRR4011622,170,180,Chemical/Drug	SRR4011623,182,192,Chemical/Drug	SRR4011624,194,204,Chemical/Drug	SRR4011625,206,216,Chemical/Drug	SRR4011626,218,228,Chemical/Drug	SRR4011627,230,240,Chemical/Drug	SRR4011628,246,256,Chemical/Drug	"[{""token"": ""SRR4011622"", ""start_span"": 170, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""SRR4011623"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Chemical/Drug""}, {""token"": ""SRR4011624"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Chemical/Drug""}, {""token"": ""SRR4011625"", ""start_span"": 206, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""SRR4011626"", ""start_span"": 218, ""end_span"": 228, ""type"": ""Chemical/Drug""}, {""token"": ""SRR4011627"", ""start_span"": 230, ""end_span"": 240, ""type"": ""Chemical/Drug""}, {""token"": ""SRR4011628"", ""start_span"": 246, ""end_span"": 256, ""type"": ""Chemical/Drug""}]"	train
Although amitriptyline, milnacipran, and imipramine inhibit both SERT and NAT, the relative activity to SERT and NAT is different among these compounds [ 45 ].	amitriptyline,9,22,Chemical/Drug	milnacipran,24,35,Chemical/Drug	imipramine,41,51,Chemical/Drug	SERT,65,69,Gene/Protein	NAT,74,77,Gene/Protein	SERT,104,108,Gene/Protein	NAT,113,116,Gene/Protein	"[{""token"": ""amitriptyline"", ""start_span"": 9, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""milnacipran"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""imipramine"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""SERT"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""NAT"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""SERT"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NAT"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}]"	train
In addition, Lachnospiraceae, Ruminococcaceae, Syntrophomonadaceae, Peptococcaceae, Catabacteriaceae, Eubacteriaceae and Veillonellaceae were present at lower levels ( data not shown ).	Lachnospiraceae,13,28,Organism/Species	Ruminococcaceae,30,45,Organism/Species	Syntrophomonadaceae,47,66,Organism/Species	Peptococcaceae,68,82,Organism/Species	Catabacteriaceae,84,100,Organism/Species	Eubacteriaceae,102,116,Organism/Species	Veillonellaceae,121,136,Organism/Species	"[{""token"": ""Lachnospiraceae"", ""start_span"": 13, ""end_span"": 28, ""type"": ""Organism/Species""}, {""token"": ""Ruminococcaceae"", ""start_span"": 30, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""Syntrophomonadaceae"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""Peptococcaceae"", ""start_span"": 68, ""end_span"": 82, ""type"": ""Organism/Species""}, {""token"": ""Catabacteriaceae"", ""start_span"": 84, ""end_span"": 100, ""type"": ""Organism/Species""}, {""token"": ""Eubacteriaceae"", ""start_span"": 102, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""Veillonellaceae"", ""start_span"": 121, ""end_span"": 136, ""type"": ""Organism/Species""}]"	train
Moreover, camel owners consumption habits of camel meat ( cooking, without cooking, both) and raw milk consumption ( yes / no ), educational level ( uneducated, primary school, secondary school, tertiary / university) and awareness about: toxoplasmosis ( yes / no ), role of cat to transmit diseases to owner ( yes / no ), role of cat to transmit diseases to camel ( yes / no) and camel migration ( yes / no) and routes of migration were also gathered.	camel,10,15,Organism/Species	camel,45,50,Organism/Species	toxoplasmosis,239,252,Disease/Disorder	cat,275,278,Organism/Species	cat,331,334,Organism/Species	camel,359,364,Organism/Species	camel,381,386,Organism/Species	"[{""token"": ""camel"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""camel"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""toxoplasmosis"", ""start_span"": 239, ""end_span"": 252, ""type"": ""Disease/Disorder""}, {""token"": ""cat"", ""start_span"": 275, ""end_span"": 278, ""type"": ""Organism/Species""}, {""token"": ""cat"", ""start_span"": 331, ""end_span"": 334, ""type"": ""Organism/Species""}, {""token"": ""camel"", ""start_span"": 359, ""end_span"": 364, ""type"": ""Organism/Species""}, {""token"": ""camel"", ""start_span"": 381, ""end_span"": 386, ""type"": ""Organism/Species""}]"	train
In addition, MeCP2 has been linked to other cancers, such as myeloma [ 125 ], hematological malignancies [ 126 ], ductal carcinomas [ 127 ], and cervical cancers [ 128 ].	MeCP2,13,18,Gene/Protein	cancers,44,51,Disease/Disorder	as,58,60,Disease/Disorder	myeloma,61,68,Disease/Disorder	hematological malignancies,78,104,Disease/Disorder	ductal carcinomas,114,131,Disease/Disorder	cervical cancers,145,161,Disease/Disorder	"[{""token"": ""MeCP2"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""cancers"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Disease/Disorder""}, {""token"": ""as"", ""start_span"": 58, ""end_span"": 60, ""type"": ""Disease/Disorder""}, {""token"": ""myeloma"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""hematological malignancies"", ""start_span"": 78, ""end_span"": 104, ""type"": ""Disease/Disorder""}, {""token"": ""ductal carcinomas"", ""start_span"": 114, ""end_span"": 131, ""type"": ""Disease/Disorder""}, {""token"": ""cervical cancers"", ""start_span"": 145, ""end_span"": 161, ""type"": ""Disease/Disorder""}]"	train
Brain neuropathology observed in Mecp2 knockout mice is similar to that observed in RTT individuals. Mecp2 knockout mice have smaller densely packed neurons, reduced dendritic spine density, deficits in axonal fasciculation and reduced number of mature synapses. Mecp2 knockout mice die at approximately 10 weeks of life [ 150 – 152 ].	Mecp2,33,38,Gene/Protein	mice,48,52,Organism/Species	RTT,84,87,Disease/Disorder	Mecp2,101,106,Gene/Protein	mice,116,120,Organism/Species	Mecp2,263,268,Gene/Protein	mice,278,282,Organism/Species	"[{""token"": ""Mecp2"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Organism/Species""}, {""token"": ""RTT"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Disease/Disorder""}, {""token"": ""Mecp2"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""Mecp2"", ""start_span"": 263, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 278, ""end_span"": 282, ""type"": ""Organism/Species""}]"	train
LS is caused by a germline mutation in one of the mismatch repair ( MMR) genes MLH1, MSH2, MSH6 or PMS2, or in the 3 ′ end of the EPCAM gene and consequent hypermethylation of the MSH2 promoter region [ 6 – 10 ].	LS,0,2,Disease/Disorder	MLH1,79,83,Gene/Protein	MSH2,85,89,Gene/Protein	MSH6,91,95,Gene/Protein	PMS2,99,103,Gene/Protein	EPCAM,130,135,Gene/Protein	MSH2,180,184,Gene/Protein	"[{""token"": ""LS"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Disease/Disorder""}, {""token"": ""MLH1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""MSH2"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""MSH6"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""PMS2"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""EPCAM"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""MSH2"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
Statistical analysis according to the hypergeometric distribution showed that 10 TF families were significantly differentially expressed, among which the WRKY, HD - ZIP, bHLH, ERF, RAV, and NAC families were significantly up - regulated in the ifc ovary, while the G2 - like family was significantly down - regulated ( p < 0. 05, hypergeometric test ).	TF,81,83,Gene/Protein	WRKY,154,158,Gene/Protein	bHLH,170,174,Gene/Protein	ERF,176,179,Gene/Protein	RAV,181,184,Gene/Protein	NAC,190,193,Gene/Protein	G2 - like family,265,281,Gene/Protein	"[{""token"": ""TF"", ""start_span"": 81, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""WRKY"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""bHLH"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""ERF"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""RAV"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""NAC"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""G2 - like family"", ""start_span"": 265, ""end_span"": 281, ""type"": ""Gene/Protein""}]"	train
Concentration of TNFα, IL - 6 and MCP1 was significantly higher 3h after intraluminal administration of poly I: C than in controls ( Figure 5 ), while IL - 10, IL - 12p70 and IFNγ did not show changes in poly I: C - stimulated mice versus PBS controls ( data not shown ).	TNFα,17,21,Gene/Protein	IL - 6,23,29,Gene/Protein	MCP1,34,38,Gene/Protein	IL - 10,151,158,Gene/Protein	IL - 12p70,160,170,Gene/Protein	IFNγ,175,179,Gene/Protein	mice,227,231,Organism/Species	"[{""token"": ""TNF\u03b1"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""MCP1"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12p70"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""IFN\u03b3"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Organism/Species""}]"	train
Remarkably, after two weeks of gliadin ingestion, NOD - DQ8 mice showed increased levels of the proinflammatory cytokines IL - 12p70 and TNFα in peripheral blood, compared with those on gluten - free chow, indicating a causal link to gliadin challenges and not to poly I: C treatment.	gliadin,31,38,Gene/Protein	NOD - DQ8 mice,50,64,Organism/Species	cytokines,112,121,Gene/Protein	IL - 12p70,122,132,Gene/Protein	TNFα,137,141,Gene/Protein	gluten,186,192,Gene/Protein	gliadin,234,241,Gene/Protein	"[{""token"": ""gliadin"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NOD - DQ8 mice"", ""start_span"": 50, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""cytokines"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12p70"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""TNF\u03b1"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""gluten"", ""start_span"": 186, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""gliadin"", ""start_span"": 234, ""end_span"": 241, ""type"": ""Gene/Protein""}]"	train
The most significant association ( rs7890572, P = 3. 8 × 10 − 10) was observed with a linear triglyceride trajectory effect ( i. e ., SNPxAGE effect) on the X chromosome within the IL1RAPL1 gene and near the gene encoding glycerol kinase ( GK ), in which mutations have been implicated in pseudo - hypertriglyceridemia, caused by high levels of glycerol creating measurement artifacts in the triglyceride assay [ 14 ].	triglyceride,93,105,Chemical/Drug	IL1RAPL1,181,189,Gene/Protein	glycerol kinase,222,237,Gene/Protein	GK,240,242,Gene/Protein	hypertriglyceridemia,298,318,Disease/Disorder	glycerol,345,353,Chemical/Drug	triglyceride,392,404,Chemical/Drug	"[{""token"": ""triglyceride"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""IL1RAPL1"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""glycerol kinase"", ""start_span"": 222, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""GK"", ""start_span"": 240, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""hypertriglyceridemia"", ""start_span"": 298, ""end_span"": 318, ""type"": ""Disease/Disorder""}, {""token"": ""glycerol"", ""start_span"": 345, ""end_span"": 353, ""type"": ""Chemical/Drug""}, {""token"": ""triglyceride"", ""start_span"": 392, ""end_span"": 404, ""type"": ""Chemical/Drug""}]"	train
The functional annotation of the structurally and / or functionally modified proteins covers a wide spectrum including enzymes in energy metabolism, protein kinases and phospholipases involved in cellular signaling, enzymes involved in intracellular proteolysis by the proteasome, extracellular matrix metalloproteinases, membrane receptors for neurotransmitter and growth factors, membrane ion transporter and carriers in the plasma membrane, some plasma proteins, cytoskeletal proteins, heat - shock proteins, and proteins involved in translation [ 10, 27, 30 – 35 ].	protein kinases,149,164,Gene/Protein	phospholipases,169,183,Gene/Protein	extracellular matrix metalloproteinases,281,320,Gene/Protein	membrane receptors,322,340,Gene/Protein	membrane ion transporter,382,406,Gene/Protein	cytoskeletal proteins,466,487,Gene/Protein	heat - shock proteins,489,510,Gene/Protein	"[{""token"": ""protein kinases"", ""start_span"": 149, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""phospholipases"", ""start_span"": 169, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""extracellular matrix metalloproteinases"", ""start_span"": 281, ""end_span"": 320, ""type"": ""Gene/Protein""}, {""token"": ""membrane receptors"", ""start_span"": 322, ""end_span"": 340, ""type"": ""Gene/Protein""}, {""token"": ""membrane ion transporter"", ""start_span"": 382, ""end_span"": 406, ""type"": ""Gene/Protein""}, {""token"": ""cytoskeletal proteins"", ""start_span"": 466, ""end_span"": 487, ""type"": ""Gene/Protein""}, {""token"": ""heat - shock proteins"", ""start_span"": 489, ""end_span"": 510, ""type"": ""Gene/Protein""}]"	train
Both natural HZ and 4 - HNE treatment of erythroid cells results in ( i) increased regulatory proteins: p53 ( tumor suppressor protein 53) and p21 ( cyclin - dependent kinase inhibitor 1 ); ( ii) unbalanced phosphorylation of the retinoblastoma protein Rb; ( iii) decreased levels of cyclins A and D.	regulatory proteins,83,102,Gene/Protein	p53,104,107,Gene/Protein	tumor suppressor protein 53,110,137,Gene/Protein	p21,143,146,Gene/Protein	cyclin - dependent kinase inhibitor 1,149,186,Gene/Protein	retinoblastoma protein Rb,230,255,Gene/Protein	cyclins A,284,293,Gene/Protein	"[{""token"": ""regulatory proteins"", ""start_span"": 83, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""tumor suppressor protein 53"", ""start_span"": 110, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""p21"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""cyclin - dependent kinase inhibitor 1"", ""start_span"": 149, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""retinoblastoma protein Rb"", ""start_span"": 230, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""cyclins A"", ""start_span"": 284, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
Intraductal cisplatin treatment in a BRCA - associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice	cisplatin,12,21,Chemical/Drug	BRCA,37,41,Gene/Protein	breast cancer,55,68,Disease/Disorder	mouse,69,74,Organism/Species	tumor,92,97,Disease/Disorder	tumors,132,138,Disease/Disorder	mice,154,158,Organism/Species	"[{""token"": ""cisplatin"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""BRCA"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 55, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""mouse"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""tumors"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Organism/Species""}]"	train
Intraductal cisplatin and olaparib increase tumor - free latency in a mouse model of BRCA1 - associated human breast cancer	cisplatin,12,21,Chemical/Drug	olaparib,26,34,Chemical/Drug	tumor,44,49,Disease/Disorder	mouse,70,75,Organism/Species	BRCA1,85,90,Gene/Protein	human,104,109,Organism/Species	breast cancer,110,123,Disease/Disorder	"[{""token"": ""cisplatin"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""olaparib"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""tumor"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""mouse"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Organism/Species""}, {""token"": ""BRCA1"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""breast cancer"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Disease/Disorder""}]"	train
Despite the obvious species differences in rodents and humans that may underlie the long - term tumor formation after intraductal cisplatin in our used preclinical models, we think that ID administration of solvable cisplatin cannot upfront be regarded as a safe alternative to prevent BRCA - associated breast cancer in genetic carriers.	rodents,43,50,Organism/Species	humans,55,61,Organism/Species	tumor,96,101,Disease/Disorder	cisplatin,130,139,Chemical/Drug	cisplatin,216,225,Chemical/Drug	BRCA,286,290,Gene/Protein	breast cancer,304,317,Disease/Disorder	"[{""token"": ""rodents"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""humans"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Organism/Species""}, {""token"": ""tumor"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Disease/Disorder""}, {""token"": ""cisplatin"", ""start_span"": 130, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""cisplatin"", ""start_span"": 216, ""end_span"": 225, ""type"": ""Chemical/Drug""}, {""token"": ""BRCA"", ""start_span"": 286, ""end_span"": 290, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 304, ""end_span"": 317, ""type"": ""Disease/Disorder""}]"	train
The intracellular TK activity of EGFR is increased as a consequence of binding of various cognate ligands, including EGF, TGFα, and amphiregulin, leading to homodimerization of two EGFRs or heterodimerization of EGFR with other family members [ 43 ].	TK,18,20,Gene/Protein	EGFR,33,37,Gene/Protein	EGF,117,120,Gene/Protein	TGFα,122,126,Gene/Protein	amphiregulin,132,144,Gene/Protein	EGFRs,181,186,Gene/Protein	EGFR,212,216,Gene/Protein	"[{""token"": ""TK"", ""start_span"": 18, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""EGFR"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""EGF"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""TGF\u03b1"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""amphiregulin"", ""start_span"": 132, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""EGFRs"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""EGFR"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
Radiation has also been demonstrated to activate the EGFR signaling pathway by causing the release of TGFα, which is responsible for secondary activation of EGFR, mitogen - activated protein kinase ( MAPK ), and Janus kinase ( JNK) pathways [ 13 ].	EGFR,53,57,Gene/Protein	TGFα,102,106,Gene/Protein	EGFR,157,161,Gene/Protein	mitogen - activated protein kinase,163,197,Gene/Protein	MAPK,200,204,Gene/Protein	Janus kinase,212,224,Gene/Protein	JNK,227,230,Gene/Protein	"[{""token"": ""EGFR"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""TGF\u03b1"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""EGFR"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 163, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase"", ""start_span"": 212, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
DR6 is associated with the regulations on T cell function in several immunological diseases, including experimental autoimmune encephalomyelitis ( EAE ), asthma, and acute graft versus host disease in animal models212223.	DR6,0,3,Gene/Protein	immunological diseases,69,91,Disease/Disorder	experimental autoimmune encephalomyelitis,103,144,Disease/Disorder	EAE,147,150,Disease/Disorder	asthma,154,160,Disease/Disorder	acute graft versus host disease,166,197,Disease/Disorder	animal,201,207,Organism/Species	"[{""token"": ""DR6"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""immunological diseases"", ""start_span"": 69, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""experimental autoimmune encephalomyelitis"", ""start_span"": 103, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""EAE"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Disease/Disorder""}, {""token"": ""asthma"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Disease/Disorder""}, {""token"": ""acute graft versus host disease"", ""start_span"": 166, ""end_span"": 197, ""type"": ""Disease/Disorder""}, {""token"": ""animal"", ""start_span"": 201, ""end_span"": 207, ""type"": ""Organism/Species""}]"	train
Similar to DR6 deficiency, syndecan - 1 deficiency increases the severity of disease, lymphocyte activation, as well as production of antigen - specific plasma cells and immunoglobulins in the peripheral lymphoid organs of EAE, immune complex - mediated murine nephritis, and allergic lung inflammation animal models282930.	DR6,11,14,Gene/Protein	syndecan - 1,27,39,Gene/Protein	immunoglobulins,170,185,Gene/Protein	EAE,223,226,Disease/Disorder	nephritis,261,270,Disease/Disorder	lung inflammation,285,302,Disease/Disorder	animal,303,309,Organism/Species	"[{""token"": ""DR6"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""syndecan - 1"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulins"", ""start_span"": 170, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""EAE"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Disease/Disorder""}, {""token"": ""nephritis"", ""start_span"": 261, ""end_span"": 270, ""type"": ""Disease/Disorder""}, {""token"": ""lung inflammation"", ""start_span"": 285, ""end_span"": 302, ""type"": ""Disease/Disorder""}, {""token"": ""animal"", ""start_span"": 303, ""end_span"": 309, ""type"": ""Organism/Species""}]"	train
Although most CD19 + B cells do not express syndecan - 1, CD19 + autoreactive pre - plasma cells express syndecan - 1 in lupus - prone mice and SLE patients3233.	CD19,14,18,Gene/Protein	syndecan - 1,44,56,Gene/Protein	CD19,58,62,Gene/Protein	syndecan - 1,105,117,Gene/Protein	lupus,121,126,Disease/Disorder	mice,135,139,Organism/Species	SLE,144,147,Disease/Disorder	"[{""token"": ""CD19"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""syndecan - 1"", ""start_span"": 44, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""syndecan - 1"", ""start_span"": 105, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""lupus"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""SLE"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Disease/Disorder""}]"	train
It is an anti - viral cytokine which is regulated by endosomal pattern recognition receptors ( PRRs) such as TLRs or cytosolic PRRs like RIG - I like receptors ( RLRs) ( 18, 19 ).	cytokine,22,30,Gene/Protein	pattern recognition receptors,63,92,Gene/Protein	PRRs,95,99,Gene/Protein	TLRs,109,113,Gene/Protein	PRRs,127,131,Gene/Protein	RIG - I like receptors,137,159,Gene/Protein	RLRs,162,166,Gene/Protein	"[{""token"": ""cytokine"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""pattern recognition receptors"", ""start_span"": 63, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""PRRs"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""TLRs"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""PRRs"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""RIG - I like receptors"", ""start_span"": 137, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""RLRs"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
IFN - α is a heritable risk factor in SLE ( 22, 23) and some people who have received recombinant human IFN - α as a treatment for viral hepatitis C or malignancy have developed de novo SLE which resolves upon discontinuation of the IFN - α treatment ( 24 ).	IFN - α,0,7,Gene/Protein	SLE,38,41,Disease/Disorder	human,98,103,Organism/Species	IFN - α,104,111,Gene/Protein	hepatitis C,137,148,Disease/Disorder	SLE,186,189,Disease/Disorder	IFN - α,233,240,Gene/Protein	"[{""token"": ""IFN - \u03b1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""SLE"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Organism/Species""}, {""token"": ""IFN - \u03b1"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""hepatitis C"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Disease/Disorder""}, {""token"": ""SLE"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - \u03b1"", ""start_span"": 233, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
RBP +, anti - RNA - binding - protein ( RBP) antibody positive; RBP −, RBP antibody negative.	RBP,0,3,Gene/Protein	RNA - binding - protein,14,37,Gene/Protein	RBP,40,43,Gene/Protein	antibody,45,53,Gene/Protein	RBP,64,67,Gene/Protein	RBP,71,74,Gene/Protein	antibody,75,83,Gene/Protein	"[{""token"": ""RBP"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""RNA - binding - protein"", ""start_span"": 14, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene/Protein""}]"	train
AA, African - American; EA, European - American; RBP +, anti - RNA - binding - protein ( RBP) antibody positive; and RBP −, RBP antibody negative.	RBP,49,52,Gene/Protein	RNA - binding - protein,63,86,Gene/Protein	RBP,89,92,Gene/Protein	antibody,94,102,Gene/Protein	RBP,117,120,Gene/Protein	RBP,124,127,Gene/Protein	antibody,128,136,Gene/Protein	"[{""token"": ""RBP"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""RNA - binding - protein"", ""start_span"": 63, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene/Protein""}]"	train
Three IFIGs ( IFIT1, MX1, and PKR) were selected for qPCR analysis to replicate the microarray observation with regards to the association between anti - RBP antibodies and IFN - related gene expression across different ancestral backgrounds.	IFIGs,6,11,Gene/Protein	IFIT1,14,19,Gene/Protein	MX1,21,24,Gene/Protein	PKR,30,33,Gene/Protein	RBP,154,157,Gene/Protein	antibodies,158,168,Gene/Protein	IFN,173,176,Gene/Protein	"[{""token"": ""IFIGs"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""IFIT1"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""MX1"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""PKR"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 158, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
Chronic azithromycin use has no effect on CF MDMs. S1A) Serum ( n = 7) and infected PBMC ( k56, n = 5) IFN - γ levels from CF and non - CF patients separated by patients with (+ azithromycin) and without chronic azithromycin prophylaxis.	azithromycin,8,20,Chemical/Drug	CF,42,44,Disease/Disorder	IFN - γ,103,110,Gene/Protein	CF,123,125,Disease/Disorder	CF,136,138,Disease/Disorder	azithromycin,178,190,Chemical/Drug	azithromycin,212,224,Chemical/Drug	"[{""token"": ""azithromycin"", ""start_span"": 8, ""end_span"": 20, ""type"": ""Chemical/Drug""}, {""token"": ""CF"", ""start_span"": 42, ""end_span"": 44, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - \u03b3"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 136, ""end_span"": 138, ""type"": ""Disease/Disorder""}, {""token"": ""azithromycin"", ""start_span"": 178, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""azithromycin"", ""start_span"": 212, ""end_span"": 224, ""type"": ""Chemical/Drug""}]"	train
According to PPI information from various databases ( Fig. 1a ), Arabidopsis has the most abundant PPI information ( 235, 215 interactions of 17, 962 proteins) followed by rice ( 76, 829 interactions of 5, 219 proteins ), potato ( 42 interactions of 48 proteins ), maize ( 25 interactions of 29 proteins ), soybean ( 10 interactions of 12 proteins ), castor bean ( 10 interactions of 10 proteins ), and poplar ( 8 interactions of 10 proteins) ( Table 1 ).	Arabidopsis,65,76,Organism/Species	rice,172,176,Organism/Species	potato,222,228,Organism/Species	maize,265,270,Organism/Species	soybean,307,314,Organism/Species	castor bean,351,362,Organism/Species	poplar,403,409,Organism/Species	"[{""token"": ""Arabidopsis"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Organism/Species""}, {""token"": ""rice"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Organism/Species""}, {""token"": ""potato"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Organism/Species""}, {""token"": ""maize"", ""start_span"": 265, ""end_span"": 270, ""type"": ""Organism/Species""}, {""token"": ""soybean"", ""start_span"": 307, ""end_span"": 314, ""type"": ""Organism/Species""}, {""token"": ""castor bean"", ""start_span"": 351, ""end_span"": 362, ""type"": ""Organism/Species""}, {""token"": ""poplar"", ""start_span"": 403, ""end_span"": 409, ""type"": ""Organism/Species""}]"	train
Similar to cassava, Arabidopsis and rice also use heat shock protein as the center of communication, but the hub protein in these two plants was heat shock protein 70 ( HSP70) 33, 36.	cassava,11,18,Organism/Species	Arabidopsis,20,31,Organism/Species	rice,36,40,Organism/Species	heat shock protein,50,68,Gene/Protein	plants,134,140,Organism/Species	heat shock protein 70,145,166,Gene/Protein	HSP70,169,174,Gene/Protein	"[{""token"": ""cassava"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Organism/Species""}, {""token"": ""Arabidopsis"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Organism/Species""}, {""token"": ""rice"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""heat shock protein"", ""start_span"": 50, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 134, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""heat shock protein 70"", ""start_span"": 145, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""HSP70"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
These included the F - box family proteins, which were reported to mediate ubiquitination during protein degradation91, and galactose oxidase / kelch repeat superfamily proteins, which functions as substrate - specific adapter proteins in ubiquitin ligase binding92. Figure 8Protein complex of the cassava ubiquitin - conjugating protein ( cassava4. 1_017321m ).	F - box family proteins,19,42,Gene/Protein	galactose oxidase,124,141,Gene/Protein	kelch repeat superfamily proteins,144,177,Gene/Protein	adapter proteins,219,235,Gene/Protein	ubiquitin ligase,239,255,Gene/Protein	cassava,298,305,Organism/Species	ubiquitin - conjugating protein,306,337,Gene/Protein	"[{""token"": ""F - box family proteins"", ""start_span"": 19, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""galactose oxidase"", ""start_span"": 124, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""kelch repeat superfamily proteins"", ""start_span"": 144, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""adapter proteins"", ""start_span"": 219, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitin ligase"", ""start_span"": 239, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""cassava"", ""start_span"": 298, ""end_span"": 305, ""type"": ""Organism/Species""}, {""token"": ""ubiquitin - conjugating protein"", ""start_span"": 306, ""end_span"": 337, ""type"": ""Gene/Protein""}]"	train
Arabidopsis, rice, potato, maize, castor bean, soybean, and poplar) using interolog - based method.	Arabidopsis,0,11,Organism/Species	rice,13,17,Organism/Species	potato,19,25,Organism/Species	maize,27,32,Organism/Species	castor bean,34,45,Organism/Species	soybean,47,54,Organism/Species	poplar,60,66,Organism/Species	"[{""token"": ""Arabidopsis"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Organism/Species""}, {""token"": ""rice"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""potato"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Organism/Species""}, {""token"": ""maize"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""castor bean"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""soybean"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Organism/Species""}, {""token"": ""poplar"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Organism/Species""}]"	train
Overexpression of the T - UCR uc. 158 − could differentiate Wnt / β - catenin dependent HCC from normal liver and from β - catenin negative diethylnitrosamine ( DEN )- induced HCC. uc. 158 − was overexpressed in human HepG2 versus Huh7 cells in line with activation of the Wnt pathway.	Wnt,60,63,Gene/Protein	β - catenin,66,77,Gene/Protein	HCC,88,91,Disease/Disorder	β - catenin,119,130,Gene/Protein	HCC,176,179,Disease/Disorder	human,212,217,Organism/Species	Wnt,273,276,Gene/Protein	"[{""token"": ""Wnt"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 119, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 212, ""end_span"": 217, ""type"": ""Organism/Species""}, {""token"": ""Wnt"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
Hepatocellular carcinoma ( HCC) is the sixth most common malignancy in the world. 1 Despite the progress of recent decades, the outcome of patients with advanced HCC remains poor, and mortality for liver cancer has increased worldwide. 1 Sorafenib is the only drug which is effective in advanced HCC with an improvement of about 3 months in median overall survival. 2 Novel therapies are urgently needed, but their development is challenged by the limited understanding of the molecular mechanisms underlying HCC progression and the subsequent lack of identified targets that drive liver transformation.	Hepatocellular carcinoma,0,24,Disease/Disorder	HCC,27,30,Disease/Disorder	HCC,162,165,Disease/Disorder	liver cancer,198,210,Disease/Disorder	Sorafenib,238,247,Chemical/Drug	HCC,296,299,Disease/Disorder	HCC,509,512,Disease/Disorder	"[{""token"": ""Hepatocellular carcinoma"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Disease/Disorder""}, {""token"": ""HCC"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Disease/Disorder""}, {""token"": ""HCC"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Disease/Disorder""}, {""token"": ""liver cancer"", ""start_span"": 198, ""end_span"": 210, ""type"": ""Disease/Disorder""}, {""token"": ""Sorafenib"", ""start_span"": 238, ""end_span"": 247, ""type"": ""Chemical/Drug""}, {""token"": ""HCC"", ""start_span"": 296, ""end_span"": 299, ""type"": ""Disease/Disorder""}, {""token"": ""HCC"", ""start_span"": 509, ""end_span"": 512, ""type"": ""Disease/Disorder""}]"	train
( C) A tissue microarray of formalin - fixed paraffin - embedded human tissues including 54 intrahepatic cholangiocarcinoma ( ICC ), 31 extrahepatic cholangiocarcinoma ( ECC ), 17 gallbladder cancers ( GBC) and 8 normal liver tissues was assessed for expression of uc. 158 − by RNA in situ hybridisation ( ISH) with AS3 probe.	human,65,70,Organism/Species	intrahepatic cholangiocarcinoma,92,123,Disease/Disorder	ICC,126,129,Disease/Disorder	extrahepatic cholangiocarcinoma,136,167,Disease/Disorder	ECC,170,173,Disease/Disorder	gallbladder cancers,180,199,Disease/Disorder	GBC,202,205,Disease/Disorder	"[{""token"": ""human"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""intrahepatic cholangiocarcinoma"", ""start_span"": 92, ""end_span"": 123, ""type"": ""Disease/Disorder""}, {""token"": ""ICC"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Disease/Disorder""}, {""token"": ""extrahepatic cholangiocarcinoma"", ""start_span"": 136, ""end_span"": 167, ""type"": ""Disease/Disorder""}, {""token"": ""ECC"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Disease/Disorder""}, {""token"": ""gallbladder cancers"", ""start_span"": 180, ""end_span"": 199, ""type"": ""Disease/Disorder""}, {""token"": ""GBC"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Disease/Disorder""}]"	train
( E) Rats with TAA - induced CCA were treated with the CTNNB1 - CTBP inhibitor ICG - 001 ( 5 mg / kg) or PORCN inhibitor C - 59 ( 20 mg / kg) or saline vehicle by intraperitoneal injection three times per week, from week 21 to 26.	Rats,5,9,Organism/Species	CCA,29,32,Disease/Disorder	CTNNB1,55,61,Gene/Protein	CTBP,64,68,Gene/Protein	ICG - 001,79,88,Chemical/Drug	PORCN,105,110,Gene/Protein	C - 59,121,127,Chemical/Drug	"[{""token"": ""Rats"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Organism/Species""}, {""token"": ""CCA"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Disease/Disorder""}, {""token"": ""CTNNB1"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""CTBP"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""ICG - 001"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""PORCN"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""C - 59"", ""start_span"": 121, ""end_span"": 127, ""type"": ""Chemical/Drug""}]"	train
